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IMPLEMENTATION OF A MITOCHONDRIAL
MUTATOR
CROSS-REFERENCE TO RELATED
APPLICATIONS

0001. This application claims priority under 35 U.S.C.
$119 from U.S. Application Ser. No. 60/456,318, filed Mar.
20, 2003, which is incorporated herein in its entirety by
reference.
GOVERNMENT LICENSE RIGHTS

0002 The U.S. Government has a paid-up license in this
invention and the right in limited circumstances to require
the patent owner to license others on reasonable terms as
provided for by the terms of the contracts awarded by the
National Science Foundation and the Department of Energy.

Oct. 21, 2004

Plant Sci. 21,111-126), and the mitochondrial genomes of
plants have acquired Structural and maintenance features
distinct from their animal counterparts.
0006 The plant mitochondrial genome appears to be
organized as a collection of Small circular and large, circu

larly-permuted linear molecules (Oldenburg & Bendich
(2001) Molec. Biol. 310, 549-562; Backert, et al. (1997)
Trend Plant Sci. 2, 477-483), not unlike what has been
postulated for yeast (Maleszka, et al. (1991) EMBO J. 10,
3923-3929; Lecrenier & Foury (2000) Gene 246,37-48).
DNA replication may be conducted by a rolling circle
mechanism, and experimental difficulties identifying repli
cation origins have led to the Suggestion of recombination

mediated replication initiation (Backert & Borner (2000)
Curr. Genet. 37, 304-314). In fact, a distinct feature of plant

mitochondrial genome organization is the prominent role of
recombination.

TECHNICAL FIELD

0003. This invention relates to using molecular and evo
lutionary techniques to identify polynucleotide and polypep
tide Sequences corresponding to commercially relevant traits
in domesticated plants.
BACKGROUND OF THE INVENTION

0004. The plant mitochondrial genome is retained in a
multipartite Structure that arises by a process of repeat
mediated homologous recombination. Low frequency
ectopic recombination also occurs, often producing
Sequence chimeras, aberrant open reading frames, and novel
Subgenomic DNA molecules. This genomic plasticity may
distinguish the plant mitochondrion from mammalian and
fungal types. In plants, relative copy number of recombina
tion-derived subgenomic DNA molecules within mitochon
dria is controlled by nuclear genes, and a genomic shifting
proceSS can result in their differential copy number Suppres
Sion to near-undetectable levels. We have cloned a nuclear

gene that regulates mitochondrial SubStoichoimetric shifting
in Arabidopsis. The CHM gene was shown to encode a
protein related to the MutS protein of E. coli that is involved
in mismatch repair and DNA recombination. We postulate
that the process of SubStoichiometric shifting in plants may
be a consequence of ectopic recombination Suppression or
replication Stalling at ectopic recombination Sites to effect
molecule-Specific copy number modulation.
0005 Argument for the mitochondrion as a central regu
lator of cellular functions has become increasingly perSua
Sive in the past Several years, as information expands

detailing cell metabolic functions (Golden & Melov, (2001)
Mech. Aging Dev. 122, 1577-1589; Naviaux (2000) Eur.
J.Ped. 159, 5219-5226), programmed cell death (Ravagnan,
et al. (2002)1 Cell. Physiol. 192,131-137), and intracellular
signaling (Epstein et al. (2001) Molec. Biol. Cell. 12,297
308). The disclosures of Golden & Melov, Naviaux, and all

other patents and publications referred to herein, are incor
porated herein in their entirety by reference. In higher plants,
mitochondrial functions and behavior have clearly been
influenced by the plant cells unique context. Co-evolution
of mitochondria and chloroplasts has permitted economy of

function via protein dual-targeting (Small, et al. (1998) Plant
Molec. Biol. 38,265-277, Peeters & Small (2001) Biochim.
BiophyS. Acta 1541, 54-63), genome capacity and coding
have been altered (Knoop & Brennicke (2002) Crit. Rev.

0007 High frequency inter- and intra-molecular recom
bination is detected within the higher plant mitochondrial
genome at large repeated Sequences that can be readily

identified by physical mapping (Fauron, et al. (1995) Trends
Genet. 11, 228-235). Their presence in direct orientation

permits the Subdivision of the genome into a collection of
molecules, each containing only a portion of the genetic
information. More intriguing, however, is the common
observation in plants of intragenic ectopic recombination
events that can occur at Sites containing as few as Seven

nucleotides of homology (Andre, et al. (1992) Trends Genet.
8, 128-132). Ectopic recombination results in expressed

gene chimeras that cause cytoplasmic male Sterility, plant

variegation and other aberrant phenotypes (Mackenzie &
Mcintosh (1999) Plant Cell 11, 571-585; Sakamoto, et al.
(1996) Plant Cell 8, 1377-1390).
0008. A phenomenon rendering the plant mitochondrial
genome unusually variable in Structure is termed Substo

ichiometric shifting. First reported in maize (Small, et al.
(1987) EMBO J. 6, 865-869) as the stable presence of

Subgenomic mitochondrial DNA molecules within the
genome at near-undetectable levels, the process appears to
be highly dynamic. Mitochondrial genomic shifting involves
rapid and dramatic changes in relative copy number of
portions of the mitochondrial genome over one generation's

time (Janska, et al. (1998) Plant Cell 10,1163-1180). These
Substoichiometric forms have been estimated at levels as
low as one copy per every 100-200 cells (Arrieta-Montiel, et
al. (2001) Genetics 158, 851-864). Generally the rapid

shifting proceSS involves only a Single Subgenomic DNA
molecule, often containing recombination-derived chimeric

Sequences, and the process is apparently reversible (Janska,
et al., ibid., Kanazawa, et al. (1994) Genetics 138,865-870).

Genomic shifting can alter plant phenotype because the
process activates or Silences mitochondrial Sequences
located on the shifted molecule. Observed phenotypic
changes have included plant tissue culture properties

(Kanazawa, et al., ibid.), leaf variegation and distortion
(Sakamoto, et al., ibid.), and spontaneous reversion to fer
tility in cytoplasmic male Sterile crop plants (Janska, et al.,
ibid., Smith, et al. (1991) Theor. Appl. Genet. 81,793-798).

It has been postulated that SubStoichiometric shifting may
have evolved to permit the Species to create and retain
mitochondrial genetic variation in a Silenced but retrievable

form (Small, et al. (1989) Cell 58, 69-76).
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0009 Mitochondrial Substoichiometric shifting has been
shown in at least two cases to be under nuclear gene control,

sequence SEQ ID NO:1, SEQ ID NO:6, SEQ ID. NO:8,

the nuclear CHM gene results in a green-white leaf varie
gation that, in Subsequent generations, displays maternal

NO:41, SEQ ID NO:43, or SEQ ID NO:45 under stringent
hybridization conditions. In Some embodiments, the protein

involving the Fr gene in Phaseolus vulgaris (Mackenzie &
Chase (1990) Plant Cell 2,905-912) and the CHM gene in
Arabidopsis (Martinez-Zapater, et al. (1992) Plant Cell 4,
889-899; Redei (1973) Mut. Res. 18,149-162). Mutation of
inheritance (Redei, ibid.). The appearance of the variegation

phenotype is accompanied by a Specific rearrangement

(Martinez-Zapater, et al., ibid.) that includes amplification of
a mitochondrial DNA molecule encoding a chimeric

Sequence (Sakamoto, et al., ibid.). Genetic analysis Suggests

that the wildtype form of CHM actively suppresses copy
number of the Subgenomic molecule carrying the chimeric
Sequence. LOSS of proper function of the CHM gene, char
acterized by two available EMS-derived mutant alleles

chm1-1, chm1-2 (Redei, ibid.) and a tissue culture-derived
mutant allele chm1-3 (Martinez-Zapater, et al., ibid.), results

in rapid and Specific copy number amplification of the
Subgenomic molecule, producing the consequent leaf varie
gation. It is not clear whether the copy number amplification
or Suppression of a Single Subgenomic molecule occurs by
differential replication or a recombination mechanism.
SUMMARY OF THE INVENTION

0.010 The present invention provides an isolated nucleic
acid molecule Selected from the group consisting of a
nucleic acid molecule comprising a nucleic acid sequence
selected from the group consisting of SEQID NO:1, SEQID
NO:6, SEQ ID. NO:8, SEQ ID NO:10, SEQ ID NO:11, SEQ
ID NO:13, SEQ ID NO:14, SEQ ID NO:16, SEQ ID NO:18,
SEQ ID NO:21, SEQ ID NO:23, SEQ ID NO:25, SEQ ID
NO:27, SEQ ID NO:28, SEQ ID NO:29, SEQ ID. NO:32,
SEQ ID NO:34, SEQ ID NO:36, SEQ ID NO:37, SEQ ID
NO:38, SEQ ID NO:41, SEQ ID NO:43, and SEQ ID

NO:45; a nucleic acid molecule comprising at least a portion
of any of these nucleic acid molecules, a complement of a
any of these nucleic acid molecules, and a nucleic acid
molecule comprising an allelic variant of a nucleic acid
molecule comprising any of these nucleic acid Sequences.
0011. In some embodiments, the nucleic acid molecule is
a plant nucleic acid molecule, a nucleic acid molecule
Selected from the group consisting of Arabadopsis, Oryza,
Glycine, Hordeum, Zea, Medicago, Allium, Citrus, Solanum,
Sorghum, Saccharum, Nicotiana, LycopersicOn, Triticum,
Zinnia, and Phaseolus nucleic acid molecules, a nucleic acid

molecule Selected from the group consisting of a nucleic
acid molecule comprising a nucleic acid Sequence that
encodes a protein having an amino acid Sequence Selected
from the group consisting of SEQ ID NO:3, SEQ ID NO:7,
SEQ ID NO.:9, SEQ ID NO.12, SEQ ID NO.:15, SEQ ID
NO:17, SEQ ID NO.19, SEQ ID NO.:22,SEQ ID NO.:24,
SEQ ID NO.:26, SEQ ID NO.:31, SEQ ID NO:33, SEQ ID
NO.:35, SEQ ID NO.:40, SEQ ID NO.:42, SEQ ID NO:44,
SEQ ID NO:47, and SEQ ID NO:65; and a nucleic acid

molecule comprising an allelic variant of a nucleic acid
molecule encoding a protein having any of Said amino acid
Sequences.

0012. The present invention also provides an isolated
MSH1 protein. In some embodiment, the protein is encoded
by a plant MSH1 nucleic acid molecule that hybridizes to the
complement of a nucleic acid molecule having a nucleic acid

SEQ ID NO:10, SEQ ID NO:11, SEQ ID NO:13, SEQ ID
NO:14, SEQ ID NO:16, SEQ ID NO:18, SEQ ID NO:21,
SEQ ID NO:23, SEQ ID NO:25, SEQ ID NO:27, SEQ ID
NO:28, SEQ ID NO:29, SEQ ID. NO:32, SEQ ID NO:34,
SEQ ID NO:36, SEQ ID NO:37, SEQ ID NO:38, SEQ ID

is SEQ ID NO:3, SEQ ID NO:7, SEQ ID NO.:9, SEQ ID
NO.:12, SEQ ID NO.:15, SEQ ID NO:17, SEQ ID NO.:19,
SEQ ID NO.:22,SEQ ID NO.:24, SEQ ID NO.:26, SEQ ID
NO.:31,SEQ ID NO:33, SEQ ID NO.:35, SEQ ID NO.:40,
SEQ ID NO.:42, SEQ ID NO:44, SEQ ID NO:47 or SEQ ID

NO:65, or a protein comprising at least a portion of an amino
acid Sequence Selected from the group consisting of SEQ ID
NO:3, SEQID NO:7, SEQ ID NO.:9, SEQID NO.12, SEQ
ID NO.:15, SEQ ID NO:17, SEQ ID NO.:19, SEQ ID
NO.:22,SEQ ID NO.:24, SEQ ID NO.:26, SEQ ID NO.:31,
SEQ ID NO:33, SEQ ID NO.:35, SEQ ID NO.:40, SEQ ID
NO.:42, SEQ ID NO:44, SEQ ID NO.47 and SEQ ID
NO:65.

0013 The present invention also provides a method to
identify a compound capable of inhibiting MSH1 activity of
a plant, Said method comprising: contacting an isolated plant
MSH1 nucleic acid molecule selected from the group con
sisting of SEQ ID NO:1, SEQ ID NO:6, SEQ ID. NO:8,
SEQ ID NO:10, SEQ ID NO:11, SEQ ID NO:13, SEQ ID
NO:14, SEQ ID NO:16, SEQ ID NO:18, SEQ ID NO:21,

SEO ID NO:23, SEQ ID NO:25, SEQ ID NO:27, SEQ ID
NO:28, SEQ ID NO:29, SEQ ID. NO:32, SEQ ID NO:34,
SEQ ID NO:36, SEQ ID NO:37, SEQ ID NO:38, SEQ ID

NO:41, SEQ ID NO:43, and SEQ ID NO:45 with a putative
inhibitory compound which, in the absence of Said com
pound, said plant MSH1 nucleic acid molecule has the
activity of Suppressing ectopic recombination; and deter
mining if Said putative inhibitory compound inhibits Said
activity. In Some embodiments, the putative inhibitory com
pound is a RNA molecule suspected of having RNAi activ
ity. The invention also provides compounds identified by the
method

0014 Further provided is a method for identification of
plant mutants arising from mitochondrial ectopic recombi
nation comprising providing a plant, Suppressing expression
of an MSH1-homologous gene in the plant, and detecting an
aberrant phenotype,
0015 whereby a plant mutant is identified. In some
embodiments, the Suppression is effected by a com
pound identified by the above-described method. In
Some embodiments, the aberrant phenotype is cyto
plasmic male Sterility. The invention also provides
plant mutants identified by the method of claim 12.
BRIEF DESCRIPTION OF THE FIGURES

0016 FIG. 1. Positional cloning of the CHM candidate
locus. The use of molecular markers permitted the estab

lishment of a genetic map (A) and identification of the
intervening overlapping bacterial artificial chromosome
clones for physical mapping (B) All physical mapping
information was derived from the Arabidopsis Genome

Initiative (50). High resolution mapping with three markers

permitted delimitation of the locus to a 80-kb interval
contained within a single bacterial artificial chromosome
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clone (C) A gene candidate was identified within the interval

based on predicted mitochondrial targeting features. The

candidate CHM locus contains 22 exons (D) with two

MutS-like conserved intervals denoted by red lines. Analysis
of two EMS-derived mutants, chm1-1 and chm1-2, and one
tissue culture-derived mutant chm1-3, as well as two TDNA

insertion mutations (T1 and T2), provided definitive evi
dence of CHM identity (E). The numbers in parentheses in
(A) correspond to the number of recombinants identified
between the marker and the gene.
0017 FIG. 2. Alignment of AtMSH1 with MutS and
MutS homologs. The amino acid Sequence alignment was
performed using the ClustalW Software and includes the
MutS sequence from E. coli, MSH1 from Saccharomyces

cerevisiae, and AtMSH6 and CHM (AtMSH1) from Arabi
dopsis. (A) Alignment of the region of the DNA-binding
domain that encompasses the conserved motif for mismatch

recognition and DNA binding. (B) Alignment of a portion of
the ATPase domain. The characteristic motifs for this

domain are indicated by red lines. M1-Walker motif,

M2-ST motif, M3–DE motif (Walker B motif); M4–TH
motif (Obmolova, et al. (2000) Nature 407,703-710; Lam
ers, et al. (2000) Nature, 407, 711-717). The asterisks (*)

indicate residues that are identical and the arrow indicates
the Site of amino acid Substitution in mutant chur1-3.

0018 FIG. 3. Alignment of MSH proteings.
DETAILED DESCRIPTION OF THE
INVENTION

0019. The present invention provides a plant nuclear gene
and corresponding gene product, in Arabidopsis thaliana
that influences mitochondrial genome organization. The
gene is designated AtMSH1, and it is believed to SuppreSS

ectopic (illegitimate) recombination of the mitochondrial

genome. The present invention provides for isolated MSH1
proteins, isolated MSH1 nucleic acid molecules, antibodies
directed against MSH1 proteins and other inhibitors of
MSH1 activity. As used herein, the terms isolated MSH1
proteins and isolated MSH1 nucleic acid molecules refers to
MSH1 proteins and esterase nucleic acid molecules derived
from plants and, as Such, can be obtained from their natural
Source or can be produced using, for example, recombinant
nucleic acid technology or chemical Synthesis. The term
“plant” refers to an individual living plant or population of
Same, a species, Subspecies, variety, cultivar or Strain. In
Some preferred embodiments, the domesticated organism is
a plant Selected from the group consisting of maize, wheat,
rice, Sorghum, tomato or potato, or any other domesticated
plant of commercial interest. A "plant' is any plant at any
Stage of development, including a Seed plant. Also included
in the present invention is the use of these proteins, nucleic
acid molecules, antibodies and inhibitors to generate trans
genic plants, and mutant plants, as well as in other applica
tions, Such as those disclosed below.

0020. The present invention is the result of studies inves
tigating the unusual plant phenomenon of mitochondrial
Subtoichiometric shifting and the role of the nuclear gene
CHM. This gene, located on chromosome III, was shown to
encode a protein that is targeted to mitochondria and that has
homology to a yeast mitochondrial MutS protein. A Sum
mary of this investigation is provided in the EXAMPLES
Section.
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0021 MSH1 proteins and nucleic acid molecules of the
present invention have utility because they represent novel
targets for modulation which would effect mitochondrial
ectopic recombination. The products and processes of the
present invention are advantageous because they enable the
express and inhibition of processes that involve MSH1.
While not being bound by theory, it is believed these newly
discovered proteins have contributed adaptive advantage by
a strategy that may be unique to the Plant Kingdom.
0022 A. MSH1 Polypeptides
0023. One embodiment of the present invention is an
isolated plant MSH1 polypeptide. As used herein, an MSH1
polypeptide, in one embodiment, is a polypeptide that is

related to (i.e., bears structural Similarity to) the A. thaliana
polypeptide of about 1118 amino acids and having the
sequence depicted in FIG. 3 (SEQ ID NO:3). The original
identification of Such a polypeptide is detailed in the
Examples.
0024. A preferred MSH1 polypeptide is encoded by a
polynucleotide that hybridizes under Stringent hybridization

conditions to a gene encoding an MSH1 polypeptide (i.e., an
A. thaliana gene). It is to be noted that the term “a” or “an”

entity refers to one or more of that entity; for example, a
gene refers to one or more genes or at least one gene. AS

such, the terms “a” (or “an”), “one or more” and “at least

one' can be used interchangeably herein. It is also to be
noted that the terms “comprising,”“including,” and “having
can be used interchangeably.
0025 AS used herein, stringent hybridization conditions
refer to standard hybridization conditions under which poly
nucleotides, including oligonucleotides, are used to identify
molecules having similar nucleic acid Sequences. Such stan
dard conditions are disclosed, for example, in Sambrook et
al., MOLECULAR CLONING: A LABORATORY

MANUAL, Cold Spring Harbor Labs Press, 1989. Examples
of Such conditions are provided in the Examples Section of
the present application.
0026. As used herein, an A. thaliana AtMSH1 gene
includes all nucleic acid Sequences related to a natural A.
thaliana AtMSH1 gene Such as regulatory regions that
control production of the A. thaliana AtMSH1 polypeptide

encoded by that gene (such as, but not limited to, transcrip
tion, translation or post-translation control regions) as well
as the coding region itself. In one embodiment, an A.
thaliana AtMSH1 gene includes the nucleic acid Sequence
SEQ ID NO:1. Nucleic acid sequence SEQ ID NO:X

represents the deduced sequence of a cDNA (complemen
tary DNA) polynucleotide, the production of which is dis
closed in the Examples. It should be noted that Since nucleic
acid Sequencing technology is not entirely error-free, SEQ

ID NO:1 (as well as other sequences presented herein), at

best, represents an apparent nucleic acid Sequence of the
polynucleotide encoding an A. thaliana AtMSH1 polypep
tide of the present invention.
0027. In another embodiment, an A. thaliana AtMSH1
gene can be an allelic variant that includes a similar but not
identical sequence to SEQ ID NO:1. During higher plant
evolution, natural allelic variation for the MSH1 locus likely
revealed the adaptive advantage that arises from Sporadic
copy number modulation of mitochondrial genomic Vari
ants. Some of these variants, when amplified, condition male
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Sterility that could facilitate advantageous outcrossing activ

ity in natural populations (Arrieta-Montiel, et al., ibid.). An
allelic variant of an A. thaliana AtMSH1 gene including

SEQ ID NO: 1 is a locus (or loci) in the genome whose
activity is concerned with the same biochemical or devel
opmental processes, and/or a gene that that occurs at essen
tially the same locus as the gene including SEQ ID NO:1,
but which, due to natural variations caused by, for example,
mutation or recombination, has a similar but not identical

Sequence. Because genomes can undergo rearrangement, the
physical arrangement of alleles is not always the same.
Allelic variants typically encode polypeptides having Simi
lar activity to that of the polypeptide encoded by the gene to
which they are being compared. Allelic variants can also
comprise alterations in the 5' or 3' untranslated regions of the

gene (e.g., in regulatory control regions). Allelic variants are

well known to those skilled in the art and would be expected
to be found within a given cultivar or Strain Since the
genome is diploid and/or among a population comprising
two or more cultivars or Strains.

0028. According to the present invention, an isolated, or
biologically pure, polypeptide, is a polypeptide that has been
removed from its natural milieu. AS Such, "isolated” and

“biologically pure” do not necessarily reflect the extent to
which the polypeptide has been purified. An isolated MSH1
polypeptide of the present invention can be obtained from its
natural Source, can be produced using recombinant DNA
technology or can be produced by chemical Synthesis. An
MSH1 polypeptide of the present invention may be identi
fied by its ability to perform the function of natural MSH1
in a functional assay. By “natural MSH1 polypeptide,” it is
meant the full length MSH1 polypeptide of A. thaliana. The
phrase “capable of performing the function of a natural
MSH1 in a functional assay” means that the polypeptide has
at least about 10% of the activity of the natural polypeptide
in the functional assay. In other embodiments, the MSH1
polypeptide has at least about 20% of the activity of the
natural polypeptide in the functional assay. In other embodi
ments, the MSH1 polypeptide has at least about 30% of the
activity of the natural polypeptide in the functional assay. In
other embodiments, the MSH1 polypeptide has at least
about 40% of the activity of the natural polypeptide in the
functional assay. In other embodiments, the MSH1 polypep
tide has at least about 50% of the activity of the natural
polypeptide in the functional assay. In other embodiments,
the polypeptide has at least about 60% of the activity of the
natural polypeptide in the functional assay. In other embodi
ments, the polypeptide has at least about 70% of the activity
of the natural polypeptide in the functional assay. In other
embodiments, the polypeptide has at least about 80% of the
activity of the natural polypeptide in the functional assay. In
Still other embodiments, the polypeptide has at least about
90% of the activity of the natural polypeptide in the func
tional assay. Examples of functional assays are detailed
elsewhere in this specification.
0029. As used herein, an isolated plant MSH1 polypep
tide can be a full-length polypeptide or any homologue of
Such a polypeptide. Examples of MSH1 homologues include
MSH1 polypeptides in which amino acids have been deleted

(e.g., a truncated version of the polypeptide, Such as a
peptide), inserted, inverted, Substituted and/or derivatized
(e.g., by glycosylation, phosphorylation, acetylation, myri

Stylation, prenylation, palmitoylation, amidation and/or
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addition of glycerophosphatidyl inositol) Such that the

homolog has natural MSH1 activity.
0030. In one embodiment, when the homologue is admin
istered to an animal as an immunogen, using techniques
known to those skilled in the art, the animal will produce a
humoral and/or cellular immune response against at least
one epitope of a natural MSH1 polypeptide. MSH1 homo
logues can also be Selected by their ability to perform the
function of MSH1 in a functional assay.
0031 Plant MSH1 polypeptide homologues can be the
result of natural allelic variation or natural mutation. MSH1

polypeptide homologues of the present invention can also be
produced using techniques known in the art including, but
not limited to, direct modifications to the polypeptide or
modifications to the gene encoding the polypeptide using,
for example, classic or recombinant DNA techniques to
effect random or targeted mutagenesis.
0032. In accordance with the present invention, a mime
tope refers to any compound that is able to mimic the ability
of an isolated plant MSH1 polypeptide of the present
invention to perform the function of an MSH1 polypeptide
of the present invention in a functional assay. Examples of
mimetopes include, but are not limited to, anti-idiotypic
antibodies or fragments thereof, that include at least one
binding Site that mimics one or more epitopes of an isolated
polypeptide of the present invention; non-polypeptideaceous

immunogenic portions of an isolated polypeptide (e.g.,
carbohydrate structures); and synthetic or natural organic
molecules, including nucleic acids, that have a structure
Similar to at least one epitope of an isolated polypeptide of
the present invention. Such mimetopes can be designed
using computer-generated Structures of polypeptides of the
present invention. Mimetopes can also be obtained by gen
erating random Samples of molecules, Such as oligonucle
otides, peptides or other organic molecules, and Screening
Such Samples by affinity chromatography techniques using
the corresponding binding partner.
0033. The minimal size of an MSH1 polypeptide homo
logue of the present invention is a size Sufficient to be
encoded by a polynucleotide capable of forming a stable
hybrid with the complementary Sequence of a polynucle
otide encoding the corresponding natural polypeptide. AS
Such, the size of the polynucleotide encoding Such a
polypeptide homologue is dependent on nucleic acid com
position and percent homology between the polynucleotide
and complementary Sequence as well as upon hybridization

conditions per Se (e.g., temperature, Salt concentration, and
formamide concentration). It should also be noted that the
extent of homology required to form a stable hybrid can vary
depending on whether the homologous Sequences are inter

spersed throughout the polynucleotides or are clustered (i.e.,
localized) in distinct regions on the polynucleotides. The

minimal Size of Such polynucleotides is typically at least
about 12 to about 15 nucleotides in length if the polynucle
otides are GC-rich and at least about 15 to about 17 bases in

length if they are AT-rich. Preferably, the polynucleotide is
at least 12 bases in length.
0034. As such, the minimal size of a polynucleotide used
to encode an MSH1 polypeptide homologue of the present
invention is from about 12 to about 18 nucleotides in length.
There is no limit, other than a practical limit, on the maximal
Size of Such a polynucleotide in that the polynucleotide can
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include a portion of a gene, an entire gene, or multiple genes,
or portions thereof. Similarly, the minimal size of an MSH1
polypeptide homologue of the present invention is from
about 4 to about 6 amino acids in length, with preferred sizes
depending on whether a full-length, fusion, multivalent, or
functional portions of Such polypeptides are desired. Pref
erably, the polypeptide is at least 30 bases in length.
0035) Any plant MSH1 polypeptide is a suitable polypep
tide of the present invention. Suitable plants from which to

isolate MSH1 polypeptides (including isolation of the natu

ral polypeptide or production of the polypeptide by recom

binant or synthetic techniques) include maize, wheat, barley,
rye, millet, chickpea, lentil, flax, olive, fig almond, pistachio,
walnut, beet, parSnip, citrus fruits, including, but not limited
to, Orange, lemon, lime, grapefruit, tangerine, minneola, and
tangelo, Sweet potato, bean, pea, chicory, lettuce, cabbage,
cauliflower, broccoli, turnip, radish, Spinach, asparagus,
onion, garlic, pepper, celery, Squash, pumpkin, hemp, Zuc
chini, apple, pear, quince, melon, plum, cherry, peach,
nectarine, apricot, Strawberry, grape, raspberry, blackberry,
pineapple, avocado, papaya, mango, banana, Soybean,
tomato, Sorghum, Sugarcane, Sugarbeet, Sunflower, rapeseed,
clover, tobacco, carrot, cotton, alfalfa, rice, potato, eggplant,
cucumber, Arabidopsis, and Woody plants Such as conifer
ous and deciduous trees, with Soybean, tomato, potato, rice,
wheat, and barley being preferred.
0036) A preferred plant MSH1 polypeptide of the present
invention is a compound that when expressed or modulated
in a plant, is capable of Suppressing ectopic recombination
of the mitochondrial genome.
0037. One embodiment of the present invention is a
fusion polypeptide that includes an MSH1 polypeptide
containing domain attached to a fusion Segment. Inclusion
of a fusion segment as part of a MSH1 polypeptide of the
present invention can enhance the polypeptide's Stability
during production, Storage and/or use. Depending on the
Segment's characteristics, a fusion Segment can also act as
an immunopotentiator to enhance the immune response
mounted by an animal immunized with an MSH1 polypep
tide containing Such a fusion Segment. Furthermore, a fusion
Segment can function as a tool to Simplify purification of an
MSH1 polypeptide, such as to enable purification of the
resultant fusion polypeptide using affinity chromatography.
A Suitable fusion Segment can be a domain of any size that

has the desired function (e.g., imparts increased Stability,
Simplifies purification of a polypeptide). It is within the

imparts increased immunogenicity to a polypeptide, and/or
Scope of the present invention to use one or more fusion
Segments. Fusion Segments can be joined to amino and/or
carboxyl termini of the MSH1-containing domain of the
polypeptide. Linkages between fusion Segments and MSH1
containing domains of fusion polypeptides can be Suscep
tible to cleavage in order to enable Straightforward recovery
of the MSH1-containing domains of such polypeptides.
Fusion polypeptides are preferably produced by culturing a
recombinant cell transformed with a fusion polynucleotide
that encodes a polypeptide including the fusion Segment
attached to either the carboxyl and/or amino terminal end of
a MSH1-containing domain.
0.038 Exemplary fusion segments for use in the present
invention include a glutathione binding domain; a metal
binding domain, Such as a poly-histidine Segment capable of
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binding to a divalent metalion; an immunoglobulin binding
domain, such as Polypeptide A, Polypeptide G, T cell, B cell,
Fc receptor or complement polypeptide antibody-binding
domains, a Sugar binding domain Such as a maltose binding
domain from a maltose binding polypeptide; and/or a “tag”

domain (e.g., at least a portion off-galactosidase, a Strep tag

peptide, other domains that can be purified using compounds

that bind to the domain, Such as monoclonal antibodies).

Other fusion Segments Suitable for use in the invention
include metal binding domains, Such as a poly-histidine
Segment; a maltose binding domain; a Strep tag peptide.
0039) Preferred plant MSH1 polypeptides of the present
invention are Arabadopsis MSH1 polypeptides, soybean
MSH1 polypeptides, tomato MSH1 polypeptides, rice
MSH1 polypeptides, and common bean MSH1 polypep
tides. Other preferred plant MSH polypeptides include corn
MSH1 polypeptides, wheat MSH1 polypeptides, Sugar cane
MSH1 polypeptides, medicago MSH1 polypeptides, onion
MSH1 polypeptides, orange MSH1 polypeptides, Zinnia
MSH1 polypeptides, tobacco MSH1 polypeptides, and bar
leyMSH1 polypeptides.
0040. One preferred A. thaliana AtMSH1 polypeptide of
the present invention is a polypeptide encoded by an A.
thaliana polynucleotide that hybridizes under Stringent
hybridization conditions with complements of polynucle
otides represented by SEQ ID NO:1. Such an AtMSH1
polypeptide is encoded by a polynucleotide that hybridizes
under Stringent hybridization conditions with a polynucle
otide having nucleic acid sequence SEQ ID NO:1.
0041. Inspection of AtMSH1 genomic nucleic acid
Sequences indicates that the genes comprise Several regions,
including an ATP-binding domain, comprised of four well

conserved motifs designated M1-M4 (Obimolova, et al.,
ibid.; FIG. 2B), and a DNA binding domain (aa 129-206)
containing the aromatic doublet (FY) motif.
0042 Translation of SEQ ID NO:1 suggests that the A.

thaliana AtMSH1 polynucleotide includes an open reading
frame. The reading frame encodes an A. thaliana AtMSH1
polypeptide of about 1118 amino acids, the deduced amino
acid sequence of which is represented herein as SEQ ID
NO:3, assuming an open reading frame having an initiation

(start) codon Spanning from about nucleotide 124 through
about nucleotide 126 of SEQ ID NO:1 and a termination

(stop) codon Spanning from about nucleotide 3478 through
about nucleotide 3480 of SEO ID NO:1.

0043. Similarly, translation of SEQ ID NO:20 suggests
that the Oryza sativa MSH1 polynucleotide includes an open
reading frame. The reading frame encodes an Oryza Sativa
MSH polypeptide of about 1132 amino acids, the deduced
amino acid Sequence of which is represented herein as SEQ
ID NO:22, assuming an open reading frame having an

initiation (start) codon Spanning from about nucleotide 1

through about nucleotide 3 of SEQ ID NO:22 and a termi

nation (Stop) codon Spanning from about nucleotide 3394
through about nucleotide 3396 of SEQ ID NO:20.
0044 Similarly, translation of SEQ ID NO:29 suggests
that the Glycine max MSH1 polynucleotide includes an open
reading frame. The reading frame encodes an Glycine max
MSH polypeptide of about 1130 amino acids, the deduced
amino acid Sequence of which is represented herein as SEQ
ID NO:31, assuming an open reading frame having an
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initiation (start) codon Spanning from about nucleotide 1

through about nucleotide 3 of SEQ ID NO:29 and a termi

nation (stop) codon Spanning from about nucleotide 3391

through about nucleotide 3393 of SEQ ID NO:20.
0045 Similarly, translation of SEQ ID NO:38 suggests
that the Lycopersicon esculentum MSH1 polynucleotide
includes an open reading frame. The reading frame encodes
an Lycopersicon esculentum MSH polypeptide of about
1124 amino acids, the deduced amino acid Sequence of
which is represented herein as SEQ ID NO:40, assuming an

open reading frame having an initiation (start) codon Span
ning from about nucleotide 1 through about nucleotide 3 of

SEQ ID NO:38 and a termination (stop) codon spanning
from about nucleotide 3369 through about nucleotide 3371
of SEO ID NO:20.
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0050. These plant MSH1 polypeptides, and the poly
nucleotides that encode them, represent novel compounds
with utility in ectopic recombination of the mitochondrial
genome.

0051) Preferred plant MSH1 polypeptides of the present
invention include polypeptides comprising amino acid
Sequences that are at least about 30%, preferably at least
about 50%, more preferably at least about 75% and even
more preferably at least about 90% identical to one or more
of the amino acid Sequences disclosed herein for A. thaliana
AtMSH1 polypeptides of the present invention. More pre
ferred plant MSH1 polypeptides of the present invention
include: polypeptides encoded by at least a portion of SEQ
ID NO.1, SEQ ID NO.:20, SEQ ID NO.:29, SEQ ID
NO.:38 and/or SEO ID NO:45 and, as Such, have amino acid

0046) Similarly, translation of SEQ ID NO:45 suggests
that the Phaseolus vulgaris MSH1 polynucleotide includes
an open reading frame. The reading frame encodes an
Phaseolus vulgaris MSH polypeptide of about 1126 amino
acids, the deduced amino acid Sequence of which is repre
sented herein as SEQ ID NO:47, assuming an open reading

sequences that include at least a portion of SEQ ID NO:3,

frame having an initiation (start) codon Spanning from about
nucleotide 1 through about nucleotide 3 of SEQ ID NO:45

SEQ ID NO:47. Also preferred are polypeptides that have
amino acid Sequences that include at least a portion of SEQ

otide 3379 through about nucleotide 3381 of SEQ ID

ID NO:7, SEQ ID NO.:9, SEQ ID NO.12, SEQ ID NO.:15,
SEQ ID NO:17, SEQ ID NO.:19, SEQ ID NO.:24, SEQ ID
NO.:26, SEQ ID NO:33, SEQ ID NO.:35, SEQ ID NO.:42,

and a termination (stop) codon spanning from about nucle
NO:2O.

0047. Additional EST sequences having at least 60%
sequence identity to a portion of SEQ ID NO.1 or a
complement of SEQ ID NO:1 have been found. These

include MSH1 polynucleotides from corn (SEQ ID NO:11),
potato (SEQ ID NO:18), wheat (SEQ ID NO:41), sugar cane
(SEQ ID NO:32 and SEQ ID NO:34), medicago (SEQ ID
NO:13), onion (SEQ ID NO:14), orange (SEQ ID NO:16),
zinnia (SEQ ID NO:43), tobacco (SEQ ID NO:36), and
barley (SEQ ID NO:6, SEQ ID NO:8, SEQ ID NO:10).

Polypeptides encoded by the foregoing nucleic acid mol
ecules can be deduced using methods well known in the art.
In general, the polynucleotide or its complement is aligned
with the Arabidopsis AtMSH1 polynucleotide, a reading
frame is determined, and the resulting polypeptide Sequence
is translasted. Polypeptides encoded by the foregoing
nucleic acid molecules or their complements include corn

(SEQ ID NO:12), potato (SEQ ID NO:19), wheat (SEQ ID
NO:42), sugar cane (SEQ ID NO:33 and SEQ ID NO:35),
onion (SEQ ID NO:15), orange (SEQ ID NO:17), Zinnia
(SEQ ID NO:44), and barley (SEQ ID NO:7, SEQ ID
NO:9), and consensus (SEQ ID NO:65).
0.048 Comparison of the various A. thaliana, soybean,
corn, tomato, potato, rice, wheat, common bean, Sugar cane,
medicago, onion, orange, Zinnia, tobacco, and barley MSH1
nucleic acid Sequences and amino acid Sequences described
herein indicates that these species of plants possess similar
MSH1 genes and polypeptides. The nucleotide Sequences of
the coding region of MSH1 from the various plants have
>60% sequence identity when compared to each other,
which makes clear that they are homologous.
0049 Finding this degree of identity between soybean,
corn, tomato, potato, rice, wheat, common bean, Sugar cane,
medicago, onion, orange, Zinnia, tobacco, and barley MSH1
nucleic acid Sequences and amino acid Sequences Supports
the ability to obtain any plant MSH1 polypeptide and
polynucleotide given the polypeptide and nucleic acid
Sequences disclosed herein.

SEQ ID NO.:22, SEQ ID NO.:31, SEQ ID NO.:40 and/or

SEQ ID NO:47; polypeptides encoded by at least a portion
of SEQ ID NO:1, SEQ ID NO.:20, SEQ ID NO.:29, SEQ ID
NO.:38 and/or SEO ID NO:45 and, as Such, have amino acid

sequences that include at least a portion of SEQ ID NO:3,
SEQ ID NO.:22, SEQ ID NO.:31, SEQ ID NO.:40 and/or

and/or SEQID NO:44; and polypeptides encoded by at least
a portion of SEQ ID NO:6, SEQ ID NO.:8, SEQ ID NO.:10,
SEQ ID NO.:11, SEQ ID NO:13, SEQ ID NO.:14, SEQ ID
NO.:16, SEQ ID NO.:18, SEQ ID NO:23, SEQ ID NO.:25,
SEQ ID NO.:26, SEQ ID NO.:27, SEQ ID NO.:28, SEQ ID
NO.:30, SEQ ID NO:32, SEQ ID NO.:34, SEQ ID NO.:36,
SEQ ID NO.:37, SEQ ID NO.:41, and/or SEQ ID NO:43, or

a complement of any of the foregoing SEQID NO:s. As used
herein, “at least a portion' of a polynucleotide or polypep
tide means a portion having the minimal size characteristics
of Such Sequences, as described above, or any larger frag
ment of the full length molecule, up to and including the full
length molecule. For example, a portion of a polynucleotide
may be 12 nucleotides, 13 nucleotides, 14 nucleotides, 15
nucleotides, and So on, going up to the full length poly
nucleotide. Similarly, a portion of a polypeptide may be 4
amino acids, 5 amino acids, 6 amino acids, 7 amino acids,

and So on, going up to the full length polypeptide. The length
of the portion to be used will depend on the particular
application. AS discussed above, a portion of a polynucle
otide useful as hybridization probe may be as short as 12
nucleotides. A portion of a polypeptide useful as an epitope
may be as short as 4 amino acids. A portion of a polypeptide
that performs the function of the full-length polypeptide
would generally be longer than 4 amino acids.
0.052 Particularly preferred plant MSH1 polypeptides of
the present invention are polypeptides that include SEQ ID
NO:3, SEQID NO:7, SEQ ID NO.:9, SEQID NO.12, SEQ
ID NO.:15, SEQ ID NO:17, SEQ ID NO.:19, SEQ ID
NO.:22,SEQ ID NO.:24, SEQ ID NO.:26, SEQ ID NO.:31,
SEQ ID NO:33, SEQ ID NO.:35, SEQ ID NO.:40, SEQ ID
NO.:42, SEQ ID NO:44, SEQ ID NO:47 and/or SEQ ID

NO:65 (including, but not limited to the encoded polypep

tides, full-length polypeptides, processed polypeptides,

fusion polypeptides and multivalent polypeptides thereof) as

well as polypeptides that are truncated homologues of
polypeptides that include at least portions of the aforemen
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tioned SEQ ID NOS. Examples of methods to produce such
polypeptides are disclosed herein, including in the Examples
Section.

0053 Plant MSH1 polypeptides may have DNA binding
and ATPase activities. Identification of the chm1-3 mutation

as a cysteine-tyrosine substitution within the predicted ATP
binding domain does Suggest the importance of this region
to protein function. Substitution of the bulkier tyrosine
would likely create distortion in the region, affecting ATP
binding or hydrolysis.
0.054 Mismatch repair components appear to be involved
in not only the binding and excision of nucleotide mis
matches during the replication process, but also Suppression

of ectopic recombination (Harfe & Jinks-Robertson (2000)
Annu. Rev. Genet. 34, 359-399; Chen & Jinks-Robertson

(1999) Genetics 151,1299-1313). Investigation of the mito

chondrial SubStoichometric shifting phenomenon Suggests
two alternative models for the influence of MSH1. It is

conceivable that the MSH1 gene has shared or relinquished
its mismatch repair function, Such that its primary role in the
plant mitochondrial genome is to regulate non-homologous
recombination. Disruption of MSH1 could, thus, result in
the enhancement of intra-molecular ectopic recombination
activity detected as apparent amplification of novel mito
chondrial DNA forms. A possible weakness in this model
arises in reports that Several plant Systems with mitochon
drial DNA molecules susceptible to shifting appear to be
derived from a DNA exchange that involved at least one
molecular form no longer present in high copy number.
Some also appeared to contain unique Sequences. Therefore,
the shifted molecules were thought to replicate autono

mously (Andre, et al., ibid; Kanazawa, et al., ibid.; , Janska
& Mackenzie (1993) Genetics 135,869-879).
0055) If mitochondrial DNA molecules that undergo

shifting are, in fact, replicated autonomously, an alternative
model for molecule-Specific SubStoichiometric shifting
might apply. The Arabidopsis MSH1 product likely partici
pates as a component of the DNA replication apparatus.
Mitochondrial DNA molecules Subject to copy number
shifting may have originated by earlier ectopic recombina
tion events during the evolution of the lineage. In this case,
the resulting chimeric Sites might Serve to trigger a proceSS
of site-specific replication stalling by the MSH1 protein
during vegetative growth.
0056 Both models assume that the replicative form of the

mitochondrial genome within meristematic (undifferenti
ated) tissues differs from that of vegetative (Somatic).

Hence, Stoichiometric shifting events in vegetative tissues
do not condition irreversible loSS of the Suppressed genetic
information. Presumably, the complete mitochondrial

genetic complement is retained within the transmitting (mer
istematic) tissues (Arrieta-Montiel, et al., Janska & Mack
enzie, ibid.).
0057 B. MSH1 Polynucleotides
0.058. One embodiment of the present invention is an

isolated plant polynucleotide that hybridizes under Stringent
hybridization conditions with an A. thaliana AtMSH1 gene.
The identifying characteristics of Such genes are heretofore
described. A polynucleotide of the present invention can
include an isolated natural plant MSH1 gene or a homologue
thereof, the latter of which is described in more detail below.
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A polynucleotide of the present invention can include one or
more regulatory regions, full-length or partial coding
regions, or combinations thereof. The minimal size of a
polynucleotide of the present invention is the minimal size
that can form a stable hybrid with one of the aforementioned
genes under Stringent hybridization conditions. Suitable and
preferred plants are disclosed above.
0059. In accordance with the present invention, an iso
lated polynucleotide is a polynucleotide that has been

removed from its natural milieu (i.e., that has been Subject
to human manipulation). AS Such, "isolated” does not reflect
the extent to which the polynucleotide has been purified. An
isolated polynucleotide can include DNA, RNA, or deriva
tives of either DNA or RNA.

0060 An isolated plant MSH1 polynucleotide of the
present invention can be obtained from its natural Source

either as an entire (i.e., complete) gene or a portion thereof
capable of forming a stable hybrid with that gene. An
isolated plant MSH1 polynucleotide can also be produced

using recombinant DNA technology (e.g., polymerase chain
reaction (PCR) amplification, cloning) or chemical Synthe
sis. Isolated plant MSH1 polynucleotides include natural
polynucleotides and homologues thereof, including, but not
limited to, natural allelic variants and modified polynucle
otides in which nucleotides have been inserted, deleted,
Substituted, and/or inverted in Such a manner that Such

modifications do not substantially interfere with the poly
nucleotide's ability to encode an MSH1 polypeptide of the
present invention or to form stable hybrids under Stringent
conditions with natural gene isolates.
0061 A plant MSH1 polynucleotide homologue can be
produced using a number of methods known to those skilled
in the art (See, for example, Sambrook et al., ibid.). For
example, polynucleotides can be modified using a variety of
techniques including, but not limited to, classic mutagenesis
techniques and recombinant DNA techniques, Such as Site
directed mutagenesis, chemical treatment of a polynucle
otide to induce mutations, restriction enzyme cleavage of a
nucleic acid fragment, ligation of nucleic acid fragments,
polymerase chain reaction (PCR) amplification and/or
mutagenesis of Selected regions of a nucleic acid Sequence,
Synthesis of oligonucleotide mixtures and ligation of mix
ture groups to “build” a mixture of polynucleotides and
combinations thereof. Polynucleotide homologues can be
Selected from a mixture of modified nucleic acids by Screen
ing for the function of the polypeptide encoded by the
nucleic acid (e.g., ability to elicit an immune response
against at least one epitope of an MSH1 polypeptide, ability
to Suppress ectopic recombination in a transgenic plant
containing an MSH1 gene and/or by hybridization with an A.
thaliana AtMSH1 gene.
0062) An isolated polynucleotide of the present invention
can include a nucleic acid Sequence that encodes at least one
plant MSH1 polypeptide of the present invention, examples
of Such polypeptides being disclosed herein. Although the
phrase “polynucleotide’ primarily refers to the physical
polynucleotide and the phrase “nucleic acid Sequence' pri
marily refers to the Sequence of nucleotides on the poly
nucleotide, the two phrases can be used interchangeably,
especially with respect to a polynucleotide, or a nucleic acid
Sequence, being capable of encoding an MSH1 polypeptide.
As heretofore disclosed, plant MSH1 polypeptides of the
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present invention include, but are not limited to, polypep
tides having full-length plant MSH1 coding regions,
polypeptides having partial plant MSH1 coding regions,
fusion polypeptides, multivalent protective polypeptides and
combinations thereof.

0.063 At least certain polynucleotides of the present
invention encode polypeptides that Selectively bind to
immune Serum derived from an animal that has been immu

nized with an MSH1 polypeptide from which the polynucle
otide was isolated.

0064. A preferred polynucleotide of the present inven
tion, when Suppressed in a Suitable plant, is capable of
generating economically useful mutant plants. AS will be
disclosed in more detail below, Such a polynucleotide can be,
or encode, an antisense RNA, a molecule capable of triple
helix formation, a ribozyme, or other nucleic acid-based
compound.
0065 One embodiment of the present invention is a plant
MSH1 polynucleotide that hybridizes under stringent
hybridization conditions to an MSH1 polynucleotide of the
present invention, or to a homologue of such an MSH1
polynucleotide, or to the complement of Such a polynucle
otide. A polynucleotide complement of any nucleic acid
Sequence of the present invention refers to the nucleic acid
Sequence of the polynucleotide that is complementary to
(i.e., can form a complete double helix with) the Strand for
which the Sequence is cited. It is to be noted that a double
Stranded nucleic acid molecule of the present invention for
which a nucleic acid Sequence has been determined for one
strand, that is represented by a SEQ ID NO, also comprises
a complementary Strand having a Sequence that is a comple
ment of that SEQ ID NO. As such, polynucleotides of the
present invention, which can be either double-Stranded or
Single-Stranded, include those polynucleotides that form
stable hybrids under stringent hybridization conditions with
either a given SEQ ID NO denoted herein and/or with the
complement of that SEQ ID NO, which may or may not be
denoted herein. Methods to deduce a complementary
Sequences are known to those skilled in the art. Preferred is
an MSH1 polynucleotide that includes a nucleic acid
Sequence having at least about 60 percent, at least about 65
percent, preferably at least about 70 percent, more prefer
ably at least about 75 percent, more preferably at least about
80 percent, more preferably at least about 85 percent, more
preferably at least about 90 percent and even more prefer
ably at least about 95 percent homology with the corre
sponding region(s) of the nucleic acid sequence encoding at
least a portion of an MSH1 polypeptide. Particularly pre
ferred is an MSH1 polynucleotide capable of encoding at
least a portion of an MSH1 polypeptide that naturally is
present in plants.
0.066 Particularly preferred MSH1 polynucleotides of
the present invention hybridize under Stringent hybridization
conditions with at least one of the following polynucle
otides: SEQ ID NO:1, SEQ ID NO:6, SEQ ID. NO:8, SEQ
ID NO:10, SEQID NO:11, SEQID NO:13, SEQID NO:14,
SEQ ID NO:16, SEQ ID NO:18, SEQ ID NO:21, SEQ ID
NO:23, SEQ ID NO:25, SEQ ID NO:27, SEQ ID NO:28,
SEQ ID NO:29, SEQ ID. NO:32, SEQ ID NO:34, SEQ ID
NO:36, SEQ ID NO:37, SEQ ID NO:38, SEQ ID NO:41,

SEQ ID NO:43, and/or SEQ ID NO:45, or to a homologue
or complement of Such polynucleotide.
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0067. A preferred polynucleotide of the present invention
includes at least a portion of nucleic acid Sequence SEQ ID
NO:1, SEQ ID NO:6, SEQ ID. NO:8, SEQ ID NO:10, SEQ
ID NO:11, SEQ ID NO:13, SEQ ID NO:14, SEQ ID NO:16,
SEQ ID NO:18, SEQ ID NO:21, SEQ ID NO:23, SEQ ID
NO:25, SEQ ID NO:27, SEQ ID NO:28, SEQ ID NO:29,
SEQ ID. NO:32, SEQ ID NO:34, SEQ ID NO:36, SEQ ID
NO:37, SEQ ID NO:38, SEQ ID NO:41, SEQ ID NO:43,

and/or SEQ ID NO:45 that is capable of hybridizing (i.e.,
that hybridizes under Stringent hybridization conditions) to
an A. thaliana AtMSH1 gene of the present invention, as
well as a polynucleotide that is an allelic variant of any of
those polynucleotides. Such preferred polynucleotides can
include nucleotides in addition to those included in the SEQ

ID NOS, Such as, but not limited to, a full-length gene, a
full-length coding region, a polynucleotide encoding a
fusion polypeptide, and/or a polynucleotide encoding a
multivalent protective compound.
0068 The present invention also includes polynucle
otides encoding a polypeptide including at least a portion of
SEQ ID NO:3, polynucleotides encoding a polypeptide
having at least a portion of SEQ ID NO:7, polynucleotides
encoding a polypeptide having at least a portion of SEQ ID
NO:9, polynucleotides encoding a polypeptide having at
least a portion of SEQ ID NO:12, polynucleotides encoding
a polypeptide having at least a portion of SEQ ID NO:15,
polynucleotides encoding a polypeptide having at least a
portion of SEQ ID NO:17, polynucleotides encoding a
polypeptide having at least a portion of SEQ ID NO:19,
polynucleotides encoding a polypeptide having at least a
portion of SEQ ID NO:22, polynucleotides encoding a
polypeptide having at least a portion of SEQ ID NO:24,
polynucleotides encoding a polypeptide having at least a
portion of SEQ ID NO:26, polynucleotides encoding a
polypeptide having at least a portion of SEQ ID NO:31,
polynucleotides encoding a polypeptide having at least a
portion of SEQ ID NO:33, polynucleotides encoding a
polypeptide having at least a portion of SEQ ID NO:35,
polynucleotides encoding a polypeptide having at least a
portion of SEQ ID NO:40, polynucleotides encoding a
polypeptide having at least a portion of SEQ ID NO:42,
polynucleotides encoding a polypeptide having at least a
portion of SEQ ID NO:42, polynucleotides encoding a
polypeptide having at least a portion of SEQ ID NO:44,
polynucleotides encoding a polypeptide having at least a
portion of SEQ ID NO:47, and/or polynucleotides encoding
a polypeptide having at least a portion of SEQ ID NO:65,
including polynucleotides that have been modified to
accommodate codon usage properties of the cells in which
Such polynucleotides are to be expressed.
0069. Knowing the nucleic acid sequences of certain
plant MSH1 polynucleotides of the present invention allows

one skilled in the art to, for example, (a) make copies of
those polynucleotides, (b) obtain polynucleotides including
at least a portion of Such polynucleotides (e.g., polynucle
otides including full-length genes, full-length coding
regions, regulatory control Sequences, truncated coding

regions), and (c) obtain MSH1 polynucleotides for other

plants. Such polynucleotides can be obtained in a variety of
ways including Screening appropriate expression libraries
with antibodies of the present invention; traditional cloning
techniques using oligonucleotide probes of the present
invention to screen appropriate libraries or DNA; and PCR
amplification of appropriate libraries or DNA using oligo
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nucleotide primers of the present invention. Preferred librar
ies to Screen or from which to amplify polynucleotides
include libraries such as genomic DNA libraries, BAC
libraries, YAC libraries, cDNA libraries prepared from iso
lated plant tissues, including, but not limited to, Stems,
reproductive Structures/tissues, leaves, roots, and tillers, and
libraries constructed from pooled cDNAs from any or all of

time. The chm1-1 and chm1-2 mutants, reported in the

the tissues listed above. In the case of rice, BAC libraries,

chm mutants were the mismatch accumulation rate
enhanced.

available from Clemson University, are preferred. Similarly,
preferred DNA sources to screen or from which to amplify
polynucleotides include plant genomic DNA. Techniques to
clone and amplify genes are disclosed, for example, in
Sambrook et al., ibid. and in Galun & Breiman, TRANS

GENIC PLANTS, Imperial College Press, 1997.
0070 The present invention also includes polynucle
otides that are oligonucleotides capable of hybridizing,
under Stringent hybridization conditions, with complemen
tary regions of other, preferably longer, polynucleotides of
the present invention Such as those comprising plant MSH1
genes or other plant MSH1 polynucleotides. Oligonucle
otides of the present invention can be RNA, DNA, or
derivatives of either. The minimal Size of Such oligonucle
otides is the size required to form a stable hybrid between a
given oligonucleotide and the complementary Sequence on
another polynucleotide of the present invention. Minimal
Size characteristics are disclosed herein. The size of the

oligonucleotide must also be Sufficient for the use of the
oligonucleotide in accordance with the present invention.
Oligonucleotides of the present invention can be used in a
variety of applications including, but not limited to, as
probes to identify additional polynucleotides, as primers to
amplify or extend polynucleotides, as targets for expression
analysis, as candidates for targeted mutagenesis and/or
recovery, or in agricultural applications to alter MSH1
polypeptide production or activity. Such agricultural appli
cations include the use of Such oligonucleotides in, for
example, antisense-, triplex formation-, ribozyme- and/or
RNA drug-based technologies. The present invention, there
fore, includes Such oligonucleotides and methods in a plant
by use of one or more of Such technologies.
0071. The predicted features of the candidate CHM
encoded protein denoted MSH1 Suggest that the gene
encodes the mitochondrial MSH1 counterpart in higher
plants. MSH1 encodes a mitochondrial mismatch repair
protein in yeast, though its counterpart in animals has not yet
been identified. The CHM candidate sequence showed
strongest homology with the Arabidopsis nuclear MSH6

Sequence (FIG. 2), consistent with Suggestions that nuclear

mismatch repair components likely derived from a progeni

tor to MSH1 (Culligan, et al. (2000) Nucl. Acids Res. 28,
463-471).
0.072 Although the predicted CHM candidate protein
displayed Several features Suggesting its involvement in
mismatch repair, lines containing mutations in the locus
showed no evidence of mitochondrial point mutation accu
mulation. The primary effect within the mitochondrion
appeared to be the reproducible SubStoichiometric shifting
phenomenon. This assumption is based on the observation of
identical mitochondrial DNA restriction fragments arising
upon SubStoichiometric shifting in all chm mutants when

tested repeatedly (Sakamoto, et al., ibid., Martinez-Zapater,
et al., ibid., this report). Moreover, no evidence of progres

Sive decline in plant growth features has been observed over

1970's (Redei, ibid.), appear identical to one another in

phenotype and mitochondrial DNA configuration. Although
detailed Sequence analysis would be required to estimate the

incidence of mismatch accumulation in the chm mutants,

one would anticipate a random pattern of mitochondrial
DNA polymorphism and progressive phenotypic decline in

0073 Mutation of the MSH1 locus in yeast results in
rapid accumulation of mitochondrial genomic rearrange
ments leading to disruption of mitochondrial function. Inter
estingly, a reproducible pattern of DNA restriction fragment
polymorphism was reported in Some of the petit mutants

arising in yeast MSH1 mutant strains (Reenan & Kolodner).
This observation may be indication that mshl-associated
mitochondrial genomic rearrangements are Similar in plants
and fungi. Alignment between the yeast MSH1 protein and

the Arabidopsis CHM (MSH1) candidate shows only 17%

amino acid identity overall, with ca. 28% identity within the
predicted functional domains for ATP and DNA binding, but

with well conserved motifs (FIG. 2). The yeast MSH1

protein has been shown to have both DNA mismatch binding

and ATPase activity (Chi & Kolodner (1994) J Biol. Chem.
269,29984-29992; Chi & Kolodner. (1994) J. Biol. Chem.
269,29993–29997).
0074 C. Recombinant Molecules
0075. The present invention also includes a recombinant

vector, which includes at least one plant MSH1 polynucle
otide of the present invention, inserted into any vector
capable of delivering the polynucleotide into a host cell.
Such a vector contains heterologous nucleic acid Sequences,
that is nucleic acid Sequences that are not naturally found
adjacent to polynucleotides of the present invention and that
preferably are derived from a Species other than the Species

from which the polynucleotide(s) are derived. AS used

herein, a derived polynucleotide is one that is identical or
Similar in Sequence to a polynucleotide or portion of a
polynucleotide, but can contain modifications, Such as modi
fied bases, backbone modifications, nucleotide changes, and
the like. The vector can be either RNA or DNA, either

prokaryotic or eukaryotic, and typically is a virus or a
plasmid. Recombinant vectors can be used in the cloning,
Sequencing, and/or otherwise manipulating of plant MSH1
polynucleotides of the present invention. One type of recom
binant vector, referred to herein as a recombinant molecule
and described in more detail below, can be used in the

expression of polynucleotides of the present invention.
Preferred recombinant vectors are capable of replicating in
the transformed cell.

0076 Suitable and preferred polynucleotides to include
in recombinant vectors of the present invention are as
disclosed herein for suitable and preferred plant MSH1
polynucleotides per se. Particularly preferred polynucle
otides to include in recombinant vectors, and particularly in
recombinant molecules, of the present invention include
SEQ ID NO:1, SEQ ID NO:6, SEQ ID. NO:8, SEQ ID
NO:10, SEQ ID NO:11, SEQ ID NO:13, SEQ ID NO:14,
SEQ ID NO:16, SEQ ID NO:18, SEQ ID NO:21, SEQ ID
NO:23, SEQ ID NO:25, SEQ ID NO:27, SEQ ID NO:28,
SEQ ID NO:29, SEQ ID. NO:32, SEQ ID NO:34, SEQ ID
NO:36, SEQ ID NO:37, SEQ ID NO:38, SEQ ID NO:41,
SEQ ID NO:43, and/or SEQ ID NO:45.
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0077. Isolated plant MSH1 polypeptides of the present
invention can be produced in a variety of ways, including
production and recovery of natural polypeptides, production
and recovery of recombinant polypeptides, and chemical
Synthesis of the polypeptides. In one embodiment, an iso
lated polypeptide of the present invention is produced by
culturing a cell capable of expressing the polypeptide under
conditions effective to produce the polypeptide, and recov
ering the polypeptide. A preferred cell to culture is a
recombinant cell that is capable of expressing the polypep
tide, the recombinant cell being produced by transforming a
host cell with one or more polynucleotides of the present
invention. Transformation of a polynucleotide into a cell can
be accomplished by any method by which a polynucleotide
can be inserted into the cell. Transformation techniques
include, but are not limited to, transfection, electroporation,
microinjection, lipofection, adsorption, and protoplast
fusion. A recombinant cell may remain unicellular or may
grow into a tissue, organ or a multicellular organism. Trans
formed polynucleotides of the present invention can remain
extrachromosomal or can integrate into one or more Sites

within a chromosome of the transformed (i.e., recombinant)

cell in Such a manner that their ability to be expressed is
retained. Suitable and preferred polynucleotides with which
to transform a cell are as disclosed herein for Suitable and

preferred plant MSH1 polynucleotides per se. Particularly
preferred polynucleotides to include in recombinant cells of
the present invention include SEQ ID NO:1, SEQ ID NO:6,
SEQ ID. NO:8, SEQ ID NO:10, SEQ ID NO:11, SEQ ID
NO:13, SEQ ID NO:14, SEQ ID NO:16, SEQ ID NO:18,
SEQ ID NO:21, SEQ ID NO:23, SEQ ID NO:25, SEQ ID
NO:27, SEQ ID NO:28, SEQ ID NO:29, SEQ ID. NO:32,
SEQ ID NO:34, SEQ ID NO:36, SEQ ID NO:37, SEQ ID
NO:38, SEQ ID NO:41, SEQ ID NO:43, and/or SEQ ID
NO:45.

0078 Suitable host cells to transform include any cell
that can be transformed with a polynucleotide of the present
invention. Host cells can be either untransformed cells or

cells that are already transformed with at least one poly
nucleotide. Host cells of the present invention either can be

endogenously (i.e., naturally) capable of producing plant

MSH1 polypeptides of the present invention or can be
capable of producing Such polypeptides after being trans
formed with at least one polynucleotide of the present
invention. Host cells of the present invention can be any cell
capable of producing at least one polypeptide of the present

invention, and include bacterial, fungal (including yeast and
rice blast, Magnaporthe grisea), parasite (including nema

todes, especially of the genera Xiphinema, Helicotylenchus,

and Tylenchlohynchus), insect, other animal and plant cells.
0079 Suitable host viruses to transform include any virus

that can be transformed with a polynucleotide of the present
invention, including, but not limited to, rice Stripe virus, and
echinochloa hoja blanca Virus.
0080. In a preferred embodiment, non-pathogenic sym
biotic bacteria, which are able to live and replicate within
plant tissues, So-called endophytes, or non-pathogenic Sym
biotic bacteria, which are capable of colonizing the phyllo
Sphere or the rhizosphere, So-called epiphytes, are used.
Such bacteria include bacteria of the genera Agrobacterium,
Alcaligenes, Azospirillum, Azotobacter, Bacillus, Clavi
bacter, Enterobacter, Erwinia, Flavobacter, Klebsiella,

Pseudomonas, Rhizobium, Serratia, Streptomyces and Xan
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thomonas. Symbiotic fungi, such as Trichoderma and Glio
cladium are also possible hosts for expression of the inven
tive nucleotide Sequences for the same purpose.
0081. A recombinant cell is preferably produced by trans
forming a host cell with one or more recombinant molecules,
each comprising one or more polynucleotides of the present
invention operatively linked to an expression vector con
taining one or more transcription control Sequences. The
phrase “operatively linked” refers to insertion of a poly
nucleotide into an expression vector in a manner Such that
the molecule is able to be expressed in the correct reading
frame when transformed into a host cell. AS used herein, an

expression vector is a DNA or RNA vector that is capable of
transforming a host cell and of effecting expression of a
Specified polynucleotide. Preferably, the expression vector is
also capable of replicating within the host cell. Expression
vectors can be either prokaryotic or eukaryotic, and are
typically viruses or plasmids. Expression vectors of the

present invention include any vectors that function (i.e.,
direct gene expression) in recombinant cells of the present

invention, including in bacterial, fungal, parasite, insect,
other animal, and plant cells. Preferred expression vectors of
the present invention can direct gene expression in bacterial,
yeast, fungal, insect and mammalian cells and more prefer
ably in the cell types heretofore disclosed.
0082 Recombinant molecules of the present invention

may also (a) contain Secretory signals (i.e., signal Segment
nucleic acid sequences) to enable an expressed MSH1
polypeptide of the present invention to be secreted from the
cell that produces the polypeptide and/or (b) contain fusion

Sequences which lead to the expression of polynucleotides
of the present invention as fusion polypeptides. Examples of
Suitable signal Segments and fusion Segments encoded by
fusion Segment nucleic acids are disclosed herein. Eukary
otic recombinant molecules may include intervening and/or
untranslated Sequences Surrounding and/or within the
nucleic acid Sequences of polynucleotides of the present
invention. Suitable Signal Segments include natural Signal
Segments or any heterologous signal Segment capable of
directing the Secretion of a polypeptide of the present
invention. Preferred Signal and fusion Sequences employed
to enhance organ and organelle Specific expression include,
but are not limited to, arcelin-5, See Goossens, A. et. al. The

arcelin-5 Gene of Phaseolus vulgaris directs high seed
Specific expression in transgenic Phaseolus acutifolius and

Arabidopsis plants. Plant Physiology (1999) 120:1095

1104, phaseolin, See Sengupta-Gopalan, C. et. al. Develop
mentally regulated expression of the bean beta-phaseolin

gene in tobacco seeds. PNAS (1985) 82:3320-3324, hydrox

yproline-rich glycoprotein, Serpin, See Yan, X. et. al. Gene
fusions of Signal Sequences with a modified beta-glucu
ronidase gene results in retention of the beta-glucuronidase
protein in the Secretory pathway/plasma membrane. Plant

Physiology (1997) 115:915-924, N-acetyl glucosaminyl
transferase 1, see Essi, D. et. al. The N-terminal 77 amino

acids from tobacco N-acetylglucosaminyltransferase I are
Sufficient to retain reporter protein in the Golgi apparatus of

Nicotiana benthamiana cells. Febs Letters (1999) 453(12): 169-73, albumin, see Vandekerckhove, J. et al. Enkepha
lins produced in transgenic plants using modified 2S. Seed
storage proteins. BioTechnology 7:929-932 (1989) and PR1,
see Pen, J. et al. Efficient production of active industrial

enzymes in plants. Industrial Crops and Prod. (1993) 1:241
250, and other Sequences as described in the Examples.
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0.083 Polynucleotides of the present invention can be
operatively linked to expression vectors containing regula
tory Sequences Such as transcription control Sequences,
translation control Sequences, origins of replication, and
other regulatory Sequences that are compatible with the
recombinant cell and that control the expression of poly
nucleotides of the present invention. In particular, recombi
nant molecules of the present invention include transcription
control Sequences. Transcription control Sequences are
Sequences which control the initiation, elongation, and ter
mination of transcription. Included are those transcription
control Sequences which are Sufficient to render promoter
dependent gene expression controllable for cell-type spe
cific, tissue-specific or inducible by external signals or
agents, Such elements may be located in the 5' or 3' regions
of the native gene. Particularly important transcription con
trol Sequences are those which control transcription initia
tion, Such as promoter, enhancer, operator and repressor
Sequences. Suitable transcription control Sequences include
any transcription control Sequence that can function in at
least one of the recombinant cells of the present invention.
A variety of Such transcription control Sequences are known
to those skilled in the art. Preferred transcription control
Sequences include those which function in bacterial, yeast,
fungal, insect and mammalian cells, Such as, but not limited
to, tac, lac, trp, trc, oxy-pro, Omp/lpp, rrnB, bacteriophage

lambda () (Such as up and up and fusions that include
Such promoters), bacteriophage T7, T7lac, bacteriophage
T3, bacteriophage SP6, bacteriophage SPO1, metallothion
ein, C.-mating factor, Pichia alcohol oxidase, alphavirus

Subgenomic promoters (such as Sindbis virus Subgenomic
promoters), antibiotic resistance gene, baculovirus, Helio
this zea insect virus, Vaccinia virus, herpesvirus, poxvirus,

adenovirus, cytomegalovirus (such as intermediate early
promoters, Simian virus 40, retrovirus, actin, retroviral long
terminal repeat, Rous Sarcoma virus, heat shock, phosphate
and nitrate transcription control Sequences as well as other
Sequences capable of controlling gene expression in
prokaryotic or eukaryotic cells.
0084 Particularly preferred transcription control
Sequences are plant transcription control Sequences. The
choice of transcription control Sequence will vary depending
on the temporal and Spatial requirements for expression, and
also depending on the target Species. Thus, expression of the
nucleotide Sequences of this invention in any plant organ

(leaves, roots, Seedlings, immature or mature reproductive
Structures, etc.) or at any stage of plant development is

preferred. Although many transcription control Sequences
from dicotyledons have been shown to be operational in
monocotyledons and Vice versa, ideally dicotyledonous tran
Scription control Sequences are Selected for expression in
dicotyledons, and monocotyledonous promoters for expres
Sion in monocotyledons. However, there is no restriction to
the provenance of Selected transcription control Sequences,
it is Sufficient that they are operational in driving the
expression of the nucleotide Sequences in the desired cell.
0085 Preferred transcription control sequences that are
expressed constitutively include but are not limited to pro
moters from genes encoding actin or ubiquitin and the
CaMV 35S and 19S promoters. The nucleotide sequences of
this invention can also be expressed under the regulation of
promoters that are chemically regulated. This enables the
MSH1 polypeptide to be synthesized only when the crop
plants are treated with the inducing chemicals.
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0086 A preferred category of promoters is that which is
induced by the physiological State of the plant (i.e. wound
inducible, water-StreSS inducible, Salt-stress inducible, dis

ease inducible, and the like). Numerous promoters have
been described which are expressed at wound Sites and also
at the Sites of phytopathogen infection. Ideally, Such a
promoter should only be active locally at the sites of
infection, and in this way the MSH1 polypeptides only
accumulate in cells in which the accumulation is desired.

Preferred promoters of this kind include those described by

Stanford et al. Mol. Gen. Genet. 215: 200-208 (1989), Xu et
al. Plant Molec. Biol. 22:573-588 (1993), Logemann et al.
Plant Cell 1: 151-158 (1989), Rohrmeier & Lehle, Plant
Molec. Biol. 22: 783-792 (1993), Firek et al. Plant Molec.
Biol. 22: 129-142 (1993), and Warner et al. Plant J. 3:
191-201 (1993).
0087 Preferred tissue-specific expression patterns
include but are not limited to green tissue Specific, root
Specific, Stem specific, and flower Specific. Promoters Suit
able for expression in green tissue include many which
regulate genes involved in photosynthesis and many of these
have been cloned from both monocotyledons and dicotyle
dons. A preferred promoter is the maize PEPC promoter

from the phosphoenol carboxylase gene (Hudspeth & Grula,
Plant Molec. Biol. 12: 579-589 (1989)). A preferred pro
moter for root Specific expression is that described by de

Framond (FEBS 290: 103-106 (1991); EP 0 452 269 to
Ciba-Geigy). A preferred Stem specific promoter is that
described in U.S. Pat. No. 5,625,136 (to Ciba-Geigy) and

which drives expression of the maize trpA gene.
0088 A recombinant molecule of the present invention is
a molecule that can include at least one of any polynucle
otide heretofore described operatively linked to at least one
of any transcription control Sequence capable of effectively

regulating expression of the polynucleotide(s) in the cell to
be transformed, examples of which are disclosed herein.
0089. A recombinant cell of the present invention
includes any cell transformed with at least one of any
polynucleotide of the present invention. Suitable and pre
ferred polynucleotides as well as Suitable and preferred
recombinant molecules with which to transfer cells are
disclosed herein.

0090 Recombinant cells of the present invention can also
including plant MSH1 polynucleotides encoding one or
more polypeptides of the present invention and one or more
other polypeptides useful when expressed in plants.
0091. It may be appreciated by one skilled in the art that
use of recombinant DNA technologies can improve expres
Sion of transformed polynucleotides by manipulating, for
example, the number of copies of the polynucleotides within
a host cell, the efficiency with which those polynucleotides
are transcribed, the efficiency With which the resultant
transcripts are translated, and the efficiency of post-transla
tional modifications. Recombinant techniques useful for
increasing the expression of polynucleotides of the present
invention include, but are not limited to, operatively linking
polynucleotides to high-copy number plasmids, integration
of the polynucleotides into one or more host cell chromo
Somes, addition of Vector Stability Sequences to plasmids,
Substitutions or modifications of transcription control Sig
nals (e.g., promoters, operators, enhancers), Substitutions or

be co-transformed with one or more recombinant molecules
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modifications of translational control signals (e.g., ribosome
binding sites, Shine-Dalgarno Sequences), modification of
polynucleotides of the present invention to correspond to the
codon usage of the host cell, deletion of Sequences that
destabilize transcripts, and use of control Signals that tem
porally Separate recombinant cell growth from recombinant
enzyme production during fermentation. The activity of an
expressed recombinant polypeptide of the present invention
may be improved by fragmenting, modifying, or derivatiz
ing polynucleotides encoding Such a polypeptide.
0092 Recombinant cells of the present invention can be
used to produce one or more polypeptides of the present
invention by culturing Such cells under conditions effective
to produce Such a polypeptide, and recovering the polypep
tide. Effective conditions to produce a polypeptide include,
but are not limited to, appropriate media, bioreactor, tem
perature, pH and oxygen conditions that permit polypeptide
production. An appropriate, or effective, medium refers to
any medium in which a cell of the present invention, when
cultured, is capable of producing an MSH1 polypeptide of
the present invention. Such a medium is typically an aque
ous medium comprising assimilable carbon, nitrogen and
phosphate Sources, as well as appropriate Salts, minerals,
metals and other nutrients, Such as Vitamins. The medium

may comprise complex nutrients or may be a defined
minimal medium. Cells of the present invention can be
cultured in conventional fermentation bioreactors, which

include, but are not limited to, batch, fed-batch, cell recycle,
and continuous fermentors. Culturing can also be conducted
in Shake flasks, test tubes, microtiter dishes, and petri plates.
Culturing is carried out at a temperature, pH and oxygen
content appropriate for the recombinant cell. Such culturing
conditions are well within the expertise of one of ordinary
skill in the art.

0093. Depending on the vector and host system used for
production, resultant polypeptides of the present invention
may either remain within the recombinant cell; be Secreted
into the fermentation medium; be Secreted into a Space
between two cellular membranes, Such as the periplasmic
Space in E. coli, or be retained on the outer Surface of a cell
or viral membrane.

0094. The phrase “recovering the polypeptide” refers
Simply to collecting the whole fermentation medium con
taining the polypeptide and need not imply additional Steps
of Separation or purification. Polypeptides of the present
invention can be purified using a variety of Standard
polypeptide purification techniques, Such as, but not limited
to, affinity chromatography, ion exchange chromatography,
filtration, electrophoresis, hydrophobic interaction chroma
tography, gel filtration chromatography, reverse phase chro
matography, concanavalin A chromatography, chromatofo
cusing and differential solubilization. Polypeptides of the
present invention are preferably retrieved in “substantially
pure” form. As used herein, “substantially pure” refers to a
purity that allows for the effective use of the polypeptide as
a diagnostic or test compound, and means, with increasing
preference, at least 50%, 60%, 70%, 80%, 90%, 95%, or
98% homogeneous.
0.095 D. Transfected Plant Cells and Transgenic Plants
0096] With regard to MSH1, particularly preferred
recombinant cells are plant cells. By "plant cell' is meant
any Self-propagating cell bounded by a Semi-permeable
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membrane and containing a plastid. Such a cell also requires
a cell wall if further propagation is desired. Plant cell, as
used herein includes, without limitation, algae, cyanobacte
ria, Seeds, Suspension cultures, embryos, meristematic
regions, callus tissue, leaves, roots, Shoots, gametophytes,
Sporophytes, pollen, and microSpores.
0097. The particular arrangement of the MSH1 sequence
in the transformation vector will be Selected according to the
type of expression of the Sequence that is desired. In Some
embodiments, expressing MSH1 polypeptides is desirable,
while in others, a reduction of activity is desirable. The
former embodiment is discussed first.

0098. In one embodiment, at least one of the MSH1
polypeptides or an allele thereof, of the invention is
expressed in a higher organism, e.g., a plant. A nucleotide
Sequence of the present invention is inserted into an expres
Sion cassette, which is then preferably Stably integrated in
the genome of Said plant. In another preferred embodiment,
the nucleotide Sequence is included in a non-pathogenic
Self-replicating virus. Plants transformed in accordance with
the present invention may be monocots or dicots and
include, but are not limited to, maize, wheat, barley, rye,
millet, chickpea, lentil, flax, olive, fig almond, pistachio,
walnut, beet, parSnip, citrus fruits, including, but not limited
to, Orange, lemon, lime, grapefruit, tangerine, minneola, and
tangelo, Sweet potato, bean, pea, chicory, lettuce, cabbage,
cauliflower, broccoli, turnip, radish, Spinach, asparagus,
Onion, garlic, pepper, celery, Squash, pumpkin, hemp, Zuc
chini, apple, pear, quince, melon, plum, cherry, peach,
nectarine, apricot, Strawberry, grape, raspberry, blackberry,
pineapple, avocado, papaya, mango, banana, Soybean,
tomato, Sorghum, Sugarcane, Sugarbeet, Sunflower, rapeseed,
clover, tobacco, carrot, cotton, alfalfa, rice, potato, eggplant,
cucumber, Arabidopsis, and Woody plants Such as conifer
ous and deciduous trees.

0099. Once a desired nucleotide sequence has been trans
formed into a particular plant Species, it may be propagated
in that Species or moved into other varieties of the same
Species, particularly including commercial varieties, using
traditional breeding techniques.
0100. Accordingly, the present invention provides a
method for producing a transfected plant cell or transgenic

plant comprising the steps of a) transfecting a plant cell to

contain a heterologous DNA segment encoding a protein and
derived from an MSH1 polynucleotide not native to said cell

(the polynucleotide indeed could be native but the expres

Sion pattern could be developmentally altered, Still leading

to the preferred effect); wherein said polynucleotide is
operably linked to a promoter that can be used effectively for
expression of transgenic proteins; b) optionally growing and
maintaining Said cell under conditions whereby a transgenic

plant is regenerated therefrom; c) optionally growing said

transgenic plant under conditions whereby Said DNA is
expressed, whereby the total amount of MSH1 polypeptide
in Said plant is altered. In a preferred embodiment, the
method further comprises the Step of obtaining and growing
additional generations of descendants of Said transgenic
plant which comprise Said heterologous DNA segment
wherein Said heterologous DNA segment is expressed. AS
used herein, "heterologous DNA, or, in Some cases, “trans
gene' refers to foreign genes or polynucleotides, or addi
tional, or modified versions of native or endogenous genes
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or polynucleotides (perhaps driven by different promoters)

into constructions comprising the nucleotide Sequences, up

in order to alter the traits of a plant in a Specific manner.
0101 The invention also provides plant cells which com
prise heterologous DNA encoding an MSH1 polypeptide. In
a preferred embodiment, the transgenic plant cell is a
propagation material of a transgenic plant. The present
invention also provides a transfected host cell comprising a
host cell transfected with a construct comprising a promoter,
enhancer or intron polynucleotide from an MSH1 polynucle
otide, and a polynucleotide encoding a reporter protein.
0102) The present invention also provides a method of

to and including the ATG (while leaving the Second amino
acid unmodified), or alternatively up to and including the
GTC Subsequent to the ATG (with the possibility of modi
fying the Second amino acid of the transgene).
0107 Expression of the nucleotide sequences in trans

preparing a transgenic plant comprising: a) producing a
transfected plant cell having a transgene encoding an MSH1
polypeptide whereby MSH1 expression in said plant cell is

altered; and b) growing a transgenic plant from the trans

fected plant cell wherein the MSH1 transgene is expressed
in the transgenic plant. The expression of the transgene
includes an increase or decrease in MSH1 expression. In
Some embodiments, the expression of the transgene pro
duces an RNA that may interfere with a native MSH1 gene
Such that the expression of the native gene is either elimi
nated or reduced, resulting in a useful outcome.
0103) The invention also provides a transgenic plant
containing heterologous DNA which encodes an MSH1
polypeptide that is expressed in plant tissue, including
expression in a vector introduced into the plant.

0104. The present invention also provides an isolated

polynucleotide which includes a transcription control ele
ment operably linked to a polynucleotide that encodes the
MSH1 gene in plant tissue. In preferred embodiment, the
transcription control element is the promoter native to an
MSH1 gene.
0105. In some embodiments, a nucleotide sequence of
this invention is expressed in transgenic plants, thus causing
the biosynthesis of the corresponding MSH1 polypeptide in
the transgenic plants. In this way, transgenic plants with
characteristics related to MSH1 expression are generated.
For their expression in transgenic plants, the nucleotide
Sequences of the invention may require modification and
optimization. Although preferred gene Sequences may be
adequately expressed in both monocotyledonous and dicoty
ledonous plant species, Sequences can be modified to
account for the Specific codon preferences and GC content
preferences of monocotyledons or dicotyledons as these

preferences have been shown to differ (Murray et al. Nucl.
Acids Res. 17.477-498 (1989)). All changes required to be
made within the nucleotide Sequences Such as those
described above are made using well known techniques of
Site directed mutagenesis, PCR, and Synthetic gene construc
tion using the methods described in the published patent

applications EP 0385962 (to Monsanto), EP 0359 472 (to
Lubrizol), and WO 93/07278 (to Ciba-Geigy).
0106 For efficient initiation of translation, sequences

adjacent to the initiating methionine may require modifica
tion. For example, they can be modified by the inclusion of
Sequences known to be effective in plants. Joshi has Sug

gested an appropriate consensus for plants (NAR 15: 6643
6653 (1987)) and Clontech suggests a further consensus
translation initiator (1993/1994 catalog, page 210). These
consensuses are Suitable for use with the nucleotide

Sequences of this invention. The Sequences are incorporated

genic plants is driven by transcription control elements
shown to be functional in plants. Transformation of plants
with a polynucleotide under the control of these regulatory
elements provides for controlled expression in the trans
formed plant. Such transcription control elements have been
described above. In addition to the selection of a Suitable

initiator of transcription, constructions for expression of
MSH1 polypeptide in plants require an appropriate tran
Scription terminator to be attached downstream of the het
erologous nucleotide Sequence. Several Such terminators are

available and known in the art (e.g. timl from CaMV, E9 from
rbcS). Any available terminator known to function in plants
can be used in the context of this invention.

0108) Numerous other sequences can be incorporated
into expression cassettes described in this invention. These
include Sequences which have been shown to enhance

expression Such as intron Sequences (e.g. from Adhl and
bronze 1) and viral leader sequences (e.g. from TMV,
MCMV and AMV).
0109) It may be preferable to target expression of the
nucleotide Sequences of the present invention to different
cellular localizations in the plant. In Some cases, localization
in the cytosol may be desirable, whereas in other cases,
localization in Some Subcellular organelle may be preferred.
Subcellular localization of heterologous DNA encoded
polypeptides is undertaken using techniques well known in
the art. Typically, the DNA encoding the target peptide from
a known organelle-targeted gene product is manipulated and
fused upstream of the nucleotide Sequence. Many Such target
Sequences are known for the chloroplast and their function
ing in heterologous constructions has been shown. The
expression of the nucleotide Sequences of the present inven
tion is also targeted to the endoplasmic reticulum or to the
vacuoles of the host cells. Techniques to achieve this are
well-known in the art.

0110 Vectors suitable for plant transformation are
described elsewhere in this specification. For Agrobacte
rium-mediated transformation, binary vectors or vectors
carrying at least one T-DNA border Sequence are Suitable,
whereas for direct gene transfer any vector is Suitable and
linear DNA containing only the construction of interest may
be preferred. In the case of direct gene transfer, transforma
tion with a single DNA species or co-transformation can be

used (Schocher et al. Biotechnology 4: 1093-1096 (1986)).

For both direct gene transfer and Agrobacterium-mediated

transfer, transformation is usually (but not necessarily)
undertaken with a Selectable marker which may provide

resistance to an antibiotic (kanamycin, hygromycin or meth
otrexate) or a herbicide (basta). The choice of selectable
marker is not, however, critical to the invention.

0111. In another preferred embodiment, a nucleotide
Sequence of the present invention is directly transformed
into the plastid genome. A major advantage of plastid
transformation is that plastids are capable of expressing
multiple open reading frames under control of a Single
promoter. Plastid transformation technology is extensively
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described in U.S. Pat. Nos. 5,451,513, 5,545,817, and 5,545,

818, in PCT application no. WO95/16783, and in McBride

et al. (1994) Proc. Natl. Acad. Sci. USA91, 7301-7305. The

basic technique for chloroplast transformation involves
introducing regions of cloned plastid DNA flanking a Select
able marker together with the gene of interest into a Suitable
target tissue, e.g., using biolistics or protoplast transforma

tion (e.g., calcium chloride or PEG mediated transforma
tion). The 1 to 1.5 kb flanking regions, termed targeting
Sequences, facilitate homologous recombination with the
plastid genome and thus allow the replacement or modifi
cation of Specific regions of the plastome. Initially, point
mutations in the chloroplast 16S rRNA and rps12 genes
conferring resistance to spectinomycin and/or Streptomycin

are utilized as Selectable markers for transformation (Svab,
Z., Hajdukiewicz, P, and Maliga, P. (1990) Proc. Natl. Acad.
Sci. USA 87,8526-8530; Staub, J. M., and Maliga, P. (1992)
Plant Cell 4, 39-45). This resulted in stable homoplasmic

transformants at a frequency of approximately one per 100
bombardments of target leaves. The presence of cloning
Sites between these markers allowed creation of a plastid

targeting vector for introduction of foreign genes (Staub, J.
M., and Maliga, P. (1993) EMBO J. 12, 601-606). Substan

tial increases in transformation frequency are obtained by
replacement of the recessive rRNA or r-polypeptide antibi
otic resistance genes with a dominant Selectable marker, the
bacterial aadA gene encoding the Spectinomycin-detoxify
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Sequence in the vector generally will be at least 30 nucle
otides in length, and improved antisense Suppression will
typically be observed as the length of the antisense Sequence
increases. Preferably, the length of the antisense Sequence in
the vector will be greater than 100 nucleotides. Transcription
of an antisense construct as described results in the produc
tion of RNA molecules that are the reverse complement of
mRNA molecules transcribed from the endogenous MSH1
gene in the plant cell. Although the exact mechanism by
which antisense RNA molecules interfere with gene expres
Sion has not been elucidated, it is believed that antisense

RNA molecules bind to the endogenous mRNA molecules
and thereby inhibit translation of the endogenous mRNA.
The production and use of anti-Sense constructs are dis

closed, for instance, in U.S. Pat. No. 5,773,692 (using
constructs encoding anti-Sense RNA for chlorophyll a?b
binding protein to reduce plant chlorophyll content), and
U.S. Pat. No. 5,741,684 (regulating the fertility of pollen in
various plants through the use of anti-Sense RNA to genes

involved in pollen development or function).
0113 Suppression of endogenous MSH1 gene expression
can also be achieved using ribozymes. Ribozymes are Syn
thetic RNA molecules that possess highly specific endori
bonuclease activity. The production and use of ribozymes
are disclosed in U.S. Pat. No. 4,987,071 to Cech and U.S.

ing enzyme aminoglycoside-3'-adenyltransferase (Svab, Z.,
and Maliga, P. (1993) Proc. Natl. Acad. Sci. USA 90,
913–917). Previously, this marker had been used success

Pat. No. 5,543,508 to Haselhoff. Inclusion of ribozyme
Sequences within antisense RNAS may be used to confer
RNA cleaving activity on the antisense RNA, such that
endogenous mRNA molecules that bind to the antisense
RNA are cleaved, leading to an enhanced antisense inhibi
tion of endogenous gene expression.

(Goldschmidt-Clermont, M. (1991) Nucl. Acids Res. 19:
4083-4089). Other selectable markers useful for plastid

0114 Constructs in which an MSH1 cDNA or gene (or
variants thereof) are over-expressed may also be used to

fully for high-frequency transformation of the plastid
genome of the green alga Chlamydomonas reinhardtii
transformation are known in the art and encompassed within
the Scope of the invention. Typically, approximately 15-20
cell division cycles following transformation are required to
reach a homoplastidic State. Plastid expression, in which
genes are inserted by homologous recombination into all of
the Several thousand copies of the circular plastid genome
present in each plant cell, takes advantage of the enormous
copy number advantage over nuclear-expressed genes to
permit expression levels that can readily exceed 10% of the
total Soluble plant polypeptide. In a preferred embodiment,
a nucleotide Sequence of the present invention is inserted
into a plastid targeting vector and transformed into the
plastid genome of a desired plant host. Plants homoplastic
for plastid genomes containing a nucleotide Sequence of the
present invention are obtained, and are preferentially
capable of high expression of the nucleotide Sequence.
0112 In Some embodiments, a reduction or Suppression
of MSH1 polypeptide activity is desired. In some embodi
ments, a reduction of MSH1 polypeptide activity may be
obtained by introducing into plants an antisense construct
based on an MSH1 cDNA or gene sequence. For antisense
Suppression, an MSH1 cDNA or gene is arranged in reverse
orientation relative to the promoter Sequence in the trans
formation vector. The introduced Sequence need not be a full
length MSH1 cDNA or gene, and need not be exactly
homologous to the native MSH1 cDNA or gene found in the
plant type to be transformed. Generally, however, where the
introduced Sequence is of shorter length, a higher degree of
homology to the native MSH1 sequence will be needed for
effective antisense Suppression. The introduced antisense

obtain co-Suppression of the endogenous MSH1 gene in the
manner described in U.S. Pat. No. 5,231,021 to Jorgensen.

Such co-Suppression (also termed Sense Suppression) does
not require that the entire MSH1 cDNA or gene be intro
duced into the plant cells, nor does it require that the
introduced Sequence be exactly identical to the endogenous
MSH1 gene. However, as with antisense Suppression, the

Suppressive efficiency will be enhanced as (1) the introduced
Sequence is lengthened and (2) the sequence Similarity
between the introduced sequence and the endogenous MSH1
gene is increased.
0115 Constructs expressing an untranslatable form of an
MSH1 mRNA may also be used to suppress the expression
of endogenous MSH1 activity. Methods for producing such
constructs are described in U.S. Pat. No. 5,583,021 to

Dougherty et al. Such constructs may be prepared by intro
ducing a premature stop codon into an MSH1 ORF.
0.116) Polynucleotides of the present invention may also
be used to Specifically Suppress gene expression by methods

such as RNA interference (RNAi), which may also include

coSuppression and quelling. This and other techniques of
gene Suppression are well known in the art. A review of this
technique is found in Science 288:1370-1372, 2000. Tradi
tional methods of gene Suppression, employing antisense
RNA or DNA, operate by binding to the reverse sequence of
a gene of interest Such that binding interferes with Subse
quent cellular processes and thereby blocks Synthesis of the
corresponding protein. RNAi also operates on a post-tran
Scriptional level and is sequence Specific, but Suppresses
gene expression far more efficiently
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0117 Studies have demonstrated that one or more ribo
nucleases Specifically bind to and cleave double-Stranded

RNA into short fragments. The ribonuclease(s) remains

asSociated with these fragments, which in turn Specifically
bind to complementary mRNA, i.e. specifically bind to the
transcribed mRNA strand for the gene of interest. The

mRNA for the gene is also degraded by the ribonuclease(s)

into short fragments, thereby obviating translation and
expression of the gene. Additionally, an RNA polymerase
may act to facilitate the Synthesis of numerous copies of the
Short fragments, which exponentially increases the effi
ciency of the System. A unique feature of this gene Suppres
Sion pathway is that Silencing is not limited to the cells
where it is initiated. The gene-Silencing effects may be
disseminated to other parts of an organism and even trans
mitted through the germ line to Several generations.
0118 Specifically, polynucleotides of the present inven
tion are useful for generating gene constructs for Silencing
Specific genes. Polynucleotides of the present invention may
be used to generate genetic constructs that encode a single
Self-complementary RNA sequence Specific for one or more
genes of interest. Genetic constructs and/or gene-specific
self-complementary RNA sequences may be delivered by
any conventional method known in the art. Within genetic
constructs, Sense and antisense Sequences flank an intron
Sequence arranged in proper Splicing Orientation making use
of donor and acceptor Splicing sites. Alternative methods
may employ Spacer Sequences of various lengths rather than
discrete intron sequences to create an operable and efficient
construct. During post-transcriptional processing of the gene
construct product, intron Sequences are spliced-out, allow
ing Sense and antisense Sequences, as well as Splice junction
sequences, to bind forming double-stranded RNA. Select
ribonucleases bind to and cleave the double-stranded RNA,

thereby initiating the cascade of events leading to degrada
tion of Specific mRNA gene Sequences, and Silencing Spe
cific genes. Alternatively, rather than using a gene construct
to express the Self-complementary RNA sequences, the
gene-specific double-Stranded RNA segments are delivered
to one or more targeted areas to be internalized into the cell
cytoplasm to exert a gene Silencing effect.
0119 Using this cellular pathway of gene suppression,
gene function may be Studied and high-throughput Screening
of Sequences may be employed to discover Sequences affect
ing gene expression. Additionally, genetically modified
plants may be generated.
0120 Finally, dominant negative mutant forms of the
disclosed Sequences may be used to block endogenous
MSH1 activity. Such mutants require the production of
mutated forms of the MSH1 protein that interact with the
same molecules as MSH1 but do not have MSH1 activity.
0121 E. MSH1 Antibodies
0122) The present invention also includes isolated anti
bodies capable of selectively binding to an MSH1 polypep
tide of the present invention or to a mimetope thereof. Such
antibodies are also referred to herein as anti-MSH1 antibod

ies. Particularly preferred antibodies of this embodiment
include anti-A. thaliana MSH1 antibodies.

0123 Isolated antibodies are antibodies that have been

removed from their natural milieu. The term "isolated” does

not refer to the State of purity of Such antibodies. AS Such,
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isolated antibodies can include anti-Sera containing Such
antibodies, or antibodies that have been purified to varying
degrees.
0.124. As used herein, the term “selectively binds to”
refers to the ability of antibodies of the present invention to
preferentially bind to specified polypeptides and mimetopes
thereof of the present invention. Binding can be measured
using a variety of methods known to those skilled in the art
including immunoblot assays, immunoprecipitation assays,

radioimmunoassays, enzyme immunoassays (e.g., ELISA),
immunofluorescent antibody assays and immunoelectron
microScopy; See, for example, Sambrook et al., ibid., and
Harlow & Lane, 1990, ibid.

0.125 Antibodies of the present invention can be either
polyclonal or monoclonal antibodies. Antibodies of the
present invention include functional equivalents Such as
antibody fragments and genetically-engineered antibodies,
including Single chain antibodies, that are capable of Selec
tively binding to at least one of the epitopes of the polypep
tide or mimetope used to obtain the antibodies. Antibodies
of the present invention also include chimericantibodies that
can bind to more than one epitope. Preferred antibodies are
raised in response to polypeptides, or mimetopes thereof,
that are encoded, at least in part, by a polynucleotide of the
present invention.
0.126 A preferred method to produce antibodies of the

present invention includes (a) administering to an animal an
effective amount of a polypeptide or mimetope thereof of the
present invention to produce the antibodies and (b) recov

ering the antibodies. In another method, antibodies of the
present invention are produced recombinantly using tech
niques as heretofore disclosed to produce MSH1 polypep
tides of the present invention. Antibodies raised against
defined polypeptides or mimetopes can be advantageous
because Such antibodies are not Substantially contaminated
with antibodies against other Substances that might other
wise cause interference in a diagnostic assay.
0127. Antibodies of the present invention have a variety
of potential uses that are within the Scope of the present

invention. For example, Such antibodies can be used (a) as
reagents in assays to detect expression of MSH1 by plant,

(b) as tools to Screen expression libraries and/or to recover
desired polypeptides of the present invention from a mixture

of polypeptides and other contaminants and/or (c) to modu
late the function of an MSH1 polypeptide (e.g., increase or
decrease the level or activity of an MSH1 polypeptide).
Antibodies of the present invention can be used to target
cytotoxic, therapeutic or imaging agents to Subjects in order
to deliver therapeutic agents or localize imaging agents to
RA-affected organs or tissues. Targeting can be accom

plished by conjugating (i.e., stably joining) Such antibodies
to the therapeutic or imaging agents using techniques known
to those skilled in the art.

0128 F. Methods for Effecting Mitochondrial Ectopic
Recombination and Identification of Mutants Arising from
Mitochondrial Ectopic Recombination
0129. In one embodiment, the invention provides a
method to identify a compound capable of inhibiting MSH1

activity (e.g., effecting ectopic recombination) of a plant,
Said method comprising contacting an isolated plant MSH1
nucleic acid molecule with a putative inhibitory compound
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which, in the absence of said compound, said plant MSH1
nucleic acid molecule has the activity of Suppressing ectopic
recombination; and determining if Said putative inhibitory
compound inhibits Said activity. The present invention also
comprises a method for effecting mitochondrial ectopic
recombination comprising providing a plant, and SuppreSS
ing expression of an MSH1-homologous gene in the plant.
A preferred inhibitory compound is an RNA molecule
having RNAi activity.
0130. The invention further provides a method for iden
tification of mutants arising from mitochondrial ectopic
recombination comprising providing a plant, and SuppreSS
ing expression of an MSH1-homologous gene in the plant,
and detecting an aberrant phenotype, whereby a mutant is
identified. A preferred aberrant phenotype includes cytoplas
mic male Sterility. Cytoplasmic male Sterility is a plant trait
that facilitates a cost-effective Strategy for the production of
proprietary hybrids. Hybrid Seed is valued for producing
higher yields and more uniform crop Stands. Hybrids are
important in a large number of horticultural and agronomic
crops including corn, Sorghum, rice, wheat, tomato, rape,
Sunflower, carrot, onion, Sugar beet, to name few. Cytoplas

mic male Sterility (CMS) mutations arise as the consequence
of ectopic recombination events that produce novel
expressed DNA sequences within the mitochondrial
genome. This is well documented in the Scientific literature.
The present invention also includes mutants identified the
method of the invention.
EXAMPLES

Example 1
Identification of the AtMSH1 Gene

0131 A. Gene mapping, cloning, and sequence analysis.
A map-based cloning strategy for the isolation of the CHM
locus involved the design of PCR-based co-dominant mark
ers, using the Cereon Arabidopsis polymorphism collection

(Jander, et al., ibid.) to distinguish between the Col-0 and

Landsburg erecta ecotypes used in the F mapping popula
tions. The markers were designed in a 5-Mb region of
Chromosome III based on information from the classical

mapping experiments of CHM (Martinez-Zapater, et al.,
ibid.; Redei, ibid.). The primer Sequences for markers are

available upon request. The F mapping population was

derived from a cross between the chm1-1 mutant line and

Landsburg erecta ecotype (pollen donor). A segregating

Sub-population of 172 variegated plants was analyzed.
Genomic DNA purification was conducted according to Li
and Chory, ibid. DNA gel blot analysis was conducted using
the protocol of Sambrook et al., ibid. High resolution
mapping of the CHM locus on Arabidopsis Chromosome III
delimited the gene to an 80-kb interval as shown in FIG. 1.
0132) DNA sequencing of the candidate locus in chm1-1,

chm1-2 and chm1-3 mutants (Kanazawa, et al... ibid.) was

conducted in a Beckman/Coulter CEQ2000XL 8-capillary
DNA sequencer. Two independent PCR samples for each
mutant were sequenced. The 5' RACE analysis was done

with the GeneRacer(R) Kit (Invitrogen, Carlsbad, Calif.).
Mutants chm1-1 and chm1-2 were obtained from the Ara

bidopsis Biological Resource Center, and mutant chm1-3
was provided by a colleague. Sequence analysis of the
interval revealed a gene candidate with Similarity in
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sequence features to the MutS gene of E. coli (FIG.2). MutS

is a component of the E. coli mismatch repair and DNA

recombination apparatus (Marti, et al., ibid.). The gene,

comprised of 22 exons, was predicted to encode a 43-amino
acid mitochondrial targeting presequence with mitochon

drial targeting values of 0.916 (MitoProt), 0.943 (Predator)
and 0.856 (TargetP). RNA gel blots showed that the tran
script derived from this gene was 3.5 kb in size and the
encoded protein 1118 amino acids in length, predicting a
124-kDa polypeptide.
0133. The two sequence-indexed T-DNA insertion

mutants were identified on the SiGnAL (Salk Institute
Genomic Analysis Laboratory) website (Accessions
SALKO41951 (SEQ ID NO:5) and SALKO46763 (SEQ ID
NO:4)), and seed for the mutants obtained from the Arabi
dopsis Biological Resource Center (ABRC). The T-DNA
insertion positions were confirmed by DNA sequencing of
the insertion junctions. The first insertion was located within
the fourth exon and the second within the eighth intron.

Analysis of the T-DNA mutants (T3 generation) revealed

mild green-white leaf variegation, growing more intense in
the following Selfed generation. Variegated plants having a
green-white variegation phenotype carried a mitochondrial
genome rearrangement Similar to that observed in the
mutants chm1-1 and chm1-2. A population of 60 T4 plants

segregating for one of the T-DNA (SALKO41951) mutations
(16 wildtype, 31 hemizygous, 13 homozygous for the
T-DNA) showed co-segregation of the T-DNA with the
mitochondrial shifting phenotype. Of the 13 progeny
homozygous for the T-DNA insertion, eight were variegated
and the remaining five showed no obvious variegation
phenotype. Incomplete penetrance of the variegation phe
notype is characteristic of chm1-1 and chm1-2 mutants

(Redei, ibid.).
0.134 DNA gel blot hybridization analysis of mitochon

drial genome configuration using the mitochondrial atp9
rp116 junction Sequence associated with SubStoichometric

shifting (Sakamoto, et al., ibid.) as probe. Total genomic

DNA was digested with BamHI, Subjected to gel electro
phoresis, blotted and probed. Lane Wt designates wildtype
ecotype Columbia-0, lane C1 designates mutant chm1-1,
and TI and T2 designate two Sister lines containing the
T-DNA1 insertion mutation. DNA band pattern changes
previously associated with SubStoichiometric shifting were

noted (Martinez-Zapater, et al., ibid.).
0.135 Cosegregation analysis of mitochondrial substo

ichiometric shifting with the T-DNA1 insertion mutation. A
three-primer PCR-based assay to detect substoichiometric

shifting (Sakamoto, et al., ibid.) was used to assay wildtype
Col-0 (Wt), mutant chm1-1 (C1) and individual plants
Segregating for presence of the T-DNA insertion within the
candidate CHM locus.

0.136 All progeny homozygous for the T-DNA insertion
mutation showed the mitochondrial shifting phenotype.
None of the Segregants hemizygous for, or lacking, the
T-DNA mutation showed evidence of variegation. The hem
izygous plants showed no mitochondrial shifting. Similar
co-segregation results were obtained for the second TDNA

(SALKO46763) mutation as well.
0137 To test further the possibility that the identified
MutS-homologous Sequence was CHM, we Sequenced the
chm1-1 and chm1-2 alleles of the gene. The chm1-1 line had
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a single nucleotide (C-T) Substitution that gave rise to a
premature stop codon within the fourth exon (FIG. 1E). The
chm1-2 mutant had a single nucleotide (G-A) Substitution at
the intron-exonjunction of Exon 2 (FIG. 1E). This substi
tution resulted in two-nucleotide slippage of the intron Splice
Site, producing a frameshift and premature termination of
translation five amino acids beyond the mutation site. There
fore, in both chm1-1 and chm1-2 mutant lines, the CHM

candidate locus is predicted to give rise to highly truncated,
inactive peptides.
0138 Sequence analysis of the chm1-3 allele, derived

based on cDNA sequence analysis and is available as
GenBank Accession AY191303.

Example 2
Plant Transformation and Biolistic Delivery
0140. The amino acid sequence of AtMSH1 was analyzed

with MitoProt (Claros & Vincens (1996) Eur. J. Biochem.
241, 779-786), and the first 213 nucleotides of the gene were
PCR amplified with the primers

from a tissue culture line by Martinez-Zapater et al. (Mar
tinez-Zapater, et al., ibid.), revealed an amino acid Substi
tution (Cys-Tyr) within the ATPbinding domain (FIG. 1E).

MSHtranspFor

Substitution of a bulkier amino acid within a Site essential for

MSHtranspRev
5' GGCCATGGAAA CATCACTTGACGTCTTC3".

The mutant phenotype in this case may be due to the

protein function.
0139 B. The CHM candidate has features of a mismatch
repair component. The MutS-homologous gene identified as
a candidate for CHM displayed several features character
istic of a mismatch repair component. These features

included an ATP-binding domain (aa 761-946) comprised of
four well conserved motifs designated M1-M4 (Obimolova,
et al., ibid.; FIG. 2B). In addition to ATPase function, this

domain appears to be involved in dimerization of the protein

5' GGCCATGGTGTGAATTGCATAGTCGTCG3'
and

(SEQ ID NO : 48)

(SEQ ID NO: 49)

0141 PCR products were ligated to the Pgem(R-T Easy
Vector System (Promega) and digested with NcoI to release

the insert. Insert fragments were ligated to the pCAMBIA
1302 vector at the NcoI site that resides at the start of gfp.
This vector utilizes the CaMV 35S promotor. Bombardment

experiments used 4-week-old leaves of Arabidopsis (Col-0)

with tungsten particles and the Biolistic PDS-1000/He sys

DNA binding domain (aa 129-206) was also identified
(FIGS. 1, 2) to contain the aromatic doublet (FY) motif that

tem (Bio-Rad). Particles were bombarded into Arabidopsis
leaves using 900-psi rupture discs under a vacuum of
900-psi (1 psi-6.9 kPa). After the bombardment, Arabidop
Sisleaves were allowed to recover for 18-22 h on Murashige
and Skoog media plates at 22 C. in 16 h daylight. Local

proteins (FIG. 2A). This doublet was shown to be essential
for mismatch recognition and Specific DNA binding activity

ization of GFP expression was conducted by confocal laser
scanning microscopy with Bio-Rad 1024 MRC-ES using

(33, 34). We were unable to detect three other conserved

sion, 522 nm (green/GFP) and 680 nm (red/chlorophyll).

(Obmolova, et al.; Lamers, et al.), although this has not yet

been demonstrated for mitochondrial MutS homologs. A
is characteristic of this domain in MutS and MutS-like

domains characteristic of MutS. A connector domain,
involved in inter-domain interactions, a core domain and a

clamp domain, involved in nonspecific double-strand DNA
binding, did not appear to be well conserved. The CHM
candidate protein likely localizes to mitochondria. To con
firm that the MutS-like protein localized to the mitochon
drion, we conducted RACE-PCR and discovered a transcript
start site at 578 residues upstream to the site predicted in the

Munich Information Center for Protein Sequences (MIPS)
database (Schoof, et al.) and in GenBank (Accession
AP000382). No start site was observed by RACE analysis at
the point predicted by the MIPS database, and three clus
tered transcription Start Sites were detected at the upstream
site. The confirmed start site added 102 amino acids to the

predicted protein product and permitted the identification of
a mitochondrial targeting presequence that was omitted from
the previous database entries. The Sequence was annotated

SEQUENCE LISTING

<160> NUMBER OF SEQ ID NOS: 65
<210> SEQ ID NO 1
&2 11s LENGTH 3673
&212> TYPE DNA

<213> ORGANISM: Arabidopsis thaliana
<400

SEQUENCE: 1

488 nm excitation and two-channel measurement of emis

Mitochondria were identified by their characteristic move
ment and rapid inter-conversions from Small round to highly
elongated, shapes. Plastids located in the cells emit red

autofluorescence. Positive controls for mitochondrial (F1
ATPase gamma subunit provided by Dr. D. Stern) and
chloroplast (Rubisco Pea/SSU/TPSS, provided by Dr. L.
Alison) targeting were included with each experiment.
Example 3
Identification of Homologs
0.142 Homologs were identified by BLAST search using
the tblastin program against the est others database. The
MSH1 protein Sequence was used as the Query Sequence.
The search was done using the BLOSUM62 matrix, word
size of 3 and low complexity filter.
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ggatto agitt tagatgaggg cqcaaaacca ttagatggtg ccagtic gaat gaagctgaca

234. O

ggcctgtcac cittattggitt to atgitatct tctggalacc.g. citgttcacaa taccgttgac

24 OO

atgcaatcac totttcttct aactggacct aacggtogto gtaaatc gag tittgctdaga

2460

totaatatgcg cagotgctict acttggaatt toc ggtttaa toggttccago togaatcagot

252O

tgtattocto actittgattc catcatgctt cacatgaaat catatgacag ccctgtagac

258O

ggaaaaagtt cittitcCaggit agaaatgtcg gaaatacgat citattgtaag coaggctact

264 O

to gaga agcc tagtgctitat agatgagata tocc gaggga cagagacago: aaaaggcacc

27 OO

tgitatcgctg gtagtgtggit agaga.gtott gacacaagtg gttgtttggg tattgttatct

276 O.

actcatctoc atggaatctt cagtttacct cittacagoga aaaa.catcac atataaag.ca

282O

atgggagc.cg aaaatgtcga agggcaaacc aagccaactt goaaattgac agatggagtic

2880

tgcagagaga gtc.ttgcgtt togaalacagot aagagggaag gtgttcc.cga gtcagttatc

2.940

caaagagctgaagctottta cotcitcgg to tatgcaaaag acgcatcago togaagttgtc.

3OOO

aaacco gacc aaatcataac titcatccaac aatgaccago agatccaaaa accagtcago

3060

totgagagaa gtttggagaa goactitagca aaagctatog toaaaatctg toggaaaaag

312 O

atgattgagc ctdaag caat agaatgtc.tt toaattggtg citcgtgagct tccaccitcca

318O

totacagttg gttctt catg cqtgitatgtg atgcggagac cc.gataagag attgtacatt

324 O

ggacagaccg atgatcttga aggacgaata cqtgcgcatc gag caaagga agg actdcaa

33OO

gggtoaagtt ttctatacct tatggttcaa gqtaagagca togcttgtca gttagagact

3360

citattgatta atcaactcca togaacaaggc tactcitctgg cita acctago C gatggaaag

342O

caccgtaatt toggaacg to citcaagcttg agtacatcag acgtagt cag catcttatag

3480

tittgaaac at tagctgtgtt totagttgat catctotato, togcaattgaa caagt cagtt

354. O

tgctagaact agagtagatt actaagaaac catgcc.gttt ttcattttga gattittgcaa.

3600

aacggcatcc agttcgggta agtcggatgc cqcaattacc aattittgggt cagtctgttgt

3660

aattgtcgtt toa

3673

<210> SEQ ID NO 2
&2 11s LENGTH 3673
&212> TYPE DNA

<213> ORGANISM: Arabidopsis thaliana
&220s FEATURE

<221 NAME/KEY: CDS
<222> LOCATION: (124) . . (3480)
<400

SEQUENCE: 2

agaggactgt gagattgttga attgcatagt cqtcgtottctgg.cgggaaa agaag.cccta

60

gaaaaagggit gaaaggtogala aactcitactt cittcttctitc ttcttcttca gagtgtgaga

120

gag at g cat tog att gct acc aga aac goc gito gtt to a titc cca aaa

168

Met His Trp Ile Ala Thr Arg Asn Ala Val Val Ser Phe Pro Llys
1

5

10

15

tgg cqg titc titc titc cqc toc to a tat cqc act tac tot toc citc aaa

216

Trp Arg Phe Phe Phe Arg Ser Ser Tyr Arg Thr Tyr Ser Ser Leu Lys
20

25

30

ccc toc toc coa att cita citt aat aga agg tac tot gag ggg at a tot

Pro Ser Ser Pro Ile Leu Lleu. Asn Arg Arg Tyr Ser Glu Gly Ile Ser
35

40

45

264
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-continued
tgt
Cys

gat gga aag
Asp Gly Lys

tot ttg
Ser Telu

312

gtg aag acg toa agt gat gtt citc. act gac a.a.a. gat citc. tot cat
Wall Lys Thr Ser Ser Asp Wall Telu Thr Asp Lys Asp Telu Ser His
65
70
75

360

gtt tgg tgg aag gag aga ttg Cag aca tgt aag
Wall Trp Trp Lys Glu Arg Telu Glin Thr Cys Lys
85
9O

4.08

50
a.a.a.

a.a.a. aga atc. a Ca acg gct
Lys Arg Ile Thr Thr Ala

tot aag
Ser Lys

citc. aga
Telu Arg

55

60

tot act
Pro Ser Thr

a.a.a. cca

95

citt Cag citt att gaa agg citt atg tac acc aat tta citt
Teu Glin Telu Ile Glu Arg Teu Met Tyr Thr Asn Teu Teu

1 OO

ggit ttg gac
Telu Asp

105

cost agc ttg agg aat gga agt tta
Pro Ser Telu Arg Asn Gly Ser Telu

456

Gly

110

tgg gag
Trp Glu

504

tgc aga
Cys Arg

552

ata citt gtt
Ile Telu Wall

600

gaa tat gct ggit citc. aat cost titt ggit ggit citt Cga toa gat agt att
Glu
Ala Gly Teu Asn Pro Phe Gly Gly Teu Arg Ser Asp Ser Ile
160
1.65
170
175

648

115

a.a.a. gat gga
Lys Asp Gly

aac citc. aac
Asn Teu Asn

120

125

atg ttg Cag titt aag toa agg titt cca cgc gaa gtt ttg citc.
Met Telu Glin Phe Lys Ser Arg Phe Pro Arg Glu Wall Teu Telu
130

135

140

gta gga gaa
Wall

Gly
145

cca

titt tat gag gct att gga ata gat gct
Glu Phe Tyr Glu Ala Ile Gly Ile Asp Ala
15 O
155

aag gct ggC tgc
Lys Ala Gly Cys

att atg aat citt cga.
Pro Ile Met Asn Telu Arg

act ttg gat gac
Thr Telu Asp Asp
190

696

aca cgc aat ggit tat toa gtg tgt att gtg
Thr Arg Asn Gly Tyr Ser Wall Cys Ile Wall
195
200

gaa gtt Cag ggg
Glu Wall Glin Gly
2O5

744

aca cca gCa cgc too cgt. a.a.a. ggit cga. titt
Thr Pro Ala Arg Ser Arg Lys Gly Arg Phe
210
215

toa ggg cat gCa
Ser Gly His Ala

792

cca

18O

citg
Lel

cca

cat

185

gga agt cost tat gta tat ggg citt gto ggit gtt gac cat gat
Ser Pro Tyr Wall Tyr Gly Telu Wall
Wall Asp His Asp
225
230
235

cca

His Pro

840

Gly

citt gac titt cost
Lel Asp Phe Pro

gat
Asp

240

cost atg cost gtt gtt ggg alta tot
Pro Met Pro Wall Wall Gly
Ser

245

tgt
Arg Gly Tyr Cys
agg ggg tat

gat gat ggit
Asp Asp Gly

cgt.
Arg

toa gCa
Ser Ala

25 O
a.a.a.

gca tat

tog

cita a Ca gaa gaa gcc tta gtt acc aag citc. cgc act
Teu Thr Glu Glu Ala Telu Wall Thr Lys Telu Arg Thr

280

cgt. cgc tgt cat cat
Arg Arg Cys His His

984

285

citt titc. tta cat gCa tog ttg agg cac aat gCa
Teu Phe Telu His Ala Ser Teu Arg His Asn Ala

29 O

936

Ala Tyr Ser
27 O

265

275

888

255

atg alta tot att titc. gag act atg
Met Ile Ser Ile Phe Glu Thr Met
260

cita
Teu

220

1032

295

tgg
Trp

1080

gga gaa tgc
agC agg aat titt gaa tgg titt gaa gga gat act citt
Glu Cys Ser Ser Arg Asn Phe Glu Trp Phe Glu Gly Asp Thr Telu
320
325
330
335

1128

too gag citc. tta toa agg gto
Ser Glu Telu Telu Ser Arg Wall

1176

toa ggg acg
Ser Gly Thr

tgc cgc tgg gga gag titt ggg gaa ggg ggit
Cys Arg Trp Gly Glu Phe Gly Glu Gly Gly

305

310

cita citc.
Telu Telu

315

Gly

340

a.a.a. gat gtt
Lys Asp Wall

345

tat

ggit

Gly

citt
Teu

gat gat gaa
Asp Asp Glu
350
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aaa coc gac caa atc ata act tca to c aac aat gac cag cag atc caa

3048

Lys Pro Asp Glin Ile Ile Thr Ser Ser Asn. Asn Asp Glin Glin Ile Glin
96.O

965

970

975

aaa coa gtc agc tict gag aga agt ttg gag aag gac tta goa aaa got

3 O 96

Lys Pro Val Ser Ser Glu Arg Ser Lieu Glu Lys Asp Lieu Ala Lys Ala
98O

985

atc gtc. aaa atc tdt ggg aaa aag at g

99 O

att gag cott gala gca

at a gaa

Ile Val Lys Ile Cys Gly Lys Lys Met Ile Glu Pro Glu Ala

Ile Glu

995

10 OO

tgt citt toa att ggit gct cqt gag

314 4

1 OO5

citt coa cot coa tot

aca gtt

31.89

Cys Leu Ser Ile Gly Ala Arg Glu Leu Pro Pro Pro Ser Thr Val
O 10

ggit tot to a

O15

tigc gtg tat gtg atg

O20

cqg aga ccc gat aag

aga ttg

3234

Gly Ser Ser Cys Val Tyr Val Met Arg Arg Pro Asp Lys Arg Lieu
O25

tac att gga

O3O

cag acc gat gat citt

O35

gala gga cqa ata cqt

gcg cat

3279

Tyr Ile Gly Glin Thr Asp Asp Leu Glu Gly Arg Ile Arg Ala His
O40

cga goa aag

O45

gaa goa citg caa gogg

O50

to a agt titt cita tac

citt atg

Arg Ala Lys Glu Gly Lieu Glin Gly Ser Ser Phe Leu Tyr

Lieu Met

O55

O60

gtt caa ggit aag agc at g got tot

cag tta gag act cita

ttg att

Val Glin Gly Lys Ser Met Ala Cys Glin Leu Glu Thir Lieu

Lleu. Ile

OFO

aat Caa Ctc

O75

Cat gaa caa gg C tac

3324

O 65

3369

O8O

tot Ctg gct aac Cta

gcc gat

3414

Asn Glin Lieu. His Glu Glin Gly Tyr Ser Lieu Ala Asn Lieu Ala Asp
O85

gga aag cac

O9 O

cqt aat titc gga acg

O95

toc toa agc titg agt

aca tota

3459

Gly Lys His Arg Asin Phe Gly Thr Ser Ser Ser Leu Ser Thr Ser
1 OO

gac gta gtc

105

110

agc atc tta tag tittgaaa.cat tagctgttgtt totagttgat

3510

Asp Val Val Ser Ile Leu
115

catctotato, togcaattgaa caagttcagtt toctagaact agagtagatt actaagaaac

357 O

catgcc gttt ttcattttga gattittgcaa aacgg catgc agttcgggta agtcggatgc

36.30

cgcaattacc aattittgggt cagtctgttgt aattgtcgtt to a

3673

<210> SEQ ID NO 3
&2 11s LENGTH 1118
&212> TYPE PRT

<213> ORGANISM: Arabidopsis thaliana
<400

SEQUENCE: 3

Met His Trp Ile Ala Thr Arg Asn Ala Val Val Ser Phe Pro Llys Trp
1

5

10

15

Arg Phe Phe Phe Arg Ser Ser Tyr Arg Thr Tyr Ser Ser Leu Lys Pro
2O

25

30

Ser Ser Pro Ile Leu Lleu. Asn Arg Arg Tyr Ser Glu Gly Ile Ser Cys
35

40

45

Leu Arg Asp Gly Lys Ser Lieu Lys Arg Ile Thr Thr Ala Ser Lys Lys
50

55

60

Wall Lys Thir Ser Ser Asp Val Lieu. Thir Asp Lys Asp Leu Ser His Lieu
65

70

75

8O

Val Trp Trp Lys Glu Arg Lieu Glin Thr Cys Lys Lys Pro Ser Thr Lieu
85

90

95
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Glin Lieu. Ile Glu Arg Lieu Met Tyr Thr Asn Lieu Lleu Gly Lieu. Asp Pro
100

105

110

Ser Lieu Arg Asn Gly Ser Lieu Lys Asp Gly Asn Lieu. Asn Trp Glu Met
115

120

125

Leu Glin Phe Lys Ser Arg Phe Pro Arg Glu Val Lieu Lieu. Cys Arg Val
130

135

140

Gly Glu Phe Tyr Glu Ala Ile Gly Ile Asp Ala Cys Ile Leu Val Glu
145

15 O

155

160

Tyr Ala Gly Lieu. Asn Pro Phe Gly Gly Lieu Arg Ser Asp Ser Ile Pro
1.65

170

175

Lys Ala Gly Cys Pro Ile Met Asn Lieu Arg Glin Thr Lieu. Asp Asp Lieu
18O

185

19 O

Thr Arg Asn Gly Tyr Ser Val Cys Ile Val Glu Glu Val Glin Gly Pro
195

200

2O5

Thr Pro Ala Arg Ser Arg Lys Gly Arg Phe Ile Ser Gly His Ala His
210

215

220

Pro Gly Ser Pro Tyr Val Tyr Gly Leu Val Gly Val Asp His Asp Leu
225

230

235

240

Asp Phe Pro Asp Pro Met Pro Val Val Gly Ile Ser Arg Ser Ala Arg
245

250

255

Gly Tyr Cys Met Ile Ser Ile Phe Glu Thr Met Lys Ala Tyr Ser Leu
260

265

27 O

Asp Asp Gly Lieu. Thr Glu Glu Ala Lieu Val Thr Lys Lieu Arg Thr Arg
275

280

285

Arg Cys His His Leu Phe Lieu. His Ala Ser Lieu Arg His Asn Ala Ser
29 O

295

3OO

Gly Thr Cys Arg Trp Gly Glu Phe Gly Glu Gly Gly Lieu Lleu Trp Gly
305

310

315

320

Glu Cys Ser Ser Arg Asn. Phe Glu Trp Phe Glu Gly Asp Thr Lieu Ser
325

330

335

Glu Lieu Lleu Ser Arg Val Lys Asp Val Tyr Gly Lieu. Asp Asp Glu Val
340

345

35 O

Ser Phe Arg Asn Val Asn Val Pro Ser Lys Asn Arg Pro Arg Pro Leu
355

360

365

His Leu Gly Thr Ala Thr Glin Ile Gly Ala Leu Pro Thr Glu Gly Ile
370

375

38O

Pro Cys Lieu Lleu Lys Val Lieu Lleu Pro Ser Thr Cys Ser Gly Lieu Pro
385

390

395

400

Ser Leu Tyr Val Arg Asp Lieu Lleu Lieu. Asn Pro Pro Ala Tyr Asp Ile
405

410

415

Ala Leu Lys Ile Glin Glu Thir Cys Lys Leu Met Ser Thr Val Thr Cys
420

425

43 O

Ser Ile Pro Glu Phe Thr Cys Val Ser Ser Ala Lys Leu Val Lys Leu
435

4 40

4 45

Leu Glu Glin Arg Glu Ala Asn Tyr Ile Glu Phe Cys Arg Ile Lys Asn
450

455

460

Val Lieu. Asp Asp Val Lieu. His Met His Arg His Ala Glu Lieu Val Glu
465

470

475

480

Ile Leu Lys Lieu Lleu Met Asp Pro Thir Trp Val Ala Thr Gly Lieu Lys
485

490

495
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Ile Asp Phe Asp Thr Phe Val Asin Glu Cys His Trp Ala Ser Asp Thr
5 OO

505

51O.

Ile Gly Glu Met Ile Ser Lieu. Asp Glu Asn. Glu Ser His Glin Asn. Wall
515

52O

525

Ser Lys Cys Asp Asn Val Pro Asn Glu Phe Phe Tyr Asp Met Glu Ser
530

535

540

Ser Trp Arg Gly Arg Val Lys Gly Ile His Ile Glu Glu Glu Ile Thr
545

550

555

560

Glin Val Glu Lys Ser Ala Glu Ala Leu Ser Lieu Ala Val Ala Glu Asp
565

570

575

Phe His Pro Ile Ile Ser Arg Ile Lys Ala Thr Thr Ala Ser Leu Gly
58O

585

59 O

Gly Pro Lys Gly Glu Ile Ala Tyr Ala Arg Glu His Glu Ser Val Trp
595

600

605

Phe Lys Gly Lys Arg Phe Thr Pro Ser Ile Trp Ala Gly Thr Ala Gly
610

615

62O

Glu Asp Glin Ile Lys Glin Leu Lys Pro Ala Lieu. Asp Ser Lys Gly Lys
625

630

635

640

Lys Val Gly Glu Glu Trp Phe Thr Thr Pro Llys Val Glu Ile Ala Leu
645

650

655

Val Arg Tyr His Glu Ala Ser Glu Asn Ala Lys Ala Arg Val Lieu Glu
660

665

67 O

Leu Lieu Arg Glu Lieu Ser Wall Lys Lieu Glin Thr Lys Ile Asin Val Lieu
675

680

685

Val Phe Ala Ser Met Leu Leu Val Ile Ser Lys Ala Leu Phe Ser His
69 O.

695

7 OO

Ala Cys Glu Gly Arg Arg Arg Lys Trp Val Phe Pro Thr Lieu Val Gly
705

710

715

720

Phe Ser Lieu. Asp Glu Gly Ala Lys Pro Leu Asp Gly Ala Ser Arg Met
725

730

735

Lys Leu Thr Gly Leu Ser Pro Tyr Trp Phe Asp Val Ser Ser Gly. Thr
740

745

750

Ala Val His Asn Thr Val Asp Met Glin Ser Leu Phe Leu Leu Thr Gly
755

760

765

Pro Asn Gly Gly Gly Lys Ser Ser Lieu Lieu Arg Ser Ile Cys Ala Ala
770

775

78O

Ala Lieu Lieu Gly Ile Ser Gly Lieu Met Val Pro Ala Glu Ser Ala Cys
785

790

795

8OO

Ile Pro His Phe Asp Ser Ile Met Leu. His Met Lys Ser Tyr Asp Ser
805

810

815

Pro Val Asp Gly Lys Ser Ser Phe Glin Val Glu Met Ser Glu Ile Arg
820

825

83O

Ser Ile Val Ser Glin Ala Thr Ser Arg Ser Leu Val Leu Ile Asp Glu
835

840

845

Ile Cys Arg Gly Thr Glu Thr Ala Lys Gly. Thir Cys Ile Ala Gly Ser
85 O

855

860

Val Val Glu Ser Leu Asp Thir Ser Gly Cys Leu Gly Ile Val Ser Thr
865

870

875

88O

His Leu. His Gly Ile Phe Ser Leu Pro Leu Thir Ala Lys Asn Ile Thr
885

890

895

Tyr Lys Ala Met Gly Ala Glu Asn Val Glu Gly Glin Thr Lys Pro Thr
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9 OO

905

910

Trp Llys Lieu. Thir Asp Gly Val Cys Arg Glu Ser Leu Ala Phe Glu Thr
915

920

925

Ala Lys Arg Glu Gly Val Pro Glu Ser Val Ile Glin Arg Ala Glu Ala
930

935

940

Leu Tyr Lieu Ser Val Tyr Ala Lys Asp Ala Ser Ala Glu Val Val Lys
945

950

955

96.O

Pro Asp Glin Ile Ile Thr Ser Ser Asn. Asn Asp Glin Glin Ile Glin Lys
965

970

975

Pro Wal Ser Ser Glu Arg Ser Lieu Glu Lys Asp Leu Ala Lys Ala Ile
98O

985

99 O

Wall Lys Ile Cys Gly Lys Lys Met Ile Glu Pro Glu Ala Ile Glu Cys
995

10 OO

1005

Leu Ser Ile Gly Ala Arg Glu Leu Pro Pro Pro Ser Thr Val Gly
O 10

O15

O20

Ser Ser Cys Val Tyr Val Met Arg Arg Pro Asp Lys Arg Lieu. Tyr
O25

O3O

O35

Ile Gly Glin Thr Asp Asp Leu Glu Gly Arg Ile Arg Ala His Arg
Ala Lys Glu Gly Lieu Glin Gly Ser Ser Phe Leu Tyr Lieu Met Val

Gln Gly Lys Ser Met Ala Cys Gln Leu Glu Thr Lieu. Leu. Ile Asn
Glin Lieu. His Glu Glin Gly Tyr Ser Lieu Ala Asn Lieu Ala Asp Gly
Lys His Arg Asn Phe Gly. Thir Ser Ser Ser Leu Ser Thr Ser Asp
Wal Wal

Ser Ile Leu

<210> SEQ ID NO 4
&2 11s LENGTH 8O393
&212> TYPE DNA

<213> ORGANISM: Arabidopsis thaliana
<400

SEQUENCE: 4

aagcttgcat citctoaagaa citctgacaat cagtcaaagg gattittctot gag cottatc

60

agcaaactitg aggtaagatc atgtttctoc aaactcaiaca citttcttcto gattittacaa

120

titccatcata aacaaagg to ttctotgttc cittctocagg to attgttgt cagtcttatt

18O

taatctotca aatcgaac at ttaggatatg taataa.catg attaa.gc.cat tdtcc tagac

240

caaatacagt ttgcaa.catt gtagatgtaa gtgcttittgg ttittgcticag cqtaacgatt

3OO

tgtc.tc.ttgc tictact agtc. aggaactago gaacticcittg gatttagaga ccc.ggcaaaa

360

cittatcaggc titcatggatg citgttgagaa aatactcgtg cagoa aacco gtgaagaact

420

caagttccaat gaatcc tocc aaaagtgagt accalagalacc accitcaagag tttgttgcagt

480

ttctatotcc titattgttitt tdtcttgggit tattatctg.c aactcitttgttgtaattact

540

ttggaaattig gaattgitatc aatactcittg cittatgtcct caagtttcct ttatatato a

600

atatoctitaa acacattatt atcttactict cogccatata taatcagaga actaatgaaa

660

taatctocaa ataatctoca aatacttcto cattctggitt aatggaggaa alacaccalacc

720
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atatataact tacggagaag taatctocaa ataatctoca aatacttcto cattctggitt

78O

aatggaggaa alacaccalacc atatataact tagtgattac ttcto cqtaa gotgacaa.ca

840

aaactcagag gtc.tctittaa atggaagaag citaaagttgttctittgagtg ttitta actot

9 OO

tactittagtc. aatttalagga agt caatatg gottagtaaa totaattalaga aaaccattta

96.O

aaatctacca agtttagt cit aaaag actgt tdtctacact tagctaalacc aaaaaacaga

O20

accagaacca gcaccaaata aacctaatga aattitccatt ttaaattaaa ccacgttcag

O8O

attgttcttg tottcactitg agattcttgt gcagtggaac citctttgcct totagaaagt

14 O

ttittcaatcg tittgcttcaa gacaggtttcaatctittctd ttacaag agt gacctc.gc.gc

200

agtttctgat tcaaccggitt caagatc.gca ggtaaaactc tittgatgatt ttctttcact

260

atttcaag.ca tatctotaccatataaattt totgcacatc totagaactt coctocaaga

320

totttcaggit coctotctoc gittaataact tccitctgcat tctitc.gctg.c acttgttaga

38O

aatcccacca acatatotag citcgaacatc tdatctitccc agttgtacat atctttittcg

4 40

atat cq gtta ggttcttctg. tcc citggata totata actot to acaa.ccca agtgttgttt

5 OO

agtact gtag acgaga.ccgg totctgttct tcc ttgg gala ttagcttata gttaggtgtc.

560

gctcgttcag totttctoct tittcttcaga ggtotctdag gttggtotga titcctittgga

62O

ggcaac attc citctottccc ctittccctcc aacttgatct tatcc.gactic tatgtcttgg

680

gggittatcat Caactittaac Cotagttcca gCCtcatctt CitcCatgacc gtagg caatg

740

totacgaacc gttgataaag attcttgtat ttatc gatca aac gttgaag agacittaacg.

800

aattggctgt aatcgattct atgagacitta aagtc.tttac acaa.gcaagt gtaaact citc

860

aatticc gacc gagittagt ct citcctcgata gccttcaata actctgtcaa cittctgtttc

920

gcttctaaac ggtoctitcat citttctotcc acatcgtott taggitttata aactato.cgt

98O

atac gaggta to atctittgg titcattaaga agaatagggit totcittc.cgg cittct catca

20 40

tgatcaatct titcgattaag gttattgttct ttaagccitcc taagttctot agtgagttcg

2100

ggatttctga gtag acgtac cqaagatcgt aaccttgtct gtacc gatga agacitgttgtc.

216 O

ttgacaccgt togtottcat caacticatca gcgtoagicca tatcttctga atctogatag

2220

cgtgtgagcg aaacaaacga cittagggtag agtatatata aggtotttitc gttitt.cctitt

228O

ttttittgagg agattalacta totagatttg citgaaagtac goagattact tottttctaa

234. O

ccaatggtaa taaatcaatt tatttaaatt agttittctitt caactgatta aaaacaatta

24 OO

aacgcaaatt aaattittgag aatcagtatt totcittatat ataaattitat acatgaaaaa

2460

tataaaatat ttacaacaaa aatcatcatc titatgaagag titcatgaatc. tcatcaaatc

252O

totctgttitt citcttgcaac aaaactcacg gtgatgtc.gt citatacaaat cittgttgctt

258O

tittatattag aatttgttag attctagtag gotggaaggg atcttgaagg atttgttgttt

264 O

agagattitat gtcattct cattttaggagg to gagaagttcaaaag agaat calaccatcta

27 OO

gcagotcaat toggaagtatg tdaagtgatt gatgatgaca tottttatag titttgtttct

276 O.

attatatgaa gottgttgccc catctgaaat tittctatatt totcittagtt cittitcctctg

282O

gcta acatac ctaagatact gtatgatatgcatccaacct caaagttata ttttgttgaa

2880

tottalaggtg totgtcataa cct atcttaa aactgcaggc aggta aggtt acact cittca

2.940

gtgctaga.ca caagat cittc agtccagtgg gttgtc.gc.ca aagtgcaaga tataattatt

3OOO
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totaacaact ttgagaaaag attttgttgat gagttcgaaa acaattagtt gag cott.ccc

3060

tittcagtagc titaagaggct gaatttittct titcgtagcta acticatgtca ttgagttcto

312 O

tgagcaa.gcc aattgactgc atgttttgttg atccitatggc agg cacacgt to gaatact a

318O

cgacaaagat gaaacaattg to act catat agctggaggit attgatgcat ttittaaaggt

324 O

citctgatggit toggccactgc tigaatacccc attaaatgga agaagctaaa gttagtgttt

33OO

taactattac tatatagtica atttagga aa gttcaatattg cittagtaaat caattaagaa

3360

alaccatttaa aatctacaaa citcaagttcta aaagattgtt gtctacagtt agctaalacca

342O

aaaaacagaa cca acaccala aaacaaatta accitaatgaa aattacattc taaattaaac

3480

caggttcaga ttgttgttgt citt cacttga gattottgttg cagtggaagg to atttggat

354. O

tatgtotagg tittgggattt gocto gagtg atctotacat gtggtgagtt totaagaaaa

3600

tgaagttcgg gaatcgaaaa aaacgctt.ca taalacccagt aaagctacaa gagatggatg

3660

ttacaactaa atalacacttg cacttgaaaa citaaacaaag tttittataca aagagtgc.ca

372 O

caagtggagt ggtggtatac acagagtaaa aatgagacaa totaaacaag agaaggc.ca.g

378 O.

toaa.gctaga C gagtggatc tdtcaaaggc citcaatgact togatalaccat atctatoctit

384 O

acacaaatga atactg.cggg to acgaggac ggaggtoaga citgtgcggaa gatcaat acc

39 OO

ggtgcgttta aaa.ccc.caaa toagacgctgaactacatag titc.ccaacac gatctitt cac

396 O

Caaattctoa aagtaactat caaactcaga ggcaatcaac gitaag acacic tittcatCaag

4020

catato aaga aacttctgca cagggitaatt agaga aggag cct gatgaaa gogacacaaa

408 O

gtgaccagag aacttgttta coctittctta toaaagg cag citatcaa.gca atc attacca

414 O

aacatggaga gcaaaagtga accagoatga tigtataagca gtaataggitt cittgttacca

4200

atctoattac gggagagttcaacaaaagtt gcaccaactt gaatcaggaa cittgaacaaa

4260

agttgcacca ttctoatatt gacittgattit aaatattaac aaaaaattat atctatgtta

4320

ttgtag agaa gaaaaaagaa aaacgtatat aattaaagat taggaaactic aagttcctittg

4.380

aagaaaaata agaaataaaa aaaccoaa.gc ctaaagtaaa ccttgataaa togtoatacc

4 440

ttittctgaac gatactatto tataatacat atttaactag ataagtaatc cqcaccittgt

4500

gcagaaaaaa aaattattaa ataaatttaa cattggatta aatatagaag titattotagt

45 60

ggccaaaatc tataatgact ttagg gttta tatagatata totgatatoc attatatgat

462O

caataatata ttggcaaata tagaacagaa catttatatt ttattaatat gtttagtata

4680

taaaatgatg attcttittga tattataact tattotttat aagataaata atattgctaa

474. O

ataatticgct taacgcatta gtaatact at ttt tatgtat ttttgtaaag gtgaaaacga

4800

ttittatgtaa tatatgtttgtcaaaaattt gtag tattgt ggatgaatat gatattggta

4860

ttctatttat aggaaaatat gtttittacat atgtaggaaa ttgttctttitt to cittgcaat

4920

tgttittagaa atttgttaca agatattaat gcgggaaaaa totaaattitt totttcggaa

4.980

tatctatagt aaaatatgat tttgttcc.ca tattittctaa tatttitactt atgitattatt

5040

agittaatgat atacgcagtt attctaattg gcggcagatt togctatatat acttgattag

51OO

ggg tagttitt cittttgtaga cacatcaatc totatgaaat ttacaggatgaaaaacactic

5 160

ggcc acgaag agccaaaatt taggtttgcg ttittgctgtg tdaag agaaa atatgagtca

5220

agtatgggitt togalaattcag taatttgaga agagttcatt gactaagtat tdacgtgagt

528 O
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atggtagaat

atacaataaa. ccatatacitt acatalactaa

toataaaagg aattgatagt

5340

cittatacitac

atgcactaag

acctggctta gcatttctaa acacgaattit

5 400

aatgacaat g g c gatatgaa

546 O

gaaacaaaag Cagagggcta gaccalagcat gaagttctitt aacgittattt tttgttaaga

552O

gactgaagaa gaaagaagga ttctato gag attggagaga gtggttgagc ticggg Calaga

558 O

gaataalacca atgtaccact ttagatacaa tgttittgagc tittctgaaga gaaaaaagaa

5640

gagaaaaacg. agacitaaa.ca attattagtt titt catagitt atatttaact acaaactgat

5700

tgtttitcggit gtatgtgitat aggtaccalaa to cattggct titc gagattgaaattaatta

576 O.

agaaactcat

aatatatgga cgaaatttga gtaaaattca

582O

ctaagcttct gtocataaaa ccittaagtga aaaagggaga tdaatcc caa gaatctattg

588 O

aaaatatgat aatcttaagt aaaaaagcaa acticaagaat catagottta toggatagaac

594 O

toactalacca

acaaactgtt aagatctogt ggcgtctgac

aatticcatac attacatacac

aa.catccaat

gct cittggaa gaaaacaaga atcatcc.ggg

toctattoto taccalaaa.ca

6 OOO

cittcgttittc atc.gagaatg titcatgtata

6060

tgaggaaatc ttgagattta gggcaa.cgtc. ttgggaatct cctacittata ataaattgaa

61.20

atcaagaaaa

aatatalactic

atgcaatgat cagattccag attcaagatc atataataaa

618O

toaaa.cccta

tat cittcatg

aaaaac CaC

aag acatata agaacaatca citacgagagc

624 O

agtgaattta gtagaaatca

atacaataca

taagg gttta tdaattgctt gagtaacaat

6300

gaaccoctaa acaataatgt citagagataa aagatatgta aatcgaaaag aaataaacco

6360

taag agaatg atcgaalacta attgatato.g gaatcatcaa aatcatcctc gaacttgttg

642O

aagaaatcgc tgtc.ttcggg cittcatttga aagggtgaaa titcctccaac ttcaaactg.c

64.80

atat coatgg gcc.cgaagtc gtottcatcg

gcatagg cat cqagtatcct

654. O

ggatactc.ca totcaccoag aaagttcacgg tacaccatcg gcc to atcgg gtc.ttgttcc

6600

ccatcgtttc gctitcctttg cgtgaaaatc aaacaaaacc taaggataaa

6660

aaattataac

aagagtgc.ca ccacacacga

caat atctat

aactitataca

atctocatct

gagaaagaga ggtgttctac tttittgaggg ttaggacacc cittaagtaat atc.cgggaca

ttataaaggc cc attagtag aggagattgg

agt caagata aattaa.gaga

678 O.

tittctittctit

tatgttgtcat caacaattag tttittaagat tttitttctaa aacaaagatt

6840

ttgt attaga

ttatattoaia

to cattaitac

catatgtagt

atctactaala

ataag cottt citaataatta

69 OO

taatgaccat tataaagaaa aaagtatatt

tatttittatt

tottatttitt g g tattgatt

696 O

aaaatataca

tatctaacgt citatataaga aacatatgtg ttttacaatt atcaaaactg
ttgttaacat gtattagct g aagct cittca

708O

ccagtaaaat cattgcaaag atatatgatt caaaattggg aaaaatcttic cctagtagag

714. O

attact tcca acagaaggaa acatacaaat

aacaacticala

tgacaatgtg aggacaaaag Cagagaagaa taalacactaa aagagaalacc

ttttgttatca tag tatttac

aa.catttaac

gatcataatt ttgag cattt to aggattga

726 O

toaaaatcta tatatatata

tatgataaga gactitcattt tgaataatca aataagatac

732O

aaacaaccitt

aatcc.gtata atagtcatta atttattagc ttgttggtgga ggtggtttitt

citgccaccita taggattatc acacgggaca acatgcaa.gc atgcatattg to agaalacat

440

actcaagaaa gccaaagaaa tgaccggcct cga gaatgac cagtatgcaa gqacgctata

7500

citatcctaag

756 O

toctaacticc

taatccatag

aaaaatactic

tgaac acgtg gtacgtgact
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aggtagtaga agagtc.citcc ggctgcagca tdaaggacat tagtgag cat gatgttcatc

9900

gtgttcttag citctaacgga gcc agcacaa agcatagoga agcc.gagct g catc.gcaaag

996 O

acaagatagg Cagaga agag gaggtacgtg ttgttctatag cgtaggctoc atcggtaaac

OO20

ttgttgttaa cggaac coaa citggcc.gcaa atgtagt cag cc.gct gcc.gt ggcatttggg
CCgagtaggg citgagagatc agcc.gcagag caagtaatag citcctgacat gttittagaga

O 140

Cttgagagag galaccacacg aataagaaag attgttctott gtgcagotat aaaaagaaaa
agaggaggag tittctgatto tggcttgacc aatcaaattic gtagittaagt ggagagatat
toattattaa.

attattagag atggaatcta

acaaatctta

taalactactt gcaatatacg

O260
O320

agaatctitat acggttittgg aaatttagtg attgg catgt actittittatt tagtatcaaa
cgcaatagitt

gagagggagt ttaaatticcc titatcacatg

04 40

cittcttittag caatctaagc aagct gatgg aa.gcaaattit aac coaaaat atgaatgacg

O5 OO

tottattata aaaaaagaga

acattataat

attgcaaaaa gat attaaaa

ataaaaaata

tgatctatto aattgtagca

O560

tatgtaagca

aaa.catattt gacCaaggaa

totaagaaga titc.ccgtaga gagttggtog

O 620

ggaagct cat togtgcttitt

O 680

acttitcgggg aaaaaacgtt tacatgtacc tgagtatctt ctaatttcta ttittaataga

Of 40

cc.gtttitcga citcacactgt

attatataaa.

cacaccacct cacac gaaag

caaaattagt actitctaggg tittctag caa atcaatttgt ggcaccittgc

tagttgtaga toagcaactc tttittittggg aatcaggtoa aaatticagoa ttcttaatac

O 860

gaaaatctta aatataatga actitgtaaag

O920

tattaatata

attgctgacg aaactgcaaa

tgatalacatg gtttagcggg aaccacgttt tattagttga aaattitcact td.cgatctta
ttagdalacca caatggtoga

O4. O

ataagaatga gtatagttta tagataaaat tgtag caata agtaatgttc caactatocc

100

tatatgtaaa

atalagacata cittgtaaatt cactagtgaa tatatacgta

160

C galaggagaa taaataagtt tactagatta caaattagct gatggaaaac gaagaagitat

220

acgatttaga

attacattaat

280

titttittittaa.
aaaatcatac

alaattcaa.ca

aatcaatggc gtttaatgtg

cittaatcatt

attctatata

attgggattt gacactcagg aaaatagaca aaaccaaact

totaatgtcg togac gaacg

ataalatattt

taattgcaac gggagcttitt

34 O

agagta acct gacat cattg

attaccacat

aacacaaatt aattatttga

400

taatacgttt aatttactga ttaattatag tgcatattat attittagttt aggtoaactg

460

acaattalact

ataagaacta

aaaattitact

aaatacgaaa agccacatt g g gacgtttitc

tgttittatga aattatgcaa cgg.cgcattg cgg.cgtotct agctatocto tatgcatato
agacitataaa atatttgttc gtgaaattac tttittatgtt citataatagt gattgagtgt

640

agaacatcat

aaaaaaaact

citatagataa tdataataat tigcattaaca

FOO

tatttggcta tittgccaaaa

caatttalact

caatactggit tgatttgcaa toctagagga

760

tataaatcaa gtggtag togg

820

ttaataacca

tottaaagaa ccatcttaga ttctaagtag

taaacaaata

tittagcgatt cccattctag gaag.cgttgc cittgtcggto tagaacaaga aaagatt cat
tacaaaac at

tgaattatct acatcaattg

titttittctitt

attattagaa aatttggtga atacact agt acttgacgac tataatcact

ttatttacct

agtcgaaata gtgttatatt

940

citaagaaatt agttgggtgg taaaatgtcg gattacc gat agata attaa aataaaataa

2060

aactictaagt

2120

citaalactata Cgggcaagaa

tatttaactg gttcgitaatt attittaatat
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tttittcttac tacgaccogt taaaggtaat caaaattctt gtacaatgtt citgtctttgt

218O

ttgggtgaca tatgaaatat acgtttgaga atatttaaat acagtttgac gactaatatg

2240

cacaaaaaga tigatgtgcaa gotiataagct actggaattg catcgtaatt coatgattot

2300

acaggtotcg aaagtgtata caaacaagga atatatgtta taaaaattitt totttagcag

2360

aatttgaaat aaataaaaaa tactattgaa at attagg to citaaaattta totalaccacaa

2420

aatatggg to atactic ctitt gtttaaagtt atc gaggacg caagaatttg atttatattt

24.80

taattittagt ttgtacgatt aatagdaaca attgttaggc taataaaacc cattaggctt

2540

agttcaatag ttctaaacaa gtgaccagtt acatagatgt aatgacatgt catatttctt

2600

citag tatt at ttattalacca acatc gttca agtaaaagat aatat citacg totacctaag

2660

cgtggctagt talactaattg gaaaaaatcg citttacgtgt acataaggga atgactaagt

2720

totgcttittg gtacgaaatg gtacacaaat gatttitt cag aatttatatt attctaagaa

2780

caacttttgt gtactic caat titcctaatgc cqtcggcaga acaaaaacct aag caaagtt

284 O

gtatacagta tatgcataac totcctttitt ggatcaccaa aagttgtata tataaattitc

29 OO

taagaaatag cataaacatt agcc.gaggca totaaaatta aaattcaaga aaaaaaaaaa

2960

aaacataaac taaaac actt ataaacacaa aaagacgata ggtoactitaa aacaaac caa

3020

aa.catccaaa tatttatatt toaaaaccala aacco aaa.ca atacttaaac ggtaataaat

3O8O

taccaaaaag ttgaaaatta aacg.cgagga ggagtagctg atcgagggaa aggagatcCa

314 O

ggat.ccactc tatgagacitc atcatcatta toatggtaga tataagcaaa gocaccgtga

3200

cgtgtcatat coatcc cittg cattt catgc tigctocq aga. tcc taag cag attgagc citt

326 O

ttgaggatga agaagagtgttcc cattgttg gcactaacco atcctacaat cacaagtatt

3320

tgaaccaatt gtgctcccaa cagottcc ct cotcc.gc.cca taaatagtcc atatggccitt

3380

cc.cggggtgg cqc cataaac citcgtttaga tacttct citt togcaaacaa toctacgaat

34 40

atcaa.ccc.cc acgc.gc.caca Coctocatgt agttgggctd cotcgagtgg atcatcatat

3500

tgtacaagct cogcqagctt gttgcatc.cg ataaggacga cagaa.gc.cat gaag.ccgcac

356 O

acaatcgctg. cccatggcto tacgacggag caacct gcgg titatggcc.gc. aalacc caccg

362O

agta accogt togcaaacg to C gttacgttc cagtggcctd ataggagacg tttaccaaag

3 680

agtgtggitta gagctgctgt gcatcctgag agtgtggtgt talacc.gctgt acggc.cgatt

3740

cc.gcto catt goccgtagtt goalaccagaa ttatacggaa cq agitat citt agtgaaggaa

38 OO

cc.ggggttga aaccatacca tocaalaccat aggagga agg titcctaagac tactago gag

3860

gcagagtggc cqc.gcagagc aatagogcga ccaccitttct c galaccg acc acgac gagga

392 O

ccttcaataa gag caccc.ca taalacctgct atgccaccala ccatctgaac aac accggag

398O

ccagoaaagt caatggctico ggtgctaaac aaacgatcat cogctgaacg aaagggactg

4040

gcc catcc at coggggacca aaaccagtga gagacaa.ccg ggtaaacaaa toc ggittaag

41 OO

aaagaagagt atatoaagta agccacgaac tagt cotct citgc gatcga accacttgtg

416 O

attccagogg cc.gc.gattgc gaacgcc.cat togtagagga agaaagagta atcagctgtg

4220

ggagtcggaa agt citctaag agcaaagttg tdtctitccaa togaac cottc ggaggat.cct

428O

ccaaaggcaa aggcgtaacc aaagagatag tagaagag to citc.cggctgc agcgtcaagg

434 O

acattggtaa goatgatgtt catcgtatto ttggctotaa cagaaccago acaaag cata

4 400
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gCgaag.ccga gctgcatggC galaga Caagg taggcagaga agaggaggta ggtgttgtct

4 460

atgg.cgaagg citgcatcggit gaacttgttg ttaacggtgc ctaattggcc gcaaatgtag

4520

toggcc.gc.cg cc.gtgg.cgitt ggggcCaagt agggtgg.cga gatcggcc.gc agagcatgtt

4580

attgcticcitg acatgtttga gagagctgag agagagaaag agagatacgg agaagaaagg

4 640

ttgtct cittg totgtc.tc.tt aaaaggaaga aggaggagtt tagggttgac tittagattcc

47 OO

ggctag acca attaagttcg tatttalagag agtttatcaa ttatttalaga agittatgttga

476 O

cgtaacaa.ca ttattgaatt agagatgtaa totgccaaat cittcttaata acttgcaaat

482O

tacgatccita atcctatacg gtttittggtg attaagtgat togc catgitaa totgtgaata

488 O

aaaaaaaggit aaattaaagg cittgtataaa aaaattacaa aaataaattt gtgaataaaa

494. O

ttgatactag tatttaaagt aataaatcaa agaataattg toctagotca accgtatatg

5 OOO

ttcaa.gcaaa cc gatcagaa cittactacat agatgtc gat tittagat cag cagttittatg

5060

aaattaagttcaag attcago actictittata cqacaatctt atgataatct tdcaaaattit

5 120

taataaagtt catalaccalaa tattaattaa gtttgctgaa gottgaalacc aaaaatgata

5 18O

acatgggitta gcgggalacca C gttittattt gctgaaaatt gcactttaca cocittaactic

5240

ttagatatgt coaaaattac toagatcatc aacagaag.ca ttaaaaaaaa ttatcttggit

53OO

tttgtataat aatact acat gcatotataa agtattoaat taggaaaa.ca aaaaaatgaa

536 O

gacacacgac atatagitttcaa.gcaa.gaga tatatacaat aattcgatcc aattgacatt

542O

gaaacctatt alacagttcat gaataattica cqtttatacc aaaacaaaaa cattcatgtt

54.80

taagatatat atatatatat atatatatat atattittaag atatttaatg attgaaaaaa

554. O

gacatttatc. tcticagtttg toccaa.gc.ca taaaattca agt caagtat tacttittagg

5 6.OO

aacatgatga totcttittga toaaaaatct attatgatgt atttgaataa atatacttaa

566 O

aagttgttac aagtgctgat gtttcaccaa taggctttitt attgtcacta actagttcta

572O

aaaactgaaa gotttctata tatgtatgtg totgttgttgtc. to accittaat catgttittaa

578O

gtoaacctaa cittaatcatt atgggagaca cittgttgacitt gttatctata tatttactga

584 O

tgagttgtaa atgagagttg acacticagaa aaatagacaa agcaaactgt tittctaaaat

59 OO

aatgaacgtt aaattatgca catattittag tagacggtag citttctaaat cqtacaaaat

596 O

aatgtcaaga attgacgtga catcattgat taccacatala caaatattga ttctittagta

6O20

atacgtagta actattgatt aattgtagta catatttittt aatttagg to aactgaaaat

608 O

tataaatgta aaattgttta citaaatacga aaa.gc.catag taagtgattt acattatatt

614 O

ggitt tatgaa ataaaactaa agcaggcttg ttatact.gtg talactaggta agcaccacgg

62OO

citcgacgcaa tag cacgtta gggagtctat agctogc citc tatgcatato aaaattcaca

6260

attitttgttc gtgaaattct ttttittatcc totgatgtta gaaaccaaag goatcataag

632O

aaaaattgcg ataatcaaga cittittgcatt aacttttgttg ccaaaaaa.ca attacgc.cala

6,380

gagtggtaga citttgcattg citt catgatg actittaaaga accotgctgg attctaagta

6 440

gtaccattca aatctattgt titccagotag ttctatatat tittaaagaat gagittattga

6500

citctattagt citctaattat tatacttctt agattitttitt tttittttittg gttcaaagtt

656 O

caac gagtag acattcacag caagattatt ttaaatgcc.g. aaagtatttic tattaatatt

662O

cittgcaacta coactittaaa totaatccaa attattgtac agtataattgaaagtttc.gc

6680
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atttgttgtc. tttgtttago to acatatga aagatacatt taacaagaaa aaaatgcgtg

6740

atgcaaatac agtttgacta atatgcagaa aatatgatgt gcaaggaaaa got attggac

6800

citgatcgcat ttaatatogt gataa.catga tactacagtt atccaaact g aatctaacga

6860

atgaataaaa goatttgtat tdggtttagg alacatagaat gttattgaat tottcatcta

6920

ggcaaaatta agttctataa attaatc.gcc taccaaatat g g gcc acto a tttitttgttt

698O

aggaagttctt togcaaagatt tta aggcaac gaatggittag goaaataaag cocatttagg

O4. O

citcg accogt aaacgtttac aagtggccac ttagatttac toga catcacci ttatctaagg

71OO

ttattatt at tdatcago cit aagtattittg gttggtaaag totaaaagga aatat coacg

716 O

tatacctaaa cqcagotago taact agttg agaaaaaatc gttcaagtta catataagat

220

tactittgaat aactittatct ttgagatata atttgtttag g gaattitatig cittcg attct

7280

tgtttc galaa C gatgtacca tactatoatcatalactaggit coaga attct agacggc gcc

734 O

cittgtaaact acaagaggaa toatcaag.ca agtaaag agg taatgctgaa tocaagacita

7400

aattagaaag taagagattt cattagctitt aatgagttca aagggaattt caccitagtgg

460

aagttcggatt cataactatt togttccttaa aag.cggatto atgtttaaca tatttatttg

752O

ttaaagtaag aataattaat atggctdaaa cc.gtgttctt gtttittcttt tocgtag cac

758O

tatgcc acta totttatt at acaaaagctt cqgaaattgg atggg acacg tittagccaaa

764 O

to caaatgat agatatogat tccttgttac ggaaaaaaaa aaaaaaaaag atato gattc

7700

citttgttitta gttittaattt tttttgtcgt citactitcatc act attacaa gatattaata

776 O

tttitccitatc cqgtaaaact tactittatta acatacaaat titc.gcatttt toc gataatt

782O

gaattic caaa cataaaataa aataaactitt ttggtoaaac acttaatgat atgagct tcc

788O

aaaaat atta atacacattt aagatctaaa taattittgga aagaaagcta aataaatatg

794. O

aacaaacaag ggaaattaac tagaaattitt ttttgttitta aaaaag.cgga toactggttt

8 OOO

ttatttittat tittcttittaa aattitatgtt taattittact ttctaataat gaactagtgt

8060

atgatgatga toc ggaagac tat coaac at gcagttaagt gttaaaaaaa attittaatta

812O

agtttacgag aggctittaat aaaagagcta agtacatact ggalactatta aaa.gcaacca

818O

aattgaacag aac actittct attaatctac aagaaactca ttaggataat coaagttgga

824 O

ataatctact gtaatatott aatctoatca agaagatatt ttcactacaa tatgcaagtg

8300

acaaaaaaaa tatttgatct attggagtga gttgttgttgt actaccattg acatalag cat

8360

tottccacat actittcttaa attctactac atcactcittt tatgataaaa ccaaatgagc

842O

ttcttacatc acacacaatt cataccaaaa ttatatatgt taaaaccaaa aatctoaaat

848 O

aaatgaaacc acaaactaaa citcaaacticg accitaagttg toggtoaagt ttittctottt

854 O

cattatcc.gg cagataagat attittaaagg toaagttaac agaagggaat gaccatgttc

8600

tggaaatagt gct tcc ttgg ggcacaag ca gcgccaccaa alactitcott g to cittcaaaa

8660

tdcagattcc ataaaccqtc ccaaatagog titatcttcat tcacattagc citcagg tatt

872O

gttaccggaa ccaccgggta ataccc.gtta citatttggitt cacalaccaga agttgttgtt

878O

gaatgtgttga totgatgagg tacatataat gcticcactitt cqccactact gctactgctg

884. O

aaggtgttat caccattgtt gttgtcgtca totagtaacg acatgat citt titt catgtc.g

89 OO

atttgattga attgaagcaa citgttgttct tactgcaact coatttgttct ttgctgctga

896 O
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aattgttgcc tottcaag at toggttctitt gtcttctocq cactgttagt td gag acttic

9 O20

gtottcttct tdaaatgggit togccaatag ttcttgattt cqttgttctgttctitccc.ggit

9 O8O

aaactacgtg caatcgtgga ccaccitacaa atacaaatca toaga caaaa aaccittagaa

914 O

taaggaaaaa gagatgagtt acttattagg gtaaagctac aattgtttca tattittagtt

920 O

to gaatgtaa taaaaaaag ttaa.gagaag aaaattctat ttagcatact agaggatgtg

9260

aataaacaat caaagcttag gttaattacc tattgc.ccca cittagcatgt aactcaagga

932O

taatggtttc titcatgagga gtgatttgtc. citctott gag gtctggtott aggtagittaa

9380

cccatcttaa cct gcagott titcccatttc. tcttcaacco cqc gag ccto goaacagagt

944. O

to catcgc.cc titcaccgtga agctocacat aatcgatcaa aaggcggtot tottcagoag

95 OO

tdcaagg.ccc titttctocaa ccttcttcta ccattcc.cca toctoctocc atcccitcccc

956 O

acaaactcat tatttcttct tagtttittitt ttctittagtgaaagctaaat aag agaagta

962O

gtgtcttcto cittctotaac agtc.ccacca atctotttitt gtctotctgt cittgttgaaac

968O

ctaagttgttc citctgttttgtctttgttgtt gtgttttgtt citgtttittcc tottccccitt

974. O

toattattta tatatacact cactctagot cottggctoc accacttittt ttgtttgttt

98OO

gttittctata gagatataga citagtgacaa gacaatcttt ttacatttitt agagttgttgt

986 O

accttittaga atcataaata toatctaacc actaactaaa agaaaattcc gtgcaatata

992 O

cataccttitt tocccttaaa citacaaaaat agttctacaa gotcittaatt agcaataatt

998O

agaatttaat gtaaacacaa aagaattacg agaacttggg togctotcgtt accocittitt c 20040
actggtogtt ttcataagttc tittcgitatgt atcatttcct citgtccattcaactcittgat 20100
citccaaaggc atcatcatac acaaattact aaattaccoc tottgttggit atatttctitt 20160
tgagttittaa toatggatga aaacatgcat tigatacatta aaccaaaact tittcttctitt 20220
totccaacta cattttgagt cottagttgc taaccaaatc tdaaagacaa aagtttacaa 20280
gtttaattitt tittaaaaaca attctaagaa totaag citta atagt citctg. tatgg gaatt 20340
acaagtatag aaattaataa aacco gagaa attagaaaag tita acacatt gtaaactagt 20 400
gtoatggtag gttgaaattt tittggattaa titccaag gag acgtaacaat ggtgagttgt 20460
ggctactitca toacaatcag tittcaaaaac citatcaatat atatoctitat agaaaaatat 20520
tottcataac citataacaaa attittcatct tcaaatgaaa cagtgaaggg tocaatgaaa 20580
atttitcccitt gaag cactat citgatcgtct coctataggc tataagcaaa tacttcttac 20640
gcatatggtg gaatgaatca gaagaattitt acgagctato gatcc cacat caaaatttct 20700
gaaaaggtot toccaaagag tat citttcct acatalaccitc gacagaccala gataa.ccgtt 20760
cactitactac acaagttitta aactcattag titttagg gtt tttgtttitta atatgttaaa 20820
ccaaaaaaaa gaaaaataaa ttaaatcaaa cagaaattat atttgtatat atatatatat 20880
atatatatat atataaacga attcagocta aatcaaaaac taalacagatc caaag catala 20940
tittatttgat titcagttaga attctattga aaagtttaag aaactaaatc aaatttaaat 21000
gttataatta ttaagccacc caagcttcat cattctoata tacacgaaac gaggatatta 21060
cagggctatt cattttgatc cattattitta tocaagatta aagaaataat gttaagg cat 21120
taggtaacat g gtttaacaa ggcatcaaat coaatagaat aatccttitta atctaaattt 21180
ttatctttitt gatagg gtta agctaaagtt atttacaact tatgttttgttgccacgitat 21240
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atgatctaga ggtttaatgc agg gacatat attatgatta ttataattat ttaactitcct 21300
taatgaac at tittcttagaa agcataatta aaagtaaaag aatat catgg togctggatta 21360
ttittaaggitt atacacatta ttgaaccact aag gtttcto caagttgttcaa ggatattitat 21420
acatg.cgatc ttacactaat citttgttgtt gtcgtataag attcgttgga titccacataa 21480
ggagittatta caataaacta tagaaacaaa ccaaataata toaaaaagtt gatggtgttt 21540
gtacgtdacc atgggacagg toggtottata attctdtcct cittagatatt totaatgtct 21600
cittcto attt citttctag at attgttgatca atccaaaaaa atgaatgtct ag.cgtttcca 21660
totttittcca tagtagaaat caaacaaaaa aatactgcaa aatactaata taacaagaaa 21720
tatctacgtgaaagatgagt tattatatgt cattaatago gttittatgaa aatcacaaac 21780
tatgtatt at gtc.tctggitt to atgttggg tacgitatttc agatgaacct aaaac caaaa 21840
citatcggttg gttitttgttt citaaaataca tataacattt toagtaacat coaataaata 21900
ggatactgaatgttaagttt acgtgtatac atattgcaac ttatttatca aaatatoaat 21960
tggacggttgaaatttctitt tattaagttcc atgacaaaac taacgtdaac tocaaattitt 22020
tgatgcgaca aaa.cat agta gttagtta at tag cactaca aac attagac taattittcta 22080
galactagggit cqgatttagg gtatttcatg cca agcttga cc gatcg act gaccgatcca 22140
cittgctag to aaaggtaata gattittctitt ttaatataga ttacctatga atgaatctitt 22200

taaatgccaa aataaggtac atcatcaaat cataattact taaataatgc gtaaactgat 22260
cgitatgggitt ttgaatctot caagctgtta cqgtggaact attgggg cac titc galagatt 22320
aggacaattt citaagaagtg aaacgaaata cqttaag acc taatctotag aatatagttc 22380
cc.gtgtc.ttt coaaag acat ttgatgccita taaaatataa atcacatgac to atcggaag 22440
agtcgaaaaa cacaaataga act at ggtga aaattcaaat ggttcaa.cag atttittattt 22500
totaagtatt ttaatcag at tttgttcaca aag caattct caaatttgttg tacctcaacg 22560
gcto agagac tacagacaca aaggcgtgcc tataagacgt cagdaat atc attcactgat 22620
tatacataaa aaataattitt taattgaatg attag acact aatcacttitt ttaattccac 2.2680
atgattaatt atttaattga atcatctaat aaagttttgt cqttggaggit catttgaact 22740
cc.gtgtttcg tacgggittitt catattattt citg acctittg tactgcaaag acatgtttag 22800
cagotaag.ca totgattittg citagatatgc titttacgitta agaattattt attittattitt 22860
aaagtatgtc titttcaggag aattattatt tttittittttgtttitttittca catcatatoc 22920
citctdaaatt atttgtagitt tatgttgttgat ttgttittggit atatataatg tdtgaatttg 22980
tttittittaga aacactagag actcc.gtatt gaaatgttta tittaaattat ttgatagaac 23040
tottttittat aaacacatgt taaaaagacg gtcttgctdt atato agaaa ataaattatc 23100
aaaact tact cotaaactat atcc.gctaga atttgttgttgt ggagaaatat cqaaaatata 23160
aattcacatt toggataaac aaaacataaa tttittaaaat gtcataattit aaaatttagt 23 220
ttaatgttitt tdataaaacg gtoaaattitc gttgatttgg citacttggga taaatcatta 23280
aattitttgtt aacaagttta atttittatta aaaaataaga aagaatattg aaccaaaatc. 23.340
gaattgatga tottttagac taatacaa.ca aactittaaac cattgaag.ca cqatago att 23 400
titcg tatgct agatataata citagg tagta agagatgttga aagaaaaaat gattgcaaag 23460
aacggataac tittgactaat ttcttactag atacgacaat tittatcaaat attitcgaatc. 23520
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gtacaagtaa taaaataaac aaaaattcaa atccaac gtt totgcgtgag atgcaacttig 23580
gcatgtactt tattgatcaa atcatcgitaa tottttgttgt aacttatata acatttitcgt 23640
catttitttitt ttaagtttitc cccctttittg gtgactittct ttgtcgatta aaaataaagt 23700
ttgcacgata citttggaatt agcttittaaa ttaattataa taatgttgtt cotatottaa 23760
gttgaaagtg cagg gatgtg tacttgccaa taatcttcta galaccagagt gaatcattgt 23820
tattotcaca gctittgatta caaacatttc ccc.ccaaaaa taaaataata caaaaac cat 23880
atatoaattig caaatctatg g gttcatata taggittittggit aaattcttitt atctittggitt 23940
gtgacccata toggagtatga ccttggctgt gaccittattt gtggatticta aatctaggac 24000
ttggittatag togatagact caatatggat totaattitca taaataggat titatgcaaaa 24060
aatgtatatg g g gaattgta ttagtaaaaa aaaaatcatt ttgcggcata tottaccalaa 24 120
gttc gaattic cqgttattgc gttat catgc ataatagaga ttgaattat g c gacittgtcc 241.80
attccaataa totcaaaaac aattgacaat tttittataac act actoaaa atagg cacat 24240
ttaaacttitt attatataaa attagaaata ggcttacitta gagggattitc cataaactitt 24.300
tdcaaaaact atttgtttct gcacacactc tdaaagaaac to atctottc ccatctaaag 24360
atttcagact catcacagtg citcct tactic aagct attat citagaacatt tagaaagagc 24 420
agaattcaag aaccatatat gtttcacgtt cqc.cggctitc catagdaagt gacat cataa 24480

caagatgttt cittggcctitt caaacttcta tatttattac atcaggc.cat tctocacatc 24540
cittittggittt tag cattatg atccaaccac accatgacga titt catgtgc aagtttcctg. 24600
aaatcttctt ataggaagag tittttittgcc attataattic acatgtttitt cittgtaattit 24660
tittatctotc. tcttctttitt attctaagtt toatagtgaa atattttgta atgtcttact 24.720
tattoaatag aagtagaata atatttatto acatacaact titcctaaact tdatagaatc 24780
citatctaggit aaacaaaatt ggtoaagaac ttaaaccatc tatttcttitt tattatgcgt 24840
cggataagac gtttgattitt ttittgaagta tatattocto acatgtcttt ttctgaaact 24900
tttittcgtda citgctcittct tttittatata actacaatgt gttattgttgt cqaagaataa 24960
attcaaaaca gacaac atta tattatttct acgtttittga ttaaaacata atcacttitcc 25020
citaaatcatc catcgaaaga atgattctica toaagaaatt acaagatggt agagittaatc 25 080
toactittcag aatagg tatt tagtataaat coatcataga tatagataac cittatctott 25 140
atacaataaa taactcittitt gaccaaatta attcatatgc tigcaatcttcaactcittitat 25200
gtttaattitc gtatatacac citcaaaccita agagtatata aattggaata totagaaagga 25260
tgcaaaatta togtatttaa ttatatatoa gaaaatatat acttattgta tactttittaa 25320
aaagaaatcg catcacaa at tdaatcaata tttgttgttct cotaatttitt goaaagaaag 25380
aalacca actt ttalaccaggit coc gttggitt cagtggattt gagtag tatt goctacc gag 25440
gtttgagtaa tittaacatag tttitcc.gaac citcaggatta atttitttgag totaggaagic 25500
citttaaaatc acttgagtta to gattaaaa aagaaagatg agittattoaia gataggatta 25560
cgittatatat gttagataaa acataatata ttatttacaa aacaacataa acaataatgt 25 620
tatccaaaga accaacttitt to atttaaaa attaggtaac atagtaaaat tag acattcc 25680
atattatt at tatatagitaa aggtacagtc attagacitat tcttaggata aattitcactt 25740
tacatcaccg goctag cqtt atgtag attt cqgtgtttct aatacatgat citgagtctitt 25800
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ttagtccaaa goaatcgtca toataaagtt gttcggacat gaaggaacta gaaaatticta 25860
ctaactittgg acaaaattica gttittaaata gttgataata taaccoatag titataatcag 25920
ttaattittct attitcctggit citatgtc.gcc tagaatgata tacgaattat aaatcttatt 25.980
tgatagaaaa gaaaatgtta taagagacaa gqcacgcaag aatgattgaa gatggtag at 26040
aatttaggaa toc agaatac atgataaatt attaccttac ggcattc gala aaagttgttca 26100
aattatcaat tcttattott tttitttctta taacttgttga titttgttgttgt tittagtggat 26160
tittctaatca ttaggtaaaa agtgtggtoa tittagtttaa caaaattgta aatat cqaat 26220
ttgatacaaa atgaaattaa toagtttalaa aataaaggitt togacaaaaaa aaaag agttt 26280
aaaaataaat aaaaaaactt agagaatcaa aatgagagtt tta attcttg to atgttittg 26340
ttittgatgca agaaaaagta toc gaggatg citaaatagot tagaatgtca togaatacgtg 26400
atgaaatcat tacccaagct totaticatat gaaagtattt agggaaaatt gttcaatticag 26460
aatttcttac aatgagtcaa tagtaggaaa gttttgtaac aattittataa aatttgg gtt 26520
aacatttgta aggtaaaaaa aactacattg aag gaccact acatattoga citatattitta 26580
ttttgttitta ataatcagag gtggtgttgg aaacaacgta aggttggatt aag caaatgt 26640
gaag catcca aatcgittaat taattaatga cagcaaatca agtttggctg. ittaaacacta 26700
aag accaatc. caccitctago tatctattitt actittgacga aacco attta tdagttgtga 26760

aataattact citttgattac tittataaaac cittaaccitaa caagttgaaac tottttaatt 26820
acttittgctt agctcaagttc tactggttga aagaaaagat acattgttctt ttctotatto 26880
caagttcgag totagtgaat ggattgaaaa citctagaaga tatatgagtic atctaaaagt 26940
taagaaagtg agagatattg agtagaagtg caaaaccitta ggitta agg to gagggtggtg 27000
gggctattitc atcaacaatt tacgcacgaa toccaaaaca aag cittatca atttitttittg 27060
gcatagtata totaattagt gttgttaggc aaatacttac atcattcttt taaaatatto 27 120
tittcttctitt ttgttataaa gaaataaata actatttittt ttctitcctitt cocacaaatt 27 180
tattittittat gaccatctoa tttittaaaga taacttgata gattaggaac toacatttaa 27240
actagtttca aaatctgtaa aag atctato tttactattt atattacaaa ggctitatggt 27.300
aattitccaca citttataaat g g g attttgt gcaaaagaaa cccttcttag togcctattt 27360
ttgcaactitt accotctato tcc.gaaaaat gcataataac totatgaagit taaaaataat 27420
aaacaatata ttggctattg tdaagtttitt aaaatttaat aagtaatata toaaatcgag 27480
actcitc.gaga cigaggagttcaactcittitat aatticcittitt taaaccottt agaatatoat 27540
atatttctitc tag agtgtta citttctttct acaaaattat tatctaatct titactctgta 27600
atattacatt togaaaagttg cacattcatg tatgcatcat titcctaattt tagaaaagat 27660
atatttccta gttaatgata tacggatcaa tttitccaaac aattatttgt gatatottaa 27720
agaaactitta atttcagttg to catgaaac atgtggtaat atagaga.gca titcc taggta 27780
acaacatcaa cittgtaatat atatattoct gaacaatgtt acaag catct aatgagctitc 27840
atagttcatc gtgcatgcgt tdttgtagag gaatattaac agttggaact gtattgc.cat 27900
caaactgttg toc gag.cggc ataacatcat citcctacacc atttgctgct tittccagota 27960
attgagctitt aatago agca gtagc cattc gttgcagttt cagaatticcg atgcgttittg 28020
aaacaacgta aacaac agca aag acaaaga gagaaaatcc aactato agg attatcc tot 28080
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tgatagtgcc acagaaaa.ca agagittagtt agtattatta ttcaccitata gaatggtttg 281 40
gtaaaacaga gtctattotc titttcaaata cct gtcaatt acatcttgac gotgcattgt 28200
tgaaagtaga ttacgggtoc togacaa.cag agatctatoga cctttgtatt cactcitcggc 28260
ttttittaagt acticcagtag attcatctac aaatgttaac atgtataata ataataatat 28320
gtoagttitta totcittaatc tatttitcact aagg acttaa ttatctggca tattatgaat 28380
gacataccala aagccacgag agtgtttgta citt.cgttcaa cct cotgitaa cccaagttcaa 28440
gagagtattt togatcacaca ttgtttataa attaagaagc cqaatatgca aacaagtgta 28500
aatgcacaat catttcataa citagttttitt totgacctga accatcagot gcc.gtgaacg 28560
cctgag actt toagittatgc tittcagdatc ggatgtcacg ccago atttg citctataaac 28 620
aaccacaaat gttagattca citggaaacta acactgaact cittitttittag td catgatgc 28680
atttaccalat aaacaaaag.c ataatacaac ttaaacatgt coaa.gaggag toccaattga 28740
attgctggat tttgtaggat aaatatagoa gagtttccala gatgtacata citgtcgttta 28800
cgtotgagaa citgtag acto tdttccacca cc gaggagaa got citcticta caatcattga 28.860
aag cactcitt tacacaaaaa tttcaaaagg agctggctgg taaaaac agt ggcagagaga 28920
gagaatgctt aag coatgag actttacctd ttcttgagct gctttccitca tottatcctt 28.980
agcttgcaaa ttagcactitc. tcaagtttac cct caaacto accacaaaca cagtgacaaa 29040

actcat atta gtttcaccca tittatcttitc cct gaactca tactcitcact citcttgttgt 29 100
accagaattic taagtaactg agatcaaact caatttcaag gaaatactitt aaaac acto a 29160
tatatoattg aaaaggatat ataac attcc totcgttctt acaaactact acaacgatga 29220
citcaagtacc cittatgccaa aaggittaaac goacactato acatcatttgtccitagagat 29280
tgaattactic aactg.cctaa agacaaccitt aattgtacaa atgcaaggitt catatattot 29340
acttgttgaaa tottgtag at to cacaagca gacagtaaac caaattitcca agtacct gtg 29 400
atattgattc titccacgttt Caaggagtga citgagtggat tda acct gat catcaga agg 29 460
aagctgaggit gcgagcagat coaaattgaa ttgaagg gala ttgagaagag agagaccatc. 29520
citgagccaat cogttgagcc totgtaacga aaacttctot totccitccat citcccctcct 29580
tgatttaccg tactgttgaa to gagataat atgtccaatc gtcttctogt acgcttctitc. 29640
ccattctdtc titcgtottct coacttcaac aacaaccitca tocatgtcgt aactgcaaat 297.00
ttcatalaatt ataaaactgc agagtttagt aatcaaaaga gatataalaca agctacggaa 29760
totcccaatig caatctgcta atagotctdt aaacatccaa cacgtataac catctaatgg 29820
tittctgitatgaattat gatc gaatcactac aggaacggta totagaag act c gattgattit 29880
gatgggatat aagggtoaca aacttacatt gttgatcga aagagatgaa gag.cggaga a 29940
aatgagaatgaaattgcgaa act agggitat aaggttgaag aagatctggg aaccagagag

30 000

tgttggagat caatattgat citgtagaaga caccitcaaat tittgatttct ggggaagaag

30 060

agaaataact aaaaacgacg tagttittaga taalaccatgt citattotaaa ccc.ggittatc. 30120
ttgcaattgc tatcattgtc. tdgtocaatg tocggittitat cagittattta gttatatggt 30 180
catattotta ttggittaaaa tittctago at tacttattga tigaataaaga agtttactgc 30240
tgagttttgttcaaagtaca C gttaatcgg atttatgaaa cigacaattac acagacitgac

30 300

ccaaaattgg taattgcggc atccg actta ccc.gaactg.c atgcc.gttitt gcaaaatcto

30360
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aaaatgaaaa acgg catggit ttcttagtaa totactctag ttctago: aaa citgacittgtt 30420
caattgcaca tagagatgat caactacaaa cacagotaat gtttcaaact ataagatgct 30 480
gacitacgt.ct gatgtactica agcttgagga cqttcc.gaaa ttacggtgct titc catcggc

30540

taggittagcc agagagtagc cittgttcatg gagttgatta atcaatagag totctaact g

306.00

acaag.ccatg citcttacctt gaaccataag gtatagaaaa cittgaccctt gcagtcctitc. 30660
citttgctoga tigcgcacgta titcgtccttcaag atcatcg gtctgcagtt togtaacaga 30720
aatcctcaga atcaataact titcgttittct gtctattota agagaagttt tataatatta 30780
atatggtaag tatgtacctg. tccaatgtac aatctottat cqggtotccg catcacatac 30840
acgcatgaag aaccaactgt agatggaggt ggaagct cac gag caccaat tdaaaga cat 30900
totattgctt caggctcaat catctttittc ccacagattt tdacgatago ttittgctaag 30960
toctitctoca aacttctotc agagctgact g gtttittgga totgctgg to attgttggat 31020
gaagttatga tittggtoggg tittgacaact tcagotgatg cqtcttittgc ataga.ccgag

31080

aggtaaagag cittcagotct ttggataact gacitcgg gaa cacct tccct cittagctgtt 311 40
tdaaacgcaa gactictotct gcag actoca totgttcaatt tocaagttgg cittggitttgc 3.1200
cctitcgacat tittcggctcc cattgctitta tatgttgatgt tttitc.gctgt aag aggtaaa 31260
citgaagatto catggagatg agtagataca atacccaaac aaccacttgt gttcaag act c

31320

totaccacac taccagcqat acaggtgcct tittgctgtct citgtc.ccitcg gcatatotca 31380
totataag.ca citaggottct c galagtagcc tdgcttacaa tagat.cgitat titc.cgacatt 31440
totacctgat ggcacagaac cagttgagag gat atcaaac attacaatta aagaaaaaaa

31500

aacagtttgg toga attctag atttgtatgc titatatatat acctggaaag aacttitttcc 31560
gtotacaggg citgtcatatg atttcatgtg aag catgatg gaatcaaagt gaggaataca

31 620

agctgattica gctggalacca tta aaccq ga aattic caagt agagcagot g c gcatattga

31 680

totgagcaaa citcgatttac caccaccgtt agg to cagtt agaagaalaca gtgattgcat 31740
gtoaacggta ttgttgaacag cq gttccaga agata catca aaccaataag gtgacaggcc

31800

tgtcag ctitc attcgactgg caccatctaa taggittittgcg ccctatatta aaatatato a 31860
aaataggtgc atgagatata taagaataag acagoccago atgttttgttg atttcttaga

3 1920

aattgcacgc atctgtctac aaactcaacg actag caag.c acagttacct catctaaact 3 1980
gaatcc gaca agc gttggaa aaacco actt togccittcto cottcactgt agttgtgcac

32040

agtacttaga ttaaaactac agaaatttct taatgagaat tdattaa.gcg caaacttacc

32100

aag catggga aaataatgct tittgaaatga ccagaag cat agatgcaaag acaagaacat 32160
ttattitttgt ttgcaattta acggataact cqc.gcaacag titccaac acc cgagcttittg 32220
cattctoact agcttcatgg tatctgcaac aaaag cataa catgatatat caatacatac 32280
ccagtatt at tdaataaatt tottttggat ggttcaataa aac gaggaaa caacctgact 32340
aaag caattt coacctittgg g g togtaaac cattcttcto caacctttitt toctittcgag 32400
totaaggcag gtttcagotg ttittatttgg tottc.ccctg cagtaccago coagatagat 32460
gg.cgitaaacc gtttcc cctt gaaccaaaca gacticatgct citcttgcata td.cgattitcg 32520
ccttitcgggc caccaagtga agcagtggtg gccittaattic ttgatataat agggtgaaaa

32580

toctoagcta cotacacatg gatgttittga citcttacaaa tacgacaaga toaccagdac 32640
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cattatattt aa.gcaaaaaa

gtactatatg agcatctgtt atc gttcaaa gaaataagct

327 OO

gcaattgttg

aatact tact

gctaaagata aagccitcago tgatttittct acttgagtga

3276 O.

tittctitcc to

tatatgaatt cccittaacgc gacct cqc.ca tgaagacitcc attatcataaa

3282O

agaattic gtt cgggacattg

tdacatttac

ttacattctg atgactittca ttctdatcta

32880

aagagatcat

gtatcagacg cc caatgaca titcgttgacc td.gcaagaaa

329 40

titcaccalatt

cc.gaaaacta cgatttatac

toatacticat

aagctagttg gattataaaa aatgg cattc

33 OOO

aaattcaacg

gaacticgtga agggatagga actitatcatc aaggaaaata

33060

gataagaaaa Caaag.c aggg aga catacac totagagt cat gtttaaatgc ataaacttac

33 120

aaaagtgtca aagttcaatitt toa aaccagt agccacccag gtaggat.cca totaataattit

33 18O

caggattitcc acaagctoag catgtctatg catatgtaat acatcatcaa goacatttitt

3324 O

tattogacag aactcaatgt agttggct to cc.gttgctda agaagct tca caagctogcaa

333OO

aaagatgcaa

tgtaagagat gag agttcca taagtggaac gacaaaagtt

33.360

agcatcttitc agaagaattic tatgtaggaa gtgacittaaa ccittagcaga agagacgcag

33 420

gtaaactctg gaattgaa.ca tgttactgtg citcatgagct tgcacgtttctgcaaataac

33480

aatagtttga cagggacaat gagaa.gc.citt aatcatalaga aac cotaaaa gqaataaact

33540

cittattittct

attaatcacac

aaggaaactc

tottcaaatc

accittgaatt ttcagagcaa tat cqtaagc aggagggttc

33600

agaagaagat

cccitalacata

Cctgaaagga taaaggcatt ggaagaagta gaggaga aaa.

33660

ttacaaagaa gqcagaccac

33.720

aacaaggitat to cittcagta ggtaagg cac

3378O

acaataagaa cgtaaataag

atctittcacc caaac attac

tgcacgtaga tggaagtaac

accittcaa.ca

citgcagaacc

tattatcatg citttgtcatt

catalaactcc taalaccitcct

33840

agtgaag cac tattoag cat gaagaactat gcc aaccaat ttgttgtagcc gttccaagat

339 OO

gCaacggacg tggcc.gattt tittgaaggta cattgacatt totaaaggaa actitcatcat

3396 O

caag accata aacatctittg acctgagggg gaacaataga aagtagttgt ttittcacaaa

34 O20

actgaaatgt cacaattgca tatttagtca gCagccaaag tdcgtcgttctgacccttga

34 080

taagagctcg gaaagagtat

acatalatata

citcottcaaa. ccattcaaaa.

titcctgctac togcattctoc

34140

coccotto.co. caaacticitcc. ccagogg cac

gtoccitgcat aataaaaaat

34,200

taacaagaat tgitatcagaa aag accacaa agctoaaaag totaattalagt togacacaaaa

34,260

catgaatcgt. atttctdttg taactgtcto cag actotct aaagtatttg citagatcata

34320

tgctaccacc tgagaatact tatgttcatg tgaggataaa atgg caccog totacattct

34380

attattggca

citaticittcaa.

cagttcagag atgctaagac aatgtagaat tdaagatagt

34 440

attcaaalacc

tgatgcattg tgc citcaacg atgcatgtaa gaaaagatga tigacagogac

34500

gagtgcggag cittggtaact aaggcttctt citgttag acc atcatctago gaatatgctt

345 60

tdatagitcto gaaaatagat

accoccittgc tgaac gagat atc.cctgtac

34 620

ttittaatagg ttgtagc goa

34 680

ataagaaata cittaccaa.ca acagg catag

3474. O

gatcaggaaa gtoaagat.ca tggtoaacac cgacaagccc atata cataa gqact tcctg

34.800

gatgtgcatg

gtacatgtca gacagacgaa tgcaagaaaa aaaaagtttc

34.860

agtgitattitt cctagotaat aagataatga atattgcago ttgtttaatc agaaaatticc

34920

ccagagtaga

atcatacaat

ttacagaaaa aatcaagttca tgtaatacitt
aaataatata

toactgacta

ccitatataca

acaaaatacc

attatataaat
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aggttctato

a tattacata

ccctdaaata aatcg acctt tacgggagc g togctggtgtt

34.980

ggcc cctoaa

citt.ccitccac aatacactac

agtgaagaaa aaaacatgca gtaatttitta

35040

tittaacatgc ttgagggiaca tggtaaatgg taaggaatta tttittctgaa citcaccactg

35 100

gCgtgtcagg to atccaaag totgtcgaag attctgtaga aagaaaacaa

3516 O

gaatttgttgg caaagaaaaa attaattgta gacaacgaaa gCCt9aaggg aagagtaatg

35220

atgattaatt gCagCagaac atatgcttgc

aaag.caccac aacttgattic

3528O

cgtgtacgca atggcc acta aagtagctgt titatgtaact tg.cccaagtt citgccitcaat

3534. O

gattacaact citcagagact aaatagaatc aaaaaagatt ata actttac tacaa.gcaaa

35 400

gattaagaag citataatggc tgttgtatatt tatttgcccc cittaagaaga tigtggct citc

3546 O

citcttgttta acagtaattit

totcaiacaca

ataccagaga cgaattagtc. tattittatca

35.520

taggaacaaa

gaatcacata aatgctdata atgtgagtaa gottgaaatt

3558O

caaaaaggat tgttgtaccat aattgggCag ccagoctttg gaatact atc tdatc galaga

35 640

ccaccaaaag gattgagacc agcatattoa acaagtatac aag catcitat to caatagoc

357 OO

citcctacctg gagaaacaaa titt cagaa.ca gta acagtct tcatalagata

3576 O.

aag acttcaa atgacattat totgctaatt tttgttctga agtaacaaag atcacaaaac

3582O

totaatggaat tagaaaaa.ca

totgcagagc aaaactitc.gc gtgga aacct

3588 O

tgacittaaac tgcaa.catct CCC agttgag gtttccatct tittaaactoga aatgaagaaa

3594 O

attic caaata

ttgcatacat aaaggccaca aagttaccgt. aacaaactogg actaaagtag

36 OOO

tggaCtagga

ataaaactaa

tggattgttt ccaactaaag tacttagagc ctitcacaact

36060

aaagtagott aagtcatact aagatacact agctacttitt catttgataa cca agctaaa

361.20

aatgattaaa ggctgacatc tagalaggtga gatgaaatct totaatagtic to agaag aga

3618O

actgacctitc

gctagggtoc aalaccalagta aattggtgta cataagc citt

3624 O

totaataagct galagagtaga tggitttctta catgtctgca atctotgagt agacacagaa

36,300

aataac catt

toataaaatt

ttataaactt

cattcc toala

acaaacatac

tat cocaiacala

tataaaaaat

cagtatataa cgaaacaata totalagacittg

aaaacaagct

ttacct cott

ccaccaaac

to acttgacg
citgaga caag

aaattitctta accaaaaaac

36360

aaatgagaga gatctttgtc. agtgagaa.ca

3642 O

tottcactitt

cittagaagcc gttgttgatto ttittcaaaga cittitccatct

36480

attatcc ccto

agagtacctt citattactgt

caa.ca catala caaaatacala

3654. O

aaaaagtttc ataacaagat tottatcaag aacta gacca aacaccaaaa toaaagaaat

36600

tgagttcaat attcaaaagt acaggaattic

aaaaatctga acttgctaac

36660

atattagaga agattataca aggagatgag aggattacag tagaattggg gaggagggitt

36 720

tgagggalaga gtalagtgcga. tat gaggagc ggaagaagaa cc.gc.cattitt go gaatgaaa

3678 O.

cgacgg.cgtt totggtagca atccaatgca

totototoac

actctgaaga agaagaagaa

36840

gaagaagtag agttittcacc

tittcaccott

tittctagggc ttctttitccc gccagaagac

369 OO

gacgactato

totcacagtc citctaatgga aaacatgttt totcttctot

36960

tottgtctitc ttagtttaaa ggtaattagg attittagcct tittaaaaaga gtaatttcto

37020

atttgctocc tataatgttt

taatttacca aaattaatca

3708 O

toggctagtt ttgitatctitt ttggaatgtc taacaaagaa cccatctota tdaacacatc

37140

cagttttgtt tgtaaagatt gtaatttcto tgcttittcaa agaggatcaa

372OO

totaatctot

caatticacala

caaattacat

ataaaataca

tottgttcat
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aagttttgta attagaaatc ttaaaatgac tat cagttgt ttctgaattic tatacaaact

3726 O

atgagtatta ataataagaa

aaaaaac Ca

citaaatgtct agacticagtg

3732O

cagtgtgttga gtgtgtgttgt ttgtttggca

caacaaaitac

gaaac atcta gaattacata

3738O

agaatttgtg gtgagt caat ggattitat.ca gataggcatg cacaaagtgt titcaccalatg

37.440

gctattittgc atgttgttgtc tgcttctitta actgaactaa gtacaaatca caaat atcca

375 OO

ttaacaaaga citccataaag aaaagagaag aaaag acto a

375 6.O

taatacticta

atca catttic atc.ttctoco

taalacagaga aaaaaatggc aggaga.gaga toaaagttaa

caacaalacca cittittataat

3762O

atcto acaag tittccattgc citcaagcaac

3768 O

acgagtaatg taggagittaa Ctggggaata atggc gag to accagottcc accagaaaag

3774. O

gttgttgaaga tgctaatgga caatagitttc actaagctda aactatttga agc.cgaccala

378OO

aa.catcttag acgctotaat tggcticagac attgaagttca tgataggaat accaaac cqg

37860

tittcttaaag aaatggctica agata catct gtag cagctt catgg gttga agaaaacgtt

3792 O

actgcttatt cittacaacgg tggagtcaac atcaagtaca tagctgttgg aaacgagcct

3798O

titccttcaga catataatgg aacttacgitt gagttcacat taccagotct tatcaacatc

3804. O

caac gag cac tagaggaagc tgatctgaaa aatgttgaaag toactgttcc tittcaacgca

381OO

gacatctatt tittcccctga agc galacc ct gttccatcag citggagacitt tag acct gag

381.60

ctaagg gatg Caacgattga gataatcaat ttcttgtatt cacatgattc gcctttcacg

38220

gttaacatat

tag totctat ggaaatgctt actittcctitt ggattittgcc

3828 O

ttctittgatg ggactaacaa gtotttgaga gatggaaatt tggtotacac caatgtgttt

38340

gatgcgaatc togacactitt gatttgttgct atggagagat atagottctt goggatgaag

384 OO

atcattgtag gag aggtogg gtggccitacg gatggaga.ca agaacgctaa totaaag agt

384 60

gcaaagagat totaatcaggg aatggtaaag catgctatgt citggaaatgg aacgc.ctg.cg

3852O

aggaaaggag tgattatgga tgtttacctt ttcagocttg ttgatgagga cqccaag agt

3858O

atago accgg ggacttittga gaggc actgg gggat.ctittg agtttgatgg gaga.ccgaaa

3864 O

tatgagcttg actitgtcagg taaaggaaat gacaa.gc.citt tggttcc togt ggaagatgtg

387 OO

aagtatctgc ccaaaacttg gtgitattott gaccctaatg catata acct c gatgacittg

3876O

cctgataata togactatoc ttgtagtttg totgattgca cago acticgg gtatggatcc

3882O

tottgtaacc atctoactg.c tacaggaaat gtttcatatg cctittaatat gtattatcag

3888 O

atgcac gatc agaaaacatg ggactg.cgat ttcttggggit tgg gtttgat cacagatgaa

38940

gatcCatctg atgaactittg cgagttcc ct gtaatgattg atacaggaga ttcaac gagg

39 OOO

ttgcagocto gatcttcaag agtgttgacc agagtc.gcag cc.gcggttitt agittatottg

39 O60

gtoctitcc.ca tottgtagta agtacctgtt gtttgttatg tottgtaaat citctdaagtt

39 120

ttactitcctg caaaagaatc

tittcaaacta

aaggttgttc cctitcgatta gcatagoctt

39 18O

ggaaaataca

aactagaaga aattgaatca cagaattaca tattact aga

39240

catcagatta ttctttgtta

accottittct

caactitcaitt

cittitotitatic

gtgatctgtt ccaaagctgg aagttaagta

citagagt citc agagtgg gat

393OO

taacagagag aaatgatatt totaatcagaa gaagctggta ttcatgtcag atttctittgg

3936 O

gtgataaagt

atatgttgttt cagottctog tgcc.galacca totcg to gag

39420

gattctatot ttggaaacaa cittcgttgtt aatcggcttg to cittctoat togtagaaga

394.80

atcttcticala

atataalacac
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gaag accagt toggatatgc gatgtttcto actittgctta cagtacttgttccactcaga 395.40
tgtgtc.tttg accatgagat ggtaaatgaa cacago acgc titttgaccala ttctgaaag c

39600

togactitatg gottggctitt caacagaagg gttccaaaca acatcaagaa toacaactct 39660
tgaag.cgc.ca acaagacitga tacccitcaga acatgcttitt gttgatgcca gtagaactitt 39720
agatccactg. tctggitttgttgaagttgtc gatcatatgc tigcctgtctd tttgttcaac 39780
tttaccatgc atcaag agaa tttgttcc cc titcagtc.cag tdacattctg caatgagctg. 39840
citccatgatc agcttcagag tdtcaatata ttggctatac accaacactt totctittcac 39900
ggttccactg atgcggatga agtcgataag gaactttgtt ttcacaccitt cotcg tattt 39960
aagttctaagc citcttgagag titcctaatgttgctgg.ccca ataaccaagt cittccttctt 40020
ggtoggattg cago.acaaat acagagatgg gtgtactgaa acagotgaaa gottgtgctic

40080

aaattcaaat gtgttittgag aagtgtcaat totgtcaaga attittcttct gttgaaaagg

40140

cgggttcaac acgaca acac agt citcttag acctggaagg citttcttgaa goatggttcc

40200

ttcatggaca to cacaaaat gag caatcat agccittaaga tocacaattic tatttitcctc 40260
attcaccott cogtgttcto cittcttggct acacttgcta agttcatgta toctogaaga 40320
aatcgitatct ttatcagotg gtc.ttgc.cag goatalagacg ttagaaagtt cottgaaatt 40380
attctggaac agtgtc.cctg aaagaaagat acgcttittct gttctgacitt cagtaag cac

40 440

tttcCaaatg agaCtactict g gtttctogg g g togtggccc togtoaagga Ccago aacco

40500

cggcaattct accaacatcc toctaaacac ttgcattcct tcagtgttct tatttgcc.gc. 40560
gagcttctica tacagagggit agctaatticc aagaatgctt ttctgct tcc accacgaaac

40620

tagcttaacc atacggatgg aattatgatg cctattitccc totaaacgtg agacagottc. 40680
agcatcctca taccctgata actgcag act attcatgtta taaaatggaa tatttacgitt 40740
ccatttcc to actitcgtc.tt cocaagtacg cattagagtt gcaggagcta toaccatagg

40 800

atggctattt goaaac cqtt ttaagtatga citgaagaaaa acgacggtoa aacgtgtc.tt 40860
accagttcca gccittatgcg aaataatgca tocgc.cactt cocittaacco citacgctgtt 40920
caacto atta attitttgttg toccagotaa attctitccaa ataaattcaa accottcttg 40980
ttggtotggg tacaaagtat citttgatgcc agg gacgitat togc.ca.gacag titccittctat

41040

attatccaaa goggcgacaa aactgctggg atctgaag.ca toaaacticaa goctottagg

41100

taaagg gtca coctittctat cactacattt cittattgtca tta acactag gacgatactt 41160
gtoctocaca atgcaggaaa atgaacatgt taagaactca gataagaaaa toaacaaata

41.220

gtacaactica atctaggatt to a gag.cgct ataaaaatgt taccatggct ggtgagatgt 41280
citttgatcto gacago caca tacgcacagt ggacgcattt caaac cqatt to atcatcca

41340

ggacaaagtc gtgtgtc.cct ttgctacata gcatatotcc attctaatac atcagaga.gc. 41400
aagtaattta atttcatggit gaatcaatga tacaaaaaaa aaaggtggag atacgaacca

41460

aaaag.cacgc aacaagattg to agg catag cct gggcaat atagaagaat tagtagt citt 41520
actittatcag g g g tagatga gtgcattcct tccaatgtta gag caac gtt catat ctitcc

41580

cacaa.gctgt citaattctitt citcctcittct gttittctoga taag cacagg citcctc.gcag 41640
ccaaatctoa agtttaaagg aggtgaatct tctgtc.gagt agtttattgt citcttctoca 41700
tdacagagitt tttc.gccaccataaaaactc. tcaccattca agtggttctt citcccitcacc 41760
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citatggaaac toctocqttc ccttggitttc ccatgttcat ttaccttcto acttgagctc. 41820
toccitaacta caggatctitc. tctagaatca accitctgcta ttttgtc.cca ggagaaaata 41880
tottccittga aaacgtctitt gctcitccaac atagatttag citagdaggitt aattacatcg 41940
aagttatgct tccitacgaaa agtccitcgac ttctitatgat ggtatactitt titcacttggg 42000
ttctttitc.gc atgtag catc gitotctggta ccaccctcitt catccitcaga acaaacgaaa 42060
toactatoag agotcitctac atcagaagaa totgaactitt cocccacgta atcagatgag

42120

tdagaatcat tag catctitc atccatatoa citctdaccag aatctotato titc.gc.cacta 42180
actitccitcto ttgaatcagt coctaattcc totaaagggit ctitccitcatc atcagaacta 42240
gaacttagaci ttacaaccitc atcag acaca taagttcttct cotcacccct caaattagda 42300
to atccagaa gaatatocaca aacct cagaa ccago attga catcc togac atgctgattic

42360

totc.ccg.cga tagttccaag gaaaacaa.ca to atcatcat catcc.ggaga taaagggttc. 42420
totttaccac toactittagc atcatcctca toaaaatcac aaaccotagg agaaatcacc 42480
gaag cagaac caacattgtc atcatcctct acatgatcat tctdtctotg aacagttcca 42540
acgaaaacaa catcatcatc atcatctata gggittaaaat tagaagctitt citcttcacat 42600
cccaaattac gatcatcago atcaaaatca caaaccotat caccaaaatc aaacgattitc. 42660
gattgtaaat tcc.cagaagt agaaccaaca ttctdatcat citc.gcttacc titcaggatat 42720

toagttctaa caaatacaac atcgtcgtca to atcct tcc toc gocgtcg tittcttctitc. 42780
citcggagaag gtgaacaagc atcacgcatg tta actotcc tottctoagt cotcgaattt 42840
acacaaccoa gag actgatc ttcttcttct coagaaatcc cctittgattt attgagaatc. 42900
gagttcaagt aagatticagt cotcgaacga gttcttctag caacacaact agt catato c

42960

atggctgaag agagaaatcg aaaaccotag aatagtggat ttgacgaaga aggaagaaag

43020

citcatgtcct citctoctotg ttgttctotgc aaattitttitt ttttittgcct ttgg.cggitaa 43 080
cgattoaact ttctogaaac attcaataaa aaaggitttitt ttttgtttgt ttctittatta 43140
gggtaaattg taatatttga aaagatgagg ggctaagtga aaattaatag ataagtttgc

43200

ttcatttcta ttggtgggaa ttgattgaca tagagtttcaaagttaaag gtggatgtta

43260

citggttctgt cagtagatag agg tatttaa taggggtoaa aat attagt g gaaaaatgaa. 43320
aagcttittag tatttcaaat atattittaca aattggittac taattitttitt tattgtaatg 43380
gtgctggtaa ggacaaaaat totattattt gcttaggatt citctoctitta tattittgatg 43440
tgagtatgtg actaatattt citgcaaacga tittagtgttg ggittattaga gaaagatato

43500

ttctggagaa cqaaaatctg gaggtgagat cattgctgat ttgaattgta aattitttitat

435.60

gaaaattittg togtaatcaa atctaatggc gaaaattcat agacagagtic acticacagag

43620

atatgcaatt tatacaactt ttacgattat atattittittg cggitttaatc tatcaaaaca 43680
tgtattataa cittaaataga agattatt at tatttgtttgtttcaaaaat aaaaagagitt 43740
tgcggaataa ttagtagaac atgttagagt taatataaat atgatagaga atgagttaaa

43800

tagaatgtta actittgacac ttctaaattt ataattacag taataaatta tacataccag 43.860
aggctatata taaaaatact aaaaaaataa attatatoac tittaatactt atttaaaatg 43920
tgtaacaatc taaaaaaatg gtotggtagt atattacgaa ttaaattitta ttagttatat 43980
aaaaaaaaat atgatgaaga ggctdaattic citcaaag caa tittatgtgag agttcaatta

44040
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ttattagatt totaaaatta tatttittgag attggattitc taaagttcta tttittgagtt 44 100
tgaactitt.ca acgagittata aaattggaaa tacaaaatct tatggaatcg aattatctaa.

44 160

cc.gg gtttag gttccaccga totagacitaat cqgatcagot caagttctaa aatatgtaaa. 44220
agctic gtaac gagaactittcaaatttgggg caaaaaaa.ca toga actttct aaatgtcatt 4428O
taaatctoaa agtttggttt gactittataa taaaatggitt aagttttgtt gaccgagtca

44340

ttittagg cat gtcgittaaat titttgttaat taaaagatga cc.gagittaac ttittcataat 44400
gtttgg gttt agaacgatac Cittatatgta tittagaaaga tacct cataa gotttctgat 44 460
accotacgitt gtgatggittt ttctotttaa tdacatcata tatgtatata agatttattt 44520
attitcc caaa cigaaaaatta actctgtcgt citttittatta acggaaattt atcgatatgc 44580
citataatgat tcaatcaacg aaatttacta ttittattata aagttcaaacc aaaatttaag 44640
attittattaa cattttgaaa attcatgttt titatgtc.cca aatttgaaag tittgcaaaaa. 44700
aattittgaca tttittccc.ga totaaattta ccatttaaac aataaaaagt aaaaggtoaa. 44760
aatgtaac at tittagaaa.ca caaaggacaa aatgataaat atcatgccala C go gttgatc. 44.820
ggtttittagc ticttittctitc cqattitcgtt ttittctttct tcatctotaa gattaag cac 44880
accttgg cat coatttitcgt ttgaatctoa acgttttittg cittgattitta gcttctgaga 44940
gagtccagat coaaggaatt gaggaagaa taatgtcggc aaggcatcgg caatcgtc.gt 45 000

atc.gagatcg gagtgacgaa ttcttcaaaa ttgtggagac totaaggaga to gattgctc. 45060
cggcto cqgc ggc gaataat gtgcc.gtatg gtaataatcg gaacgatggit gc gagaagag

45120

aggatctitat caacaaatcc gagttcaa.ca agaga.gctitc. tcatattggt ttagctatta

45 180

atcaaacg to goagaagcta togaa.gcttg cqaaacgtaa gttgttt tag tdtttagctic

45240

atttgatttg gtgagatctt gtgaatctgg attagttaac citgtaatggc tittagct tag

45.300

gaattagaat ggtgcttaga to gagaac cq atttatttag togtotgaat ttctoaagtg

45360

cittatcttag tactc.gagaa totgtaattg gtatggaaga tigctd tattt totgcataat 45 420
tgttaactitt gtcgttitttgttgcaaatca gttgcaaaga gga catcagt gtttgatgat

45.480

cc tacticagg agatacaaga gctgacggta gtcatcaagc aagagatcto tcc totaaat 45540
totgctctgg to gacct tca attgttcc.gc agttctgaga atgatgaagg gaataactct

45 600

agagacaggg acaaaagtac toacticagoa actgttgttg acgatctaaa gitatcgtttg

45 660

atggatacta ccaaag agitt taaggatgtt cittaccatga galacc gaggt tttittctittg

45720

titcc.gtcg at ttctttitcga taaagcttga gitatgcagtc gtgactgagc tatgatttac 45780
ttgtctggtg ttgcagaata toga aggtoca togaaagtaga aggcaactct tct cittcaaa.

45840

tgcttcaaaa gaatcaacaa acco attcgt togc.cagogt cotttggct g c taaggctgc

45900

tgctagtgaa totgttccitc titccatgggc aaatgggtot tottcatctt catctoagitt 45960
agtc.ccatgg taaagtacta tta accgaat aaccacagtt gcaaatacag catacttctt 46020
gaaatctggc taagaatttg gtctaatggg agtccagaaa gttgtcatgg gtttacitaga

46080

atgttittctg taccatgtca gtcgttgctg atttalagatc togcttgtca agaactcaag

46140

acgttt cata atctotgctt ttacaggaag ccgggagagg gagaatcttic accattgttg

4620 0

cagoagag to aacaacaa.ca gcaa.cago aa cagcaacaaa togtoccatt gcaag acaca

46260

tatatgcagg gtc gag caga agctotacac accgttgaat caacaatcca toagctaagc

46.320
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agtatcttca cacaactago aac catggitt totcaacaag gggaaattgc aatcaggttc

46.380

gtottcctcc tgaggaaaaa catcaatatg tgttataatg to caatgatt catagaacat

4 64 40

ttgtggaaag gaagtataat ataatgttgc tggitttatac aggat.cgatc aaaac atgga

465.00

agatacatta gCalaatgtgg aaggc gCaca gag coaactg gcc aggtatic toaac agitat

465.60

atcatcaaac

cgatggctaa tgatgaagat tittctitcgta citcattgcat ttctdatgat

46 620

tittoctotto

titcgtggcat aaacattgag

gattittaaag agtttcaa.ca

46680

totaga catg gttcttttgt ccitatcgitat cittattgaca tgtaaag act talagagaaaa

46740

aagg gatctt atgctotgtt cagattaatg gagagatata taatgtcact titcatgtaaa

46800

attgctttca agtttitccaa

acaaatttitt

gtgattctgc ttctotttitc attaccactg

46860

ccalaccatta

ggaattgttt

cittattocat

ttgtactitca titt attatgt aaagacaaaa

46920

aaaataattit

cattaccgtg

tittatatatt

tatttgtttg taagttaatc aatctacgac

46980

actaaaaatt

ttgaaaattit gataaatata tgggatatgt totaaaagctg

caa.cacalata atcaccalatt

47 O40

catgatctaa gcaatatotc tgttgtttgg ttcatacgtt tagct cittca aattcaggac

47100

ttaatggcat aaagagcgc.g to cactitcgg

titt catctac

titcgtctaag citc.gctggitt

47160

to catttcgg attctgcaac

citcatgaata agcttatagt agg cactaca

47220

aaaaaaa.ca

gaga.cgaaag agtgttgaaat gCagtgagta ggalagataaa aatgacagag acattcttga
ttittataaac

tatgttcatc tittgacgtgt gatatatata tacticag citt catgtttittg

4734 O

accoaactica

agaaattaga aag cacacaa aalaccalattg acagaatgaa citaaatcatt

47400

aaac attgag tggcaatgaa caaaaacctg gtoctitgtca gtoaagacitg citctaac acc

47.460

ttcagtgaaa to acto cqca atgcagat.ct tagagcaatg cgg tacticag titatcatcac

4752O

accgittaa.gc ttcaaaatgg aaagaatagt aag cattacg aaggaaaaac togtaattta

4758O

toggatacaa agc gtttgaa citcactgttg ccatggc gtt gttggttitta cccittgg cac

4764 O

aa.gcaactitt ggagaagtac ttgttgttgtta ggtaaagaga aaaaggtgcc cctttittcaa

477 OO

tgccittggac tgcttcatta gcc cattctg caact gtacg caaacattgt gtccaaattit

4776 O.

citcagacaca agacaacgat

ttaatgtaaa cagdalactaa cagtagt citt

4782O

tottagaaat caagattggit aacatacaag cacaaagggit ttgg tatttic aatataaaag

4788 O

gCagaaaaga agtttctittg togaaaccitt aagagacitaa tgcatatoat acctgaagcc

4794. O

toactgctct gctggaactt tittcagotct totattgttt ccittaacaga cittacttaca

48 000

citaaaagctg attctatotg aggcaaaag.c atttggaggit ggg acto agt titcaggatca

48060

citgctgtaat ttgataaagt tgcttggatg tgttgttggg gatcc ttgga act gtattac

48120

totttcttag agacitaaa.ca aagtaatact aaaagcticct atatttgaaa

4818O

tatacacatg aaatatato.g aacaaagtat tatacgaggg cctacagg to agctgacaaa

48240

atggcttcto tgagtgaacc tagcttitcca gatggtacat aatgttgtc.cc aag acco aca

48,300

aacagtgcat citgaaggtgt ggaaatccitt citcccagtca tacctaggta agc acct gca

48,360

gaatttgaag gttgaaaagt tgctggtgga taatgatact acago: aaatt gttatgcaaa

4842O

ttgttgaggg totcag citat atgaaacata cca acagatc citt.cgcc agg gctatoagct

484.80

gcaatatatg

atctggaaac aagcc gatto catttitctgg cattgc gagg

4854. O

accgtoctot ggalaatggag aacaaaacag tgacagaggit aagaaatgca tataaatgc

486.00

calacacalaat

aaaatccaac

ttcaattit.ca

US 2004/0210962 A1

Oct. 21, 2004
48

-continued
acagtacata acaagggittt actatotgca cctctgttat cactcgg tag

4.8660

cgtocatgtc cagaaag acc aag accalaat cccattgtta tgc catc.cat taaagagata

4872O

tatggitttitc tgitatccago aatcttgcat atcaggctat acticagotgt aaatacctaa

48780

aaggaa.gcaa. agittatgaaa ttaggacatc ataaacaaga aacatacatt ttgaagg gta

4.884 O

atcaaatgaa citaaag caat tgatggtgaa taaaaattgt aag acactda aggtgacitac

489 OO

ttcaaagaag ggcagatcca agcaaaaaaa gagaaag cat ggagtaaatc. tctagaatcc

48960

tagacitaaag agtgttacca cacagattat tittgatcaac agaaataaag aatagaccac

49 O20

citaa.catcat

caaactagaa gtttcctact actitcaagta cattcagtag aagtag tatt

4908 O

to totatt to

tgtttcagta

cctgactitat gggggaaa.ca attgcacaac

4.914. O

cag accitcta toatatotga caattgattt ttggatgtaa totgcttcac atcaccgcct

4920 O

gcagataaac taagaccatg gttataaaaa

tittctato.ca

gtgtgaattt gataaagaaa

4926. O

actcctittga tgcaagaaag gga aaccolaa

aaaacct cac

atagaacaaa acacagagta

4932 O

caaaaatacc

aaagagttgc aaaatgacat tttgtatgtt taaagaaaga gataagc citt

4.9380

gatacago.ca

atalacacaca attcatataa.

aaaccttittg cacaa.gagac gitattitttgt

49440

tgcaccatt cataaatggto

495 OO

gaccalaatgt tittctataag ataagataag

4.9560

ttagaaacca gaatcCacta

49 620

tataag caca citcaagaaaa gtttcttitta cctgcacaaa agg ccc.gaga tigtgctitcct

4968 O

togacgacaa cacatttgac to caggat.ca

catcaa.gcaa gottttgtac

4974. O

catccacaca

cc attaggat citctgcaa.ca

atcatcatat

actic ctittaa. tat coatticc

actictaaaac

cittcccatgg

atcagatgca

acatacttitc. aacaa attta toctacaatc

cattalaccala

tattoccatt

ttcaaatc.ca

tittctgitaaa

tdaataattg aacttgg gtt gtgaaaaag.c

4980 O

ttaattctitt

atgaaaacgg accitagatto atggc gttga gagctittagg to gatcaaga

49860

aaaaaaatct

gtaatgagag caacgc.catt tggataaa.ca

cgaactcgtc gct tccactg

4992 O

gcc attactg agaattitcc.g acgatgagat acagaga.gct ttgagaaggg aataagaaaa

49.980

gatggagagg ttctagagaa galagatgcga. gCagaa.gc.ca gagataaact cittgatcatc

5004 O

tittcotttca

actgttgatto

citaatticcac

gtttgtcgga gaalaccaaac atctgttgact ttgttittctt

coalaccacca

aaagtactict gtgtcagttt aagggtocac taatctggag atatgtcgtt

5O160

cggctdaata caaaaag.ccc aatagtgacc aataacagag ttttgtttaa gqgtaaattg

5O220

caggccacat cc.gttgacca tgttittattt ccatggattg toaaagttcaa atgtggttitt
caccatttgt cittittc.gc.ct gcaaaataac gcttctg.ccc ttgcgcttct citcttagcaa

50.340

citgttgaaat gtacggttta gtttagcagg tittagttacg tacactgttc cq gttcagtt

50400

gaagatttitt tgttcacgtt gacgc gatto ggttc.cgitta caagtgagat tatto.cgaag

50 460

tgacatcaac atttaatgcc cc caaaaagt ttagatgtga citattgtcac aattaatgca

50520

aaatcatcat tacatcaaat aat attaaaa. aaattattaa. taataataala aaaaaaattit

gttgagataa agalagatgaa cc.caggaa.ca aagaattatt gc gaacgtac attgctogctg

5064 O

aagaagtgtt gatcttgttt ttgtaccalag tittggag cat tgctogt gta agtaatgaag

5 OFOO

ttcttittaag aagtttittitt tatgtcatat taggatcttg attgttgttcg aactccattt

5076 O

ttittatcaga atatttgcaa

tgtttgttta aaatagt caa atgataattg

5082O

gttttittata totatagitat

5088O

aatctatatt

gtatttaggit ttataaatgt gtagt atcga

cattccattt
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tittccataag aaccaaacta catttcagtc gttgttgttt cittgtttccg tittaaattitt 55500
aatctaattt attgttittat gtacgtgcct tattittattg ttcaaatcct citc.gcaatgt 55560
acgtatagitt totggtgtac got atcgtgt acgtatatta gttittggtgc cittcaacatc 55 620
aaaaactgtt agatttatac titatgttgttg tacgcaattt cocaatgtac gataaacgaa 55680
gtttaatata citatatagtg tacgtacacg aagacatcta gtaatacitta aagtggtaat 55740
to attcaaaa goc agaaa.ca taaaaaagga caggcagttt atataaaggg aaatt cataa 55800
gataagataa ataaactgga acg attcaaa aaa.cataatt ttittaaacga agcatacaca 55860
tgtgttgcaa aatatgtgtg catcc.gtoat accaaaagac to gagagtag agcc.gagtag 55920
agtag cittag accittagcag ctittgcttct agtagaatat agccatctoc citgg.cgtacc 55.980
agtagaaaaa acaaac cotg cago catgat ggaacgtgca ttacccitacg caacticggcg 560-40
ggtggacaaa cctocaagac cittitcc.ca.gc gg.cgagcatt titcagtgtga agctggctda 5 6100
tgtgatacat caccatctot gcaa.ccg.cgt ggc.ca.gcttcaagggtgggt gtcatttcc c 56160
agaacttittc gctgataggg aggaaatcca agtgattacc ggtacacgta aggaacaaac 5 6220
cggttgcgaa goaa.gcaaag g gatcagata aag.cgacggit totcatgact gaaaggccct 56280
gagctact.gt cacgaagttg citc.gcttggc galacaccittcaaggtaalacc gcc.gg gatgg 56340
atccacgttc tacaag cacc togaagtatg gcc agaaggg agaccc.cggit toggagtaacg 56 400

acggccacgt catgaattica to gattgcaa gggtgttgat gtcagaactg. tag actaagt 56.460
to cittagcgt citctatogga gtctggctga C ggggaggta gttgacaagt atgct tatgg 56.520
ggitttggcaa ttggattcct aggtacaact c ggttggagg ggittagcgga gg taggaaag 56580
gcattgttitt toaaacgagg aggtotagac ggatttgttgt attcaactaa gtgttgtttgt 56640
catgagttitt aaagaggaga ataac catca atgtaagtgg gtgggtgacg toggatgtata 56700
tittagtgcat catattagta acttittaatt taaacaaatt cotgttgtacc totcataatc. 56760
gc gcc.gtgta C gtctacaaa atact catta cqttctotga cagaaggttg agttgacgtc. 56820
tgtttgtatg gcatataagt ggaacaatat ggctt catgt atagtgctat attagggg to

56.880

aacgcattta citaacaatct tittcaaataa acattaactt acttattitta totgccaaat 56940
caattgagta cattgctcgg talaccgtgta C gttctaatag agatattaat gagagtgttga 57 000
tggaggtoac ttctagagtg tatttgacag cqagtaatta atttggagcg aaatcttcta 57060
tatatgggitt atacgacg to aaacaaattt cottttgttct tcatttacaa atatogtogc 57 120
toactatata atctittatag ttggaattaa actatgccac gtgtacatta toatatatog 57 180
tgtacgtaga tattittatta ttittattatt ttaatgatgt citcat attag agtactittga 57240
gctagtatgt ttcaatcaat tacaaagtgg taatttaatt aaaaacaaac titccattact 57300
gataatcaac gtaaaaagct cacatattgttgcatggaaa acttataaat atgacaggat 57360
cgtggc gaat gtgagctcta caggatctgg citaatcc gtt tag cacacaa ccagatgtaa 57 420
cattggttgc aaagattatt galaga.gtotc gatctaatgt alacacacctic cqc.gcattca 57480
ggagtgctta cqtcaacaca titc.cgggaac gaaaaactgt tag.cgitatgt gtattittaaa 575 40
gtattaccat atttctittat atcttittagc accitcctcac aaatgtcacg td.cgtccitcc 576.00
gatticcaaag cataatggitt gottc.cgaag agc.cgaaggit agacaccacc catgtgagca 57660
ttaccago ac atatgtaaag aattgcgcat gcaagggttg cagoggc gtt cottgggg.cg 57.720
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attcgctota agtgtaggat agctocctgg atgtcag act catgtgtaac gagacgcagt 57780
ccitt catggit aaatagocgt ggggittacca gcttgtaagc accgttgaaa gaaggat.cta 57 840
tagc gatctt cqgagttgat gtcatttgga togtggcctg. cc.gc.gtagaa gtcatcggga 57900
togtogcaca toctaaaat gtttgcattt ttgagga cat coggacggta gacaatgtct 57960
cittccacgag gaccggattt talacataggit cog aggtacc accalacattt gttcagccatt 58 020
ttcttggcta tottc.gcaag caaatcgtca ggaatatttg g gtttgtcat atttaggagt 58080
aaggtgtttc gagaaaatga aatttgaaca cittaaataag catcattgaa gatatggttg 58140
ggtaagttat g gttgtattt attgcaaagg tattaagtga titatgtgitat tcatattgtc. 58.200
aaatcaaagt aatagtatto catatataat ttgttatcgt tdttatgagc aacctcttitt 58260
taataacago ttaaaactag acgtgitacgt tttactgacg gtcttagtgt acgtocacat 58320
ttacatttct acatttactic aacaaacagt gtacgttgta gtgitatgttt tagtgaacgt 58380
ccacatttac atttctacat ttgcc caaca aacagtgitac gttgtag tdt acgtttaagt 58440
gtacgtocac atttacattt citacatttgc ccaacaaaca gtgitacgttg tagtgitacgt 58500
tittagtgtac gitccatattt acatttctac atttacticaa cag acagtgt acgctgtagt 585.60
gtactattag tdtacgtoca ttcataaata toaccattta toagacaaac caaag acctc. 58620
atatgtttgc atgtgttatt ttittagtgta cqttagagtt gatatotcat gctagtgaac 58680

gtocatatot agttitt.ccga gacaaagaaa aaaccitctaa gtattatttg gtagatgcac 58740
gtgtacggag ttgttggacgc titagattitta atatocaaat ttacatttac tdcagtgtct 58800
aaatat cata totgaatttg goggaaaaat attcaacttg agaalacatala cacaccittgc 58.860
aaatttctta agcaataata taatttcaac ataaacataa acaatatagt agaaggctta 58920
toataatttg aaa.cataa.ca tag.cggataa cataaacaaa catataaagt agaatggaat 589 80
aactatagoa tittgactaac acgc.ctggca cac gaccaga ggtaa.ca.gcg gttgcaaacg 590 40
ttittggaaag citcctgatac catgitaacaa tataaggcgc aag gagg cat actaatticca 591.00
tggctogtag gataagagaa cqtaggacca tatgtattgc tigtatggagg gtcaaacttic 591.60
tittattitcCt c gatgaactc atc accoa aa acticgagtgg caa.ccgagtc. caatggataa 59220
tggttgcggg talaga.gctd tagaaacaag cc.gcc catat aatcataccc agcacatatg 59280
aatacaatgg cqcatgcaag tdttgcattt gctcgtact g gag catgacg citgitalaga.gc. 59340
citgatggcto cattgatgtt togttcatgc gttagaacac gaatacctitc gitaatacacg 59400
gcc.gtgggat tattagctgc aaaac accitt aagaaaaatg titc gatgtcg goctt catca 5946.0
gc ggat.ccgg agggattgttg gocccitccag cittggaagttc atcgggc gag to acaca agg 59520
tgagaatatt goatctttg agg acatc.cg gacggtagac aatgtcticitt coacgagtgc 59580
cggctogtac caatggacca aggtoggacc agcattgg to agc.caggttc ttagctatot 59 640
toga gagtaa atcgtoggga agagtcgggit talaccatgtt togaaatgaga tag to agagg 5.9700
togtoagtaa tittcttcact ttaataacca citactgttgaa tittggttgg g g caattacgg 59760
ttgaaatgaa tdtcatactt gtgttggtaa gogttggctg. tcaaatcaat ttatcacttig 59820
agittatgtta taaagttaat atgcagtgta cq agacatat agatatgtac gitacacattt 59880
acattatgta attataagtgaac gatgttgt acgacaatat gatagaggac aataa attaa 59940
cittctgacaa totccaaatt aaatgtagitt gcaatcatat atataagttca ggitttgttca 60000
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taataattgg ttgcaaagaa ccagaatatt gttcttggac gattaalacca agtgcacagt

60060

accggcctico cgcttgcc.gt gctcqtagat gtoaacagag tatttctgac ggtagaagac

6O120

catatotgct totcgaatgg ttgtcagatc Cgaaaaaggg tgtccaaacg caa.gcaactic
caggaactitc atcgtgitatg gcc.cgcaatc tottgtagtt gggttittgag Caacgg tagg

6024 O

acaacgcaca tactcaaaag gttcaactga gtacggagaa atcaatacat cotgg cacat

60300

cgctctgact aagtacggca toattitc.gca aataggagtc attctogcct tcacago.cga

60360

citcc cacgtg tgc gat atta aag.cgtoata cacagittatt agcc.gttcat talaggttgat
to coaaaa.ca

accoaatgtt

gttcatcgga gcatacacaa catcgacatc

60480

cittcatccac

tittatattgg gttcacggitt tatgtgaact cc attagcaa totcggatag

6054 O

taatttaccc.

catttgaacc cgttcttatt

aatacactitc.

ttgaagtc.gc ccaccc.gctt

6O 600

ggtaagaaga tgcgtoagca tdatgtccaa

tacaatacat

citgtttgcta toatctgttc

60 660

ccc.gttcttg tgccacatca acattgcc at

catttctaala

tgctgaaatg ttcaaaaaat

atat cagtgt acgtacactt ccacgaaaaa

tittaatcatc

tatgtacaat ttataacaag

6078O

gaatgtacgt. atataaatgc aacgtaccgt. actittcg acc cattcaccag gtgttagaag

6O 840

gttcgcaaaa aagtcgttgg gcacttittcg aalacc cgaaa agagtgttgaa toc totaaaa

609 OO

to cagaaaaa tatttgataa

aatgatgatt gagat attaa ataatcc att

609 60

gtacttacac agagggtc.ct ttaatgatat tgctgaattic citctacttitt

61 O20

gaaggg to aa ccacgtc.cag ggggttgtat gag acatttc cagocctgat aacaaccitct

61080

atctgttgag citggtacatc ggg caccaat actgtttittg ccittaaaacc atgaggatgg

611 40

gcatcatcct gttcatagac aagttgtttc

ttggggacga tttitttittct

61200

tottttgctt cgacagoagc agcattgttct gattcatcct gttaacaaat atgattgtca

61260

acaa.cagttt catacgttitt totatgttta aaatagg tac atacattatt tittaggaata

61320

toggtottgt citgcttcatc tgaccctggg ttagg atcct cagtttctac agaccccitcg

61380

titactataat

cactic titc.ca

calaccittaala

titcactittct

acaatacacg gctctitccat gacitacct gt gcaagttaac gtacacaagt atatataatg

614 40

tacacatata

atcctatgta tgctatto.cg aaaataagaa ttgaaacaca caaattgtta

61500

cctic caaatc.

agtggctgca gctaaatcac aaacggctitt ggitatccaac toccatatga

615 60

cctgcataat

atalaattitta

tacatttgaa cagtaaatag tacatttitat ttgttgcaag

61620

agittagctta cattgttaac tacttgaaat ggtgacgggg gatcactgt g g g tottctat

61680

tgtcactaat ttggattcto citgcc.gc.ctic aacct gtaga

61740

atttagcatc ggaaagaaac tttittagtaa tgitatgaaac aatatatatg tacacagaac

61800

atagtgacaa aaatgtacgt. acacttgttgg caggtacgtg agctgtgtct coatcagaag

61860

gctoataagt ttcttctgac togctg.ccat tagcttcagt cgatgcact g g catctottg

61920

cittctitcctg

aaacaaaaat

aatttgcaaa gtott atggg cgtacacata toggaaaaaga

61980

acaagtgtct

accatctota

tgtcago atc agctatttca toggc.ccct g tatgggtacc

gg tatttcaa

citt.ccatcat

aactaagc.ca ggttcagdaa catcctttgg

tgaaacatag gottaccatag

621 OO

agittaag.cgt. tagataagtg aagaaattaa tgtaatagitt atgcatatag to atggaaat

6216 O

citgtatataa cggttaccag aagat.ctacc totgaaactc ttgcagacac attagatgga

62220

totcggtgtc aac agtagct tottccacag gccitctottc citgttgttaca

6228O

actitct tcca

to cattatcc.
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aaga cagtcc cagacattga acctaagcag acagt cittac caacaacaat attitccticta

62340

toctgaaaca tagtttaact aacttcttaa gogaatatgt acgtacacca tittaaacaga 62400
ttgtta agag tattagtaga cqacatacca gatgggattg totggat.cca gcataaggaa

62460

citattaaaaa tocagtgtct aatatotcitt cittcagoggc agaagaattic aatccatcat 62520
ttgcagtaaa atcactittca ttattagogc catcctgitat cqaaccagac agtacagtta 62580
tacatatgga ttataaaata tittagcaatg tacgtacatg acttacatgttcatcaatga 62640
atccittgcat atctitccitta ttggaatcag gttccitcaat agtgttcaaca gcaaaagaaa 62700
catttittctt cqgctttgaa ggttittctitc titcc.gcagtg gtatgtactic caggg acatc. 62760
caaatctitcc totttggaat tacagocaac agaaagtgca ggagtgtc.ca catcatgaga

62820

aacacgagtc. aaccttgaag actittctogt tocagtgctt cottttgtag acatccttct 62880
cgatggctitc titcgcagtaa ccggtgccitt atccatagaa ataggtggitt cocgc gaatc. 62940
atgg galaggt atggtttgtt citggccttitt gcc ttittgga totaaggg cag cacgitatctg. 63000
gtoacggaca aagttctittca tatcttcatg cattggatac atttggtott coagctoctit 63060
caaag accitc citcatttcaa caataaacct citcagg caca ggctcitccaa aacaatcctc. 63120
agcagtctdt totttatcac agtccatttc agatttctgt tttitt cataa caggttctitt 63180
agggctcqgg ccc.ggtgcat titcgtttcct cittaa.catct acaatagacc agttgctgct 63240

attaattggit tittcttctag gtgcaatacc aaaaaaattt gtaaaaaaaa catttatact 63300
tatacttaca totctottct agttgttggtg gg.cgcg actg. citttggtact citagcatago

63.360

citccaaccoa titcatcctcc toccactggit gcc catctat caacagtgcc tdaatgtaat 63420
caa.cccttgg atcatcaact tcatcatc.cc atgaaagaga tiggaggacaa acattatcac

63480

citggitttcac aatatagttg accitcaacct acacaaataa gitatgttaac catagataat 63540
gtacatttac ttattatgta cqtacataca caatttaaca cacct catca gcagoctoac 63600
actccaaaat gcgagatgtc. c.ggattgcto goaga gaggc aagacgatgg atagaccitct 63660
cago: aaatgt cotgttaggit acatcatcag gtoctagott agcaattgat gggattgttt 63720
cgaaagctaa aagctggaga gctaatggga aaccato gag to catalagac cottacaagta

63 780

taccccittat tagtttctga gcatcgtaag gagtttggaa atttgctato citccccaaag 63840
tacgggtaaa gqacacccitt coccatgggt atttgcagaa aaacticcagg ttcttagtag

63900

totcgacagt citt.cgaagta ggcctgttgg ggittact.gtg gg.ccgctacc acaccgtcaa

63960

ccaaaataat aagagatagt gccagttgct tccaccocto catgcttitcc toctoctgca 64020
gccagotcac caaatcagoa attgttggaa cc.gtgtc.ccc aaaccitctoa toaaacagag

64 080

tottccaaac actictoacac toaggitttca cactgataac atcatcaacg totttcttct 64140
tgggatactt cocacattcc agcccagtta agatactaaa ttctottaat citaaatctga 64200
ttggatgacc gcc gaataca atccacatct cattcaccitt citttgtcact aactgacggc 64260
atattagtico aaggacaagc titagcattga aagatgc citt gtttittgggt attittaaaaa

64320

gttitcc caaa taggagaatcg agaagaaact gcatctotgg tittcc cctitt agtacttittg 64380
citatgtgaga aatgtactico ggtttagagt acgc.gttcat citt.cgtotcg galagg gtacc

64 440

ggtotagagc aaagagtc.tt gotggtaact cittcaactgt aagat cittca gttcggagcaa

64500

cacttggact acctgcaatt aaaagttcata tactgttgag caaacagaag tagtgtacgt 645 60
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acacagacat tittctagatt ataactcaaa atcatattitt togcggaaac agagattitcc 64620
aattctactt citcaatttitt catcctaaag atatgctaaa titcc.gacaaa ttctaac act 64680
ttaatcaaac aagctttaca attctgatac accoaaagac aacaaacggit aaattagaga

64740

ttctaaccoa gttcctcc.gt tacctttgtc gcagag.cgitt ttctocq cq g g gaaactcitt 64800
aatacacgct tctoctitccc togg accatgc tigctitccitcg g g actitcgtc gittaactitta 6.4860
titcc cago.ca tagctaaaga tigctatttcg ccggaggttcaaattitcgcc ggaaaaaa.ca

64920

gtaactittct cittggctt.cg ccgggaaaaa cagta actitt citcttggttt cqc.cgggaaa

64.980

aacagtaact ttctottggc titcgc.cggga aaaac agitaa citttctott g g ctitcgc.cgg

65040

gaaaaa.cagt aagttt cact tcatcggatg toggagttca gtggcacaat tdaactaccc

65100

aacaatticga agittatgtcg aattittgaag caatggatac togaattitcgt titc.gctttct 65160
gattctdtct caatctotcc gttattotct tttitcgttitt citcggitttct tcgtttcagt 65220
tttitttittitt tttgttcttitt toaaaactga accgcatcaa citaaaccgaa accaactgct 65280
gtagggitttg gtttacgc.cg tdaacttaac cqatacgaac toctocacgg tittggtttgt 65.340
gccatt atta agttitt.ccca aggtaatttg gtc.cgaaatt gaatgaaaag acaaaacgtg

65 400

aaaaccagtt citcactittga caaacggtga gag caaatct tttittcgtoc actitttgtga 65460
aaatttctitt ttgtttaatt gatgattgaa aagaaaacgg cacaaaccaa accitcaatct 65520

ttgtttitttc citcaatgttga gitatt attat tag catcaca tottctatog aaagatacca 65580
aagaatgaaa aaaaatatat atacaaaatc atataagtgt atcatatata gatcgtagitt 65 640
caatagagitt aaaacatttc citcaaatctt tacagittaaa aagaagaatt caaaaaaaaa 65700
aaaacatgta atttcttgca totttaacca taaccittgac cqggtotttit aatattgcc.g. 65760
gtogccttitc cct gtgtggit citg accgtca gtgctic gacc aggacgggta caaatcatat 65 820
toactaattg g gttactata taaatcttga gtctdaagttc ccacttitcct aaacttgttc. 65880
atgccttcat tigtottggct cq agtcataa totgttgctitc citccagatga gccatacaca 65940
ttgctgttgtc. cc.ggtgttgat tccttggittt agatctgatg gtgatatgtt toctitctago

66000

acacgtgcaa cct gctcgtt atttittacac caatcactca titcgattagc attagtaaca 66060
ttittaaaatg act act attt agcaaattga aaaaaggtgt agctaagaaa acatgtttgt

66120

cc cattgcta gggctgatca aataagcaaa atataaggct agg catacat accaaac caa

66180

citgagatcga acacgg tatt aaccqaalacc aattcggagc ggcaaccalaa acg acco aaa

66240

tataaatcaa totttgtaag titatattgtt cog aagccaa aaactaaact gaactgacaa 66300
atgaaaatat cittggttcta ggtttctaac tocc gtataca gtttgaaaac cqgaaag.cgit 66360
aaatgc ctitt agagaaaaga aaagaatgat taatttacct gatccatgcg aggtotacgt 66 420
ggagctgtgg accgaacaca agctg.cggca caa.gcaacca toc gagc.cat citcttctittg

66480

tdatactcat tattoagttt tittatcaacc acaacctcaa agtttccitaa titcagatact 66540
tggittaa.gca aaggtogtgc citgttccaaa ttattoacac ataggitttitt cittcattcaa 66600
aaatcacatc gtaaac atta totgaaggitt agattatttg catgtaatta tattacttac 66660
ccaatcaa.cc aagctgttat citgcatggac attgtttaca totaatagggc gacgtc.cagt 66720
tattagcticc agaagtacaa cqccaaatga gaaaacgtoa gacttitt.ccg tdagtttitcc

66780

gcttgaag.ca tatto.cggag coaaatacct aaaatccaaa agttt cataa tatgtaaaga

66840
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ttcacataaa cittittaacaa aactgcataa atgtagatat ttggtagctt caagattatc 66900
tttacccaaa agttcc catc acacgtgtag atacatgagt atttgttatca gaag caatct 66960
tggcaag acc aaaatcagca accitaagaaa tagaaga gag acacatgata caaagatact

67020

tdatgacaat atcgtaccaa ataacaaata aaaggaagaa taaatcatac ctittgcttca 67080
aatttgaaat citatcaatat gtttgacgcc ttgatatoac ggtgaataat tittaggattg 67140
cctgcatata tataaatgcc tag.cgagtaa acaaacatga cctag ctata tatttattta 67200
ttittgagaaa caaatatgga attataccat gacctatatt tattacacat gatcttatag 67260
acttacaatt ttcatgaaga taagacaatc ctittgg caga accaacagda atcttcaatc. 67320
ttgaactoca titccatcgta gg.ccgtocct titcctgtcac aaatticgatt cocaagaatt 67380
tactaattga aaacattgaa ggatgcaaga aacaataaga gagtttattt tittatttittt 67440
citaaccatgg aggtgaaact c gaga.gtgtt gttgg galaca aactoataga caa.gcaatct 675 00
ttgagcatcg gcgatgcaat aaccqacaag agcaa.ccaaa totcitat gat gtact.cggct

67560

aatgatcc.ca accitctgctt gaaactcitct ttctoctitga gaactcc citt citttcaattg 67620
tittcacagda acttctittcc cattacgitaa catacctittgaacacgitatc cqaaaccgcc 67680
ttgtc.ctaac aaattggcct cagagaatcc attggtggct citagatagot cotcgtaatt 6.7740
gaaagtgcct toatatatgc ctaagccitaa tocaa.gc.cct ggtgatggtg gaggaagaac

67800

tgattgatcc gagtagtttg agtcgtag to tcc.gctgctg. CCqctgctoa togaaatgcgg 67860
tggacgtggt ggtgcagagg agg gagacitt cqgtggtggc actgacatca ccacgtgat c

67920

tgatcgtogt gatgcattitt gttgttgctg accaccgtaa gogactic cat citgagaaacg

67.980

catgaacata atatotataa aaacggtotc. tctatggatc catatacaag tittaaaaatg 68040
tagaaaaaac atgtaataga attatcataa aatgcatatt catgattaat titccccaaat 68100
atatgaaaat gacgtatatg taaaagaaaa totagataat citagttagca caactatatt 68160
acgttctaaa to attatato tagcc gagta gaagggaaaa tatagttcaa gaaaatgtag

68220

ataagttcata cittcaagatt caatttattt taaatctttgttttacctat g g gag caggg 68280
ggtgcttcat tigtotctitcg togtttctitc ttacaaagga aaaatatoaa agccaatgcc 68340
acaagaagica caaatcctcc toctatgg.cg atccc.gacca tagctcc citt tdata attct 68400
ttggaagatt gtgcc.ggtgg agaagagcct ggagtggtag atggagtact aggagatcto

684 60

cc.gc.ca.gagg gacitc.gctgg aggtggaggg citcag actoc citaccc.gagg aggaggagtg

68520

ggtgttgagg gaggtogcgg agatcttggC ggagttgaag gagtggcggg agaggg.cggit 68580
ggaggagaag aaggcCtcaa gigagaagiac ggtggagggg aaggcgt.cala gggaggtgaa 68640
ggaatgcttg gagatggagg C ggaggtaa gaggtggtgg gaga.cggagg Cagaggagat 68.700
ggtgtcaaag gaggtogalagg agtgatggca ggtggaggag aaggagt cala gggaggtgaa 68760
ggagttgttgg gaga aggcgt Caagg gaggt galaggagttg togggagatgg aggcagagga 68820
gaaggggtca agg gaggtgg gggaga aggc gtagagggag gtataggagg alacggtggta 68880
ggtggaggtg gaggaggaag gg.cgggtgga agg gCagtag gcqgaggtgg agggggalagg 68940
gCgggaggaa gqqcagtagg toggaggtega ggagtaacgg gCagaggct g aggcggagga 69000
ggaattggga gaggctgtgg aggaggtogac ggagtaCCaC cqggagg.cgg CGCC gatgac 69060
atat cittc.cc gctagtaaaa aaaaataagc gacgggataa agaagaaaaa agaatgttaa

69 120
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aag.cgg galaa agaggtotga totcitcttgc caccgag act agacittgagt tittgattact 69180
tdaatcttitt taaaaaacct ttggtacacc gatatagagg agaatatacg taatcttatt 69240
tttgtatgag titatatagitt totgttctitc ttgcatcaaa agc gaaagaa agaaatgaga

69300

gcacttacta cattgacatt totcc gatgt ttattattaa citatctaaca toaagttaca 69360
ccaaaataat coattcaaac togaaacgtac ggacaataaa taagtattitt gttaatcata 69420
ttcaatcaag gttcttaata acagotttaa caaaaaaaaa alaggttcgta ataac aggcc

694.80

aattatatoa atatggttct titcagatato cagataatgt ttittgctcitt cagataatat 69540
atgtttatgt aaataattat tattgitatca g g g toaatgt cqtatcattc tatatatott 69600
gtttaaaa.ca toccacaaga C gottaatct aagtagaaat aaaaacagaa gttcaacg act 696.60
gattgcaatg atactttgtc. aagtttggitt taggtoaaata ttttgtttitt gtoaaattga 69.720
tittaataaaa ataccagtga tatatggtoc gaacaaccaa ttttacttaa tattggtaat 69780
agtattattt ttattitttgt taacttagga aatcttaggit cqaaactctg actatgtaat 69840
aatatatagg gottataaaa catcggacaa acaac galacg ttcaaacgaa gaacttaata

69900

cacgacgtca ttcaagaatg gatcaagctt ttgttgattt toaagttgttgt atgtttacaa 69960
galaggtoaaa ataatttggit agtggacatt gacaag cat gccaaaatgg ccaaaacaaa 70020
gtocactato aattgttctac aacactataa cctttittcat tatgtatttgtctttittctt 70 080

ggaatgttitt attcaacaac aacaaaatta togtaagaaa taaaaaattt gacagtgtga 70140
tataaagaaa cittata acat attactittca atcctatgtt taaaaaaaaa acactaaaaa 70200
tgaaaatcat tigtgctaaga atataataac acattcacat tacacaaaca tatatgaaaa 70260
attctaatag accoactitcg ttatattagt aatacgatat tatagacaag aagaaactcg 70320
atcaaacgac goaaagctct tatataagcc ttaaaactca aggaggc gcc to atgacgcc 70380
aag cagotcc aaatgtgatg to atctgtgg aaaatgc.ccg atc.gc.gtcct c gatgat citc. 70440
cactgtcg at titccccittaa tottctoctd catgaagitat gcgacggaga cagg cactac 70500
gacgtogttt cotggttgta to acatggca agg cactgac acttgtc.cca aaatctotct 70560
citcgtogcta coaaacacta tottagotaa ggcaagagct gtctogggct tcatcttctt 70620
aagggactitc. tcgaac ctitt go accgagag agagt citcto gag to gacca C gaatgagga 70680
gaaatcaa.cc gcc caagctt cqtagttgga gccaatgctd gtaatgatcg tdtcaatgtc. 70740
ttittgactica aaccotccitt totaatccitc actgtttata tacctatttg catttcaatc. 70800
tagtaacgtt actaatttga toatctaaat atcattttct citttgcgcaa aaaaaaaaaa 70860
toattittctt ttatattata agtacgttgc attgatatat atagtcaaac attatcaatt 70920
gttgcattaa attatgg.ccg actittctdac citataactat aataaatato taaagtaatc. 70980
agtcaaagta toatactitca aac agittaac toccattcga taatttctat atataggaga 71040
atatag tatgttagtggtoc acgtgatata taaagatggg ttaagttitta gtactitctaa 71100
citttaaaaat gacaataaat atattgattc atcatatgat aataaaatca taacacattt 71160
tittctaattt to gatgitatc tatatgaaat gaatgtctta ttgacatatt gatagdatat 71220
gtag catgtt tacatatatt Catctacgta tatatgcgta gacto cagag aagtaagaga 71280
agatgtgatc atatgtcata to catccaac aagctagaag citgat catgt coacatgttc. 71340
aacacttggc aacagttaca cittcattaca tatagatato aaccacataa aaact attaa 71400
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atattggcta atatagtata ttattgtaaa
acacatatto

tattttgttct

titt to citcaa.

71460

acgaaggaat cittgtacg at cgg to agact gtata accitt ataattittga

7152O

ttgcatgtgc ttagatttct cittitcgaacg

toattattitt

talaattataa. attctaaatc

atcggtottc

71580

ataaatagat

tdaatatata

ggcctaaatg

1640

atgttataca galacagaaat agattataca tatgctittga

tittittadtto

caattatgat

717 OO

taagggtaag tgttatacta agagtgaagc gtaccttgga galagcagcaa. taaggagaag

71760

atttgtaaac alagtoggg CC ttittaataga agcago.acaa ccg atcaccc cc.gacatgga

1820

atct tattta

cagatatatt

atcat attitt

atggccitacg aac acgacag ggccaaactt

atalaga.gcaa tgagatcgto

71880

agagalagacg totaaggagt tatactittga agggtoatag agagtttgat citttaatggc

1940

to cagagaaa agc.cagtcaa agaccaaaac tittgaaggat tggga Calaga ccgg tattat

72 OOO

tittatcc.cala

caacticcitcc.

accgactggit cgc.citcc.gaa accgtgtgcc aag accatcg

atctototoc

tgaaccgatg attittggcgt. toatagogga tgcaaggcc.g gatatottct gattalaccac

72120

catgcttaag tacaag agtt ttgttagatg ggacaactitt gataagttgt gtgcgtatat

7218O

atalaaggaga agagagatgg attaggttta tggttctitta attgacattc alaccacc gat

2240

tittattaggc togcattttg gtacatccala acatttatogg

ccittittcaac

aatggct gta

723 OO

tttgtattoa ttgtc.catct acatago atc ttagaggata

aaacaat atc catcatalaat

7236 O

aagaatatac tacticcatgt gaaaacgaaa

tggtag tatt aaaaaggtaa

7242 O

taattatttg gacitcgatat gaagtatata tactagttitt gtttgtatgt gtaaagttta

724.80

gagtatcaaa gtgtctittct tttitttittgg tgtgitat caa agtgtcttitt

tittctatoaa.

72540

acaatgcatt tgttgtaaaa

agctaattta

titattattitt

726 OO

cgaaaaaata aatgcattaa ctaatctgac atttagacgt. caa.catgatc

toaaatticitc.

72660

aatacattaa. catalaccata aatcttaatt

aagttatagt caatgaagaa taaag cacac

7272O

ggcaaattct aataaattga

ttaa.catcaa.

toctitgctaa toataggagt catctacgaa

72780

citctacttitt

acaat attitt tittctitittaa.

acgtataaaa tgaccttittg

tottacalata

ataacaacgc

aaattaatat aattictatta

7284 O

tatata catc

atttitcgttt

citotic cotta

gacttitcgca tatatagaca catcggaaaa

729 OO

atataaaata

caa.gcaacta attgtaatca agtttctittc

tittaataa.ca

aatcttcaga

72960

agaatggata tgaaagaaaa cgatattitat tgtaattaaa tgttittcaat ttatatagta
taataaaa.ca

catatattag

agcagtagct gtgcgtggag

tatacaccala

tgacticatta gctatatttg

a tatttcaaa.

ggggaaactg gtatttaaaa

7314 O

gtgtataaaa acggagataa aaaaaaaagg tgtacttctt tgacttctot tgaaacaaaa

732OO

ttittctagot agctgcaaat acttggittta taaactggaa to catgctdt

ttaaattitct

7326 O

gtacacgtga gatgacittgg

7332O

aaaatcttaa.

aag act catt gaaaggactg aattalagtot gaaaatattg tgttittatat

73380

gtataalacca

tatatatata actitatataa.

agaaaagata

cocaiacalaat

tdaattatcto gccaccalacc

gtgatgaaga ggaaaag.cct aaaaacggaa

taaaaaaaca

caaagtaatg cgtctgttgta

acttittcata

734 40

aaaaacaatg aacaatcgto gaaaacctaa totagggata

735OO

gccaataaaa aagcctictaa aat atcgaaa ccagaacgtg taaggtocco aataactitcg

735.60

aaaagtactic aaattitatgt gaggtttaaa ttggttcaaa ggtaaaacca

7362O

gagatatotg ggC gagaaaa aaaaagacaa gaag cacaca accgc.ccatg aggaatctga

7368O

cittaaaactic
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aggaccagac cocaaaagtt ttgttttgtc. cataccttgt cattttctitc titccaaattt 73740
g gaccaatta ttattttaca ttaaactcag aaaag gtttg aaattittcct ttatcttcac 73800
agittaatgat ttagagtaaa tatgtaaag.c attcgaatat aattactgtt titcacaaaaa 73860
gaagaagaat aatattittag gtgttgttitt to catgitatg gatacaaaag citagccticta 73920
tgcctaattg tdttagtata gagtgatcga tactatagaa gotgtactitt tttcc.gtag a 73980
taactaaaga C gaggggcaa agc gattoto cacaagaaga gtaattic cat catatgtata 74040
gcataactitt tittgacttitt to acctaaag aaaaaaag.ca tacttatttg actaaataaa 74100
titcggttctg. tataaaggct gaaatactgg agaaaaagct tagttttgtc. gtgtagtgat 74160
caatgtatat tdacaaaaga gaagagacitg gaaaaaagttc tacgaccaac tttitcct tcc 74220
citttggccitt aactitcactc acacatcatt ttittaatatt accoaaattt gtocatttitc. 7428O
aaac cattaa gacgcgatat tdtgcattitt gagattgtta gcttgtagag aattaaactt 74340
cgaaaatcct agttacaatt ttatttcata caaggtotca cag atccaca ccataccgtt 74400
accttgttga tatacaagtt gaagttgtcc ttagatatta to agcttgtt toacaaatca 74 460
taaggtotaa aaaaagattg cqatatgagt ttgttacaat cattagaata aaagaaaaag 74520
agagtaaaag aaaataagat aataaatgag gaaaatgaga gttggagagt ggagagacita 74580
gagaatacaa attgccttitt gcctittaaaa gocggttcct actictotttc. tcc.gaaataa 74640

atgtcgittag cattattatc gatcgitatct atctatacac acatgcgitac caccacgtgt 74700
tttgttgctat aatcatccita taattctitat taccaatcto tag atttgtt gttacttgtt 74760
ttataaactc titttgtttitt cqgattoatt togg cacaacc tatccaaaaa aaag.gtttaa 74.820
atgagtatgt tittaaaaaga aactaatgtt attgccaatc tdagtactcc galagagatca 74880
agctaaaatt gtaaggacca aataacaaac aatctittgca aacctttitta gctcaaaagg 74940
aaactactac taaacacatt ataag attga acatggtgac ataaatacaa actactaatt 75000
acaactagda gtttaaatat gattogtata toattgatac taacaagatt agaaaaaaaa 75060
aacactatat ataatgattg attaacaagt ttcttgtato ttagaaaaaa gaggaaaaaa 75.120
catattgatt gtttittagtt ttatacaact ttgtacacat aattaacct g caaag agagt 75180
attitcgacta togaaaggaat atgtaaatca toaaaggaaa citatttatga aagatacaat 75.240
aatataaacg tdagttgttc. tcaaaaggca ttagcctcitc attitcccatc gitatttaaat 75.300
gggagtattg caaggaaaac atatatgttg gtgtaaatga citttcttggit tatgcagaag 75.360
aatgaaatta aacttic galaa atcto cagaci ttacgggitta gottaagtgt gatggcaaat 75 420
ccag coaagt cqttgttgaaa totcc ctgaa catttitataa aacaaaataa citgtttattt 75480
ttcacatato ttgaagctta gtttgaaatt tittgcatggit attittggittt actatocaac 75540
aataaaacgg gtttaatacg tataatttgg tdaaactaac tatttitttcc titacatgg to

75600

cactictoaac tattittaaag agatgaaaag titatcatcat tigattacgaa aatgatatot 75660
aacttctott atacgc.ccca catccacaca aatgccittaa tdaaaaggitt atc.gc.gtttg 75720
cgattagaac aaaccaaaac gttaccttca atcataattit gcg atcttgt tittggittagc 75780
taatagagitt atagatcaac tacgtcctag tocaaaatct gtggittataa citgtagttta 75840
taatagitaaa aataaaagct tacagtaacc citcttittcat cattgtaaga titcataacaa 75900
tgctcittaat atgaatatac aaattitcatt ttcaagagat atcgtaaag.c gaaaacatat 75960
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tgttcaagaa citagacitt.cg actggaga.ca atggaggaac atctactago citttcaatitt

76O20

cittccaactg gtoatatgga gcaatctgca gaataac caa accoaag act cataaaattit

7608O

cacatgttitt ggtaat atct ttgtttatct agttittgatt gtgatttcta agttgtattt

76.140

ggctaa acco gtogggc.ca.g gttatc.gaga cagogtagtt toccattggit

762OO

cgitatgtc.ct caggttcg at atctitcc.gct acatc.gc.cat atagaactitt ttgctcitcca

7626 O

gtocattcat cctgtttaac aaagatccala acattgacac tittgaattct tattittaagt

7632O

tittaaaagaa gctittaagaa gaalacagatt citcaggttga

attatctittca taccacactit

7638O

atttatacct

tgtgcagatc

tat catttct

totgacggitt gCagggtgca gtaagaactic titcgtctgag

7644. O

tittggtacct

toactictaat

tgc cittgaga tacttgtc.gt atgtcacggc cqttgatact

765 OO

gtttittaaca taaaatgcac agaaaagaaa gag totttta acttaattca to cattgata

765 6.O

citaaaagaga aaggaaggtt ttittgacatg gttggttgtt taccttgct g g c gitatcttg

76 620

gc gcattgtt gcactacaca tacaccalaga to citggaacg ttctggcaac gito acttaga

7668O

ggat.ccgaca citactitcagg agttcc.gcta toccc.cgaag cagatalacta acaatcaaaa

76740

agga atttaa gaaaaactgt ttagaacaat gag to cagta atattactgttcaatcacct

768OO

gatataacaa aagaattaga tgaac attcc aagga catca aaatagottt to attcctaa

76860

agtcaaaag.c

taalatattoa

tottacatca tatatalactit

76920

attatacatac

cgttggtota atggggaggit caaagaggtg agg tatgccg aattgcttga

7698O

ccacct gcag ccaaagatgt attgtcagaa gttatctaaa tgtgtttaac gtacatgtc.g

77 O40

citgttgaaat attcattttg gtttcttgaa gtaaaactaa gag acagtat aaagt cagot

771 OO

acct cagaac citgaacctitt CCC aaaaggg taataacgtt toccatcago gtoaaagtgg

7716 O

accitactcc.g taaaaccalaa Caggaaataa

7722O

atctoggaag ttcatatotg tttgttgcag agttgagaag aaaaacaagt to acaagctic

7728O

catataaaag aaaaaggaga gtttatgatc aaagttctgga acagggaaat aaccittaagt

7734. O

tittgagaa.ca

ttittgcaa.ca totaataaacg cca acttittg aggggtogtg

774OO

acaattaccg citgctgtcaa tgg.cgcaacc tgataccaag aac attatag toatago atc

77460

taacagaaga

7752O

actgttgttgt ttcatagaac

cacatattoct ccacaa.cago aacgcaaggc

toctitacacc

atttaataat attcatcata

tittcagttgc tag caaagtt attcagttgt

tacatgcaag ggaaaaag.ca ttggcacata tatatttgca

titactitt cat toccitadata

77580

tgcgaacgaa citaaaagtaa agtagaaatg gttgtataat attcaaaacc galacct ggca

7764 O

taaggtoagt tgtatatoac cagttcCagg agg catgtcg ataacaagat agtc.ca.gctic

77700

aaaaagattt ataaatgttt citggaaaaaa catgaagttca

77760

gttgttgtaa ggagttggitt tatalacacca

7782O

gacaccatag gacctdtcat aatgg cacgc ccttgtc.ctg caaatccaaa tagacitagc

77880

ttgacgcc.ca tgtattotgt tggaatgatg gtottcttct cc.gggttcta ttgaacatat

7794. O

acagaacticg

tocc ctgcat

caaatticcitc.

atgattittat ggaaatgaac

aalaccattca

aaaaac atta

gtoctittgttg tgttactgct atcacaaggt gag to agaga

78 OOO

a tattaccat titccalatata

cggct citcag gattgac cat ggttggtaga cittggaccat

7806 O

agacatcago atcaaagata ccaactotag

cacccatacc

agctaatgta taagcaagat

7812 O

ttacag citac tgttgattitc

cctgaaatgt to atctaa.ca acagogtgtc

7818O

atgaactaaa agggacgcta gaaagaaaga tacagacaga ttactittcta totcacaaag

824 O

coal acacao
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aggaaatacc agctactgtt cogitttctat citttitccaaa aaaacttgaa cigagacaata 78300
aacaaagaac acagga catc ttattgatat cacat cacta agacitactitt goc agaagag 78360
tatgtag cat tcg tatttac acagoagagc acatcccata ttattaactt aaatttgaga 78420
agaaacttica gttcaaaaag aaa.catcaag agctgttgtaa aaagaaattic attggaagat 78.480
atatgtacct togcaactaga aac agcgatg atgttcgaaa ttcttgataa tocaaaggga 78540
agctg.ccctg caaaaatggg cittggctggit tatgctgaca ttgtcacatt taccttctitc. 78600
acco atggaa gogctgcaac tacct cattt gcc ttgttct caaactacaa aagagtcgta 78660
atccatccat caaagataca citaaaagaac to attcattg cittatataac caatgatata 78720
gctocaaaat cotcctaatg g gatgaagtt citatcagtag taatatgata aaagaatagt 78780
gaatggtaat gtcatttacc atgtc.tttga citgga catgc gggtgttgtc. agctocaaac 78840
ggaacgaaac ctacaacaag agaccaaaca tottt cagoa gccttgaaca aacaatctaa 78 900
aacagaacaa attggtgaag gataaagtat tattattacc to accoaaag cittcattaat 78960
ccccaaatct titcacaaaac cacaagaaac aatatatgtc. ccaaaatcag gatcaataat 79020
citgagacaga gccttcaaca catctttittctgatgtttga gcaac actot caccaac act 79080
actactagot gtttitccaaa atgcataagt taaaaaatat cagaacttgc titagt citcct 79140
togcgtataa cqttaacaat ttittcaggcg gag acaaagg aacaaactitt ata accittga 79200

gctgaag Cag Ctttagctac agagagattctgagagacco gtttgaggat tcttgtcCtg 79260
gagattgaga taatggaagc titgagaatgg agaaacttgt gagaaagaag caatcttgtt 79320
gtggaattgc titcttctttg g g totgaatc. tcgaaagaag gatgcc.gcaa cqactgtgga 79380
tgaagaag.cg gcattgctac aagagagaga C galagagagt ggcaaaaaaa act agcgg to

794-40

tgttgataatt tdatc.gctca actictittaaa agataaaact ttittcaaagc tittittattat 79500
ttittattatt attattocaat atatoataaa tttittacatt totaatcaga tattattgtt 79560
tttitttactg atgtgttgtca aattacatct aagataaatc aaaattaagt titttactgat 79620
gtatgttgaa ttctacaaaa gtttcttttgtta acacaaa atgttaaatg tittcgaaatt 79680
aagataaatc aaaattaagt aaattaaaac ttaaaaagac aggaaag cag atttgattga 79740
agtaaattica gatgattaaa atgttagatt tag agaaatt ttcaaaaaaa tag actaata 79800
gtag atctag caattaatca agattgttat tigcaccgttc taaaactaca aatcttaatc. 79860
tatagittaat cqactcitcgt tataattgac taactatgcc taacaatatt g gttttgttgt 79.920
citccatctaa aattacitaga attaagcaag cattagaatt cagtttgata agtttaccta 79.980
agcatctaaa ccgggttggc agt catctag titattaaggc tictoctaa.ca ataattic cag 80040
taataaacgc atctoggatt ttacatatta acttataatc aaattittagt togttactict 80 100
agaactagot ttaagaataa toaaaggaga agaactctag ggataaatac talacagatta 80 160
tdgatttacg atttcatcta aatttctaat gataaactitt aaaccoaaga aggagattac 80 220
totag acataa ttaaagaaac ataaaacatg tittgaataag attacataaa gaaatcaaaa 80280
gtagaatgga gtttaaaaaa tatcttittct citataggitat aag gttittga aatttctgaa 80340
gtagtatcca caaaccitcaa agaatttgga gag caaaaaa toaaataaag citt
<210

SEQ ID NO 5

&2 11s LENGTH 368
&212> TYPE DNA

80393
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<213> ORGANISM: Arabidopsis thaliana
<400

SEQUENCE: 5

tggg acaccg tttacacacg aac gtttact citaatagagc atgtatgtat gattgtctaa

60

titccagtgta totggtocatc. cittgttactg. c.gcatagoca acctagogga accocggatt

120

ttgaac cogt catcttatca agacitgattctg.cgc.cg acc tittgcgactic cacggag cac

18O

aattictatog togctattgca atatatgcct gcatacacgt citgcatatgc tiggtotcatc

240

gc gttittgga ggtottct catcagatacct atccagaggc tiggctg.ccca attatggtac

3OO

acaatcctitt ttgaattitca agctgcagcc cqggcc.gtog accacgc.gtg cccittagttg

360

agtcgitat

368

<210> SEQ ID NO 6
&2 11s LENGTH TO3
&212> TYPE DNA

<213> ORGANISM: Hordeum vulgare
&220s FEATURE

<221 NAME/KEY: misc feature
<222> LOCATION: (2) ... (2)

<223> OTHER INFORMATION: n is a c, g, or t
&220s FEATURE

<221 NAME/KEY: misc feature
<222> LOCATION: (7) . . (7)

<223> OTHER INFORMATION: n is a c, g, or t
<400> SEQUENCE: 6
gnacggnaaa gtoctittgac togtttgatg gttct cotat tacgaactt titatgcaagg

60

taagggagat atatggcc to gacgagaaaa citagtttccg caacgtoact atcto gttgg

120

aagg gaggcc toaacctitta tat cittggaa citgctactca aattggagtg atatoaactg

18O

aggggatc.cc cagtttacca aaaatgctac toccitccaaa ttgttgcc.ggg citt.ccgtcaa

240

tgtatattag agatcttctt cittaatccitc catcttittga tigttgccitct gcaattcaag

3OO

aggcttgcag gottatgtgc agcataactt gttcaattcc agaatttacct gcataccat

360

cago gaagct totgaaacta cittgagtoga aagaggittaa totacatc gala ttttgtagaa

420

taaaaaatgt cottgacgag attatgttga t gaatggaat cactgagctt to agctato c

480

agaacaaatt gctic galacct gctitcggtgg titactggctt gaaagttgat gctgatatac

540

taattaaaga atgtag attt attitcgaaac gtataggtga agtgatatot ttagotggcg

600

aaagtgacca ggcaat atct tcatcggaat atattoccaa goagttcttic aatgatatgg

660

agtcatcttg gaagggg.ccg tdtgaaaagg gtc catgctd aag

703

<210

SEQ ID NO 7

<211& LENGTH: 232
&212> TYPE PRT

<213> ORGANISM: Hordeum vulgare
&220s FEATURE

<221 NAME/KEY: misc feature
<222> LOCATION: (2) ... (2)

<223> OTHER INFORMATION: Xaa can be any naturally occurring amino acid
<400

SEQUENCE: 7

Thr Xaa Lys Ser Phe Asp Trp Phe Asp Gly Ser Pro Ile Asp Glu Lieu
1

5

10

15

Lieu. Cys Llys Val Arg Glu Ile Tyr Gly Lieu. Asp Glu Lys Thr Ser Phe
2O

25

30
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Arg Asn Val Thir Ile Ser Leu Glu Gly Arg Pro Glin Pro Leu Tyr Lieu
35

40

45

Gly Thr Ala Thr Glin Ile Gly Val Ile Ser Thr Glu Gly Ile Pro Ser
50

55

60

Leu Pro Llys Met Leu Lleu Pro Pro Asn. Cys Ala Gly Lieu Pro Ser Met
65

70

75

8O

Tyr Ile Arg Asp Leu Lleu Lleu. Asn Pro Pro Ser Phe Asp Wall Ala Ser
85

90

95

Ala Ile Glin Glu Ala Cys Arg Lieu Met Cys Ser Ile Thr Cys Ser Ile
100

105

110

Pro Glu Phe Thr Cys Ile Pro Ser Ala Lys Lieu Val Lys Lieu Lieu Glu
115

120

125

Ser Lys Glu Val Asn His Ile Glu Phe Cys Arg Ile Lys Asn Val Lieu
130

135

140

Asp Glu Ile Met Leu Met Asn Gly Ile Thr Glu Lieu Ser Ala Ile Glin
145

15 O

155

160

Asn Lys Lieu Lieu Glu Pro Ala Ser Val Val Thr Gly Lieu Lys Val Asp
1.65

170

175

Ala Asp Ile Lieu. Ile Lys Glu Cys Arg Phe Ile Ser Lys Arg Ile Gly
18O

185

19 O

Glu Val Ile Ser Leu Ala Gly Glu Ser Asp Glin Ala Ile Ser Ser Ser
195

200

2O5

Glu Tyr Ile Pro Lys Glu Phe Phe Asin Asp Met Glu Ser Ser Trp Lys
210

215

220

Gly Pro Cys Glu Lys Gly Pro Cys
225

<210

230

SEQ ID NO 8

&2 11s LENGTH 540
&212> TYPE DNA

<213> ORGANISM: Hordeum vulgare
<400

SEQUENCE: 8

citagtgtaaa togcggcttg gttgataggc ctdatggtot goggaaatggg ttggalacctic

60

caac aggttc ttittgg acto citgcgaaagg atgtc.gagag cattgttact gcgatatgcg

120

aaga caagct gttggacctg tacaacaaga gaagcatcto a gag cagatt gaggtggtot

18O

gtgtaactgt aggtgctagg gagcaa.ccgc caccittcaac cqttggcagg to cagcatct

240

atat cattat cagacgtgac aacaagctict atgttggaca gacggatgat citcgtgg gcc.

3OO

gtottggtgc ticatagatcc aag galaggta tocaagatgc cacaatatta tacatcgtgg

360

titcc togcaa gag.cgttgcg togccaactgg agacitcttct cataaatcag citaccct cqa

420

aaggttittaa got caccaac aaggcagatg gcaag catcg gaactittggt atgtctgtaa

480

ccitctggaga agc catggcc gcgcactgaa citgcc cc act galacatccag ttitta actog

540

<210

SEQ ID NO 9

&2 11s LENGTH 168
&212> TYPE PRT

<213> ORGANISM: Hordeum vulgare
<400

SEQUENCE: 9

Ser Val Asn Gly Gly Lieu Val Asp Arg Pro Asp Gly Lieu Gly Asn Gly
1

5

10

15
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Leu Glu Pro Pro Thr Gly Ser Phe Gly Lieu Lieu Arg Lys Asp Val Glu
2O

25

30

Ser Ile Val Thr Ala Ile Cys Glu Asp Llys Lieu Lleu. Asp Leu Tyr Asn
35

40

45

Lys Arg Ser Ile Ser Glu Glin Ile Glu Val Val Cys Val Thr Val Gly
50

55

60

Ala Arg Glu Gln Pro Pro Pro Ser Thr Val Gly Arg Ser Ser Ile Tyr
65

70

75

8O

Ile Ile Ile Arg Arg Asp Asn Lys Lieu. Tyr Val Gly Glin Thr Asp Asp
85

90

95

Leu Val Gly Arg Lieu Gly Ala His Arg Ser Lys Glu Gly Met Glin Asp
100

105

110

Ala Thr Ile Leu Tyr Ile Val Val Pro Gly Lys Ser Val Ala Cys Glin
115

120

125

Leu Glu Thir Lieu Lleu. Ile Asin Glin Leu Pro Ser Lys Gly Phe Lys Lieu
130

135

140

Thr Asn Lys Ala Asp Gly Lys His Arg Asn. Phe Gly Met Ser Val Thr
145

15 O

155

160

Ser Gly Glu Ala Met Ala Ala His
1.65

<210> SEQ ID NO 10
&2 11s LENGTH 540
&212> TYPE DNA

<213> ORGANISM: Hordeum vulgare
<400

SEQUENCE: 10

citagtgtaaa togcggcttg gttgataggc ctdatggtot goggaaatggg ttggalacctic

60

caac aggttc ttittgg acto citgcgaaagg atgtc.gagag cattgttact gcgatatgcg

120

aaga caagct gttggacctg tacaacaaga gaagcatcto a gag cagatt gaggtggtot

18O

gtgtaactgt aggtgctagg gagcaa.ccgc caccittcaac cqttggcagg to cagcatct

240

atat cattat cagacgtgac aacaagctict atgttggaca gacggatgat citcgtgg gcc.

3OO

gtottggtgc ticatagatcc aag galaggta tocaagatgc cacaatatta tacatcgtgg

360

titcc togcaa gag.cgttgcg togccaactgg agacitcttct cataaatcag citaccct cqa

420

aaggttittaa got caccaac aaggcagatg gcaag catcg gaactittggt atgtctgtaa

480

ccitctggaga agc catggcc gcgcactgaa citgcc cc act galacatccag ttitta actog

540

<210> SEQ ID NO 11
<211& LENGTH 4 44
&212> TYPE DNA

<213> ORGANISM: Zea mays
<400

SEQUENCE: 11

taattact to cittagacaag ggaaatatta taacticc cct ggc.cccitact atgcaca agg

60

citagcaccac tat cagttca acaaaactag g gogg catgg totcagttag citc.ccgc.ctic

120

citattgaata tocaatagoa aaaag accitt cagctgacta gttcc.gtcga gtagcaactg

18O

ccitc.gc.ca.ga gattc.gagat ataccgaagt toc totgctt cocgtctgcc ttgttgatga

240

gcttgaagcc cctoga aggg agctggttta tagaagggit titccagotgg caggcaacgc

3OO

tott gccagg gaccalagacg tataataccg tag.cgtoccg catgcct tcc titc gatctgt

360
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ggg.cgttcaa go.gc.cccaga agatcgtocg totgtccaac atagagcct g ttgtc.gcttic

420

tgataatcac gtagatgcta gatc

444

<210> SEQ ID NO 12
&2 11s LENGTH 94.
&212> TYPE PRT

<213> ORGANISM: Zea mays
<400

SEQUENCE: 12

Ser Ser Ile Tyr Val Ile Ile Arg Ser Asp Asn Arg Lieu. Tyr Val Gly
1

5

10

15

Glin Thr Asp Asp Leu Lieu Gly Arg Lieu. Asn Ala His Arg Ser Lys Glu
2O

25

30

Gly Met Arg Asp Ala Thr Val Leu Tyr Val Leu Val Pro Gly Lys Ser
35

40

45

Val Ala Cys Glin Leu Glu Thir Lieu Lieu. Ile Asn Gln Leu Pro Ser Arg
50

55

60

Gly Phe Lys Lieu. Ile Asn Lys Ala Asp Gly Lys His Arg Asn. Phe Gly
65

70

75

8O

Ile Ser Arg Ile Ser Gly Glu Ala Val Ala Thr Arg Arg Asn
85

90

<210> SEQ ID NO 13
&2 11s LENGTH 338
&212> TYPE DNA

<213> ORGANISM: Medicago truncatula
<400

SEQUENCE: 13

caatggtaat aattctaatg g g acacatca titc.cgaaaag tttittatcaa caatttcto a

60

ggagggaatc. tctittagcta atcca attga agttt cacat aag gaggttg agagtgctat

120

cact gtaatc toccaagatt ttatagogga actg.cga-agg aaaaagatca catcatalact

18O

tatcaagata aagtgtttct taattggcac tagggaatgg ccaccitc.cga tigacitatatg

240

citcttcaagt gtctacgtga tigctoragacc agatcagaaa citctacgtag gagagacgga

3OO

taatcto gag gatcgagttc gtgcacatcg atcgaaag

338

<210> SEQ ID NO 14
&2 11s LENGTH 679
&212> TYPE DNA

<213> ORGANISM: Allium cepa
<400

SEQUENCE: 14

ggaatctt.ca toggaaaggcc gtgttgaagag gatacatgct gaggatgtgt ttgctgaagt

60

tgacaaagct gcticagtc.tt totct attac agittatggaa gacitttgttc caatcgtttc

120

tagagtaaaa goggittatgt cittct cittgg aggtocaaag ggtgaagitat gttatgctag

18O

agaacatgaa gotgtttggit toaaagga aa gogttittato coatctgttt go.gctaatac

240

acctggggaa gag cagat.ca agaaacttaa acctgccttg gattoaaaag gaagaaaagt

3OO

cggagaggaa toggttcacaa C gatcaat at tdagaatgca ttalactaggt atcatgaatc

360

tacggaaaag goaagaatta aagttittgga cittattalaga gaactittctg gagaaatgca

420

ggctaaaatt aacatccttg tottctottc catgctgctt gtcatatota aatctottitt

480

tggc catgtt agtgaaggta ggaga agagg atgggtgttt cott gacctgc acaattic coa

540
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aatcataagg ataatagttt goacactggit aatgaaacac ttgagctaag agatttatca

600

ccitt tatggit ttgatgctgt gcaaggaagit gcaatggaaa atactgtcag aatgcattct

660

atgtttctitt tactgg gcc

6.79

<210

SEQ ID NO 15

&2 11s LENGTH 179
&212> TYPE PRT

<213> ORGANISM: Allium cepa
<400

SEQUENCE: 15

Glu Ser Ser Trp Lys Gly Arg Val Lys Arg Ile His Ala Glu Asp Wal
1

5

10

15

Phe Ala Glu Val Asp Lys Ala Ala Glin Ser Leu Ser Ile Thr Val Met
2O

25

30

Glu Asp Phe Val Pro Ile Val Ser Arg Val Lys Ala Val Met Ser Ser
35

40

45

Leu Gly Gly Pro Lys Gly Glu Val Cys Tyr Ala Arg Glu His Glu Ala
50

55

60

Val Trp Phe Lys Gly Lys Arg Phe Met Pro Ser Val Trp Ala Asn Thr
65

70

75

8O

Pro Gly Glu Glu Glin Ile Lys Lys Lieu Lys Pro Ala Lieu. Asp Ser Lys
85

90

95

Gly Arg Lys Val Gly Glu Glu Trp Phe Thr Thr Ile Asn. Ile Glu Asn
100

105

110

Ala Lieu. Thir Arg Tyr His Glu Ser Thr Glu Lys Ala Arg Ile Llys Val
115

120

125

Leu Asp Lieu Lieu Arg Glu Lieu Ser Gly Glu Met Glin Ala Lys Ile Asn
130

135

140

Ile Leu Val Phe Ser Ser Met Leu Leu Val Ile Ser Lys Ser Leu Phe
145

15 O

155

160

Gly His Val Ser Glu Gly Arg Arg Arg Gly Trp Val Phe Pro Asp Lieu
1.65

170

175

His Asn. Ser

<210> SEQ ID NO 16
&2 11s LENGTH 662
&212> TYPE DNA

<213> ORGANISM: Citrus sinensis

<400

SEQUENCE: 16

attggtttga tigcago agaa gocagtgctg tacataatac agttgatatg cagtcattat

60

ttct cotgac togtocaaat gggggtggta aatctagttt acttagatca atttgttgctg

120

cittcgttact togg catatgt ggtottatgg toccc.gcaga gtcagoctoa attcc titact

18O

ttgatgctat catgcttcac atgaaatcct atgatagocc tigctgacggg aaaagct cat

240

ttcagg tatt citggttccitt gtact gaggit totaagtttg citcatgc.cat gatagat.cga

3OO

gottagcc at gatcttgttga gg catggtag tagta actogg togcaggtgag aaatgttgag

360

tact acaatt tacacattgc actitcaccitc. tcatctoaaa totggtggala aag.cgtaatg

420

tattaattitt citgtggatat tatatgtctg cattctotta atttcagtat ttgctgcaaa

480

aggittatcto cattaagttg cacatgttgc ticagtacctt aagtttittac tittgaacaag

540

caatttitttg tatgttggaa ttatctitcga taggagtggit atcaagtaat atgcaaataa

600
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titcc gttitta atggttcagg tagaaatgtc. agaaatacgg toaattgtca citgcaac cac

660

tt

662

<210

SEQ ID NO 17

&2 11s LENGTH 81
&212> TYPE PRT

<213> ORGANISM: Citrus sinensis

<400

SEQUENCE: 17

Trp Phe Asp Ala Ala Glu Gly Ser Ala Val His Asn Thr Val Asp Met
1

5

10

15

Glin Ser Lieu Phe Leu Lieu. Thr Gly Pro Asn Gly Gly Gly Lys Ser Ser
2O

25

30

Leu Lieu Arg Ser Ile Cys Ala Ala Ser Lieu Lieu Gly Ile Cys Gly Lieu
35

40

45

Met Val Pro Ala Glu Ser Ala Ser Ile Pro Tyr Phe Asp Ala Ile Met
50

55

60

Lieu. His Met Lys Ser Tyr Asp Ser Pro Ala Asp Gly Lys Ser Ser Phe
65

70

75

8O

Glin

<210> SEQ ID NO 18
&2 11s LENGTH 600
&212> TYPE DNA
<213> ORGANISM: Solanum tuberosum

<400

SEQUENCE: 18

gcacacagac actgttgtatt gtgcactgat atcgagcaat gtattgg gtt acggcaaaaa

60

acgtc.gc.cgt titcagttccc cgttgg.cgitt cactgtc.cct tittccitcc.gt coaccacttic

120

gcc.ggc gttt cittctott to tct coacata citctgtgcc.g. agagcagata cqttgcttga

18O

aggagcggaa gttttittgcc acaacggcaa aaaaaaacto aaacaac caa aaagttgttcc

240

agaggaaaaa gacitatgtta at attatgtg gtggaaagag agaatggaat tottgagaaa

3OO

gcc titcttct gttctactgg citaagaggct tacatattgt aacttgctgg gtgtggatcc

360

gagtttgaga aatggaagttc ttaaagaggg aac acttaac toggagatgt togctgttcaa

420

gtoaaaattt cotcgtgaag titttgttctg. tagagtaggit gatttittatg aag caattgg

480

attc gatgct totattottg toggaatatgc tiggitttaaat coatttggtg goctocqctic

540

agatagtata ccaaaagctg. gttgtc.cagt tdtgaatcta agacagacgt toggatgatct

600

<210

SEQ ID NO 19

&2 11s LENGTH 187
&212> TYPE PRT
<213> ORGANISM: Solanum tuberosum

<400

SEQUENCE: 19

Met Tyr Trp Val Thr Ala Lys Asn Val Ala Val Ser Val Pro Arg Trp
1

5

10

15

Arg Ser Lieu Ser Leu Phe Leu Arg Pro Pro Leu Arg Arg Arg Phe Phe
2O

25

30

Ser Phe Ser Pro His Thr Lieu. Cys Arg Glu Glin Ile Arg Cys Lieu Lys
35

40

45

Glu Arg Llys Phe Phe Ala Thir Thr Ala Lys Lys Lys Lieu Lys Glin Pro
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50

55

60

Lys Ser Val Pro Glu Glu Lys Asp Tyr Val Asn. Ile Met Trp Trp Lys
65

70

75

8O

Glu Arg Met Glu Phe Leu Arg Llys Pro Ser Ser Val Lieu Lieu Ala Lys
85

90

95

Arg Lieu. Thir Tyr Cys Asn Lieu Lieu Gly Val Asp Pro Ser Lieu Arg Asn
100

105

110

Gly Ser Lieu Lys Glu Gly. Thir Lieu. Asn. Ser Glu Met Lieu Lleu Phe Lys
115

120

125

Ser Lys Phe Pro Arg Glu Val Leu Phe Cys Arg Val Gly Asp Phe Tyr
130

135

140

Glu Ala Ile Gly Phe Asp Ala Cys Ile Leu Val Glu Tyr Ala Gly Lieu
145

15 O

155

160

Asn Pro Phe Gly Gly Lieu Arg Ser Asp Ser Ile Pro Lys Ala Gly Cys
1.65

170

175

Pro Val Val Asn Lieu Arg Glin Thr Lieu. Asp Asp
18O

185

<210> SEQ ID NO 20
&2 11s LENGTH 3396
&212> TYPE DNA

<213> ORGANISM: Oryza sativa
<400> SEQUENCE: 20
atggcc attc agcggctgct c gc gagctcg citcgtggcc.g. ccacgcc.gc g g togctt.ccc

60

gtogcc.gc.cg actic gtttct coggcgcc.gc caccgcc citc gctgctoccc gct coccgc.g

120

citgctattta acaggagg to citggtotaaa cca aggaaag totcacgaag catttcc att

18O

gtgtc.tagga agatgaacaa acaaggagat citctgtaatg aaggcatcct gcc acatatt

240

citgtggtgga aagagaaaat ggagaggtgc aggaaac cat catcaatgca attgacticag

3OO

agacittgttgt attcaaat at tittaggattg gatccaactt taagaaatgg aagcttgaag

360

gatggaagcc tdaacacgga aatgttgcaa ttcaaatcga agtttcc to g togaagttcta

420

citttgcagag togg gagattt citacgaggct gttgg gtttg atgcatgitat cottgtggag

480

catgcaggct taaatccttt toggaggcttg cqttctgata gtattocaaa agctggatgt

540

ccagtcatga atttgcggca gacattggat gatttgacitc gatgtggitta citctgtgtgc

600

atagttgaag aaattcaagg cccaa.cccaa gotcgtgcta ggaaaggc.cg atttatttct

660

ggcc atgcac atcctggtag to cittatgta tittggtottg citgaagtaga ccatgatgtt

720

gagttc.cctg atccaatgcc totagttggg atttcac gat citgcaaaagg citattgcctg

78O

atttctgtgc tagaga caat gaaaa.cat at tdagctdagg agggcttaac agaggaagca

840

gttgttacta agctitc.gcat atgcc.gittat catcatctat accittcatag titctittgagg

9 OO

aacaattctt Cagg cacatc acgctgggga gaatttggcg aaggtgggct attgttgggga

96.O

gagtgcagtg gaaaatcttt to agtggttt gatggtaatc. citattgaaga actgttatoc

1020

aaggta aggg aaatatatgg gcttgaagag aag actottt toc gtaatgt cagtgtc.tca

1080

ttggaaggga ggc citcaa.cc cittgttatctt galacagota citcaaattgg ggtgatacca

1140

actgagggaa tacccagttt gctaaaaatt gttct cocto caaactittgg togcc titcca

1200

toattgtata ttagagatct tcttcttaac cctocatctt ttgatgttgc atcatcagtt

1260
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<213> ORGANISM: Oryza sativa
&220s FEATURE

<221 NAME/KEY: CDS
<222> LOCATION: (1) . . (3396)
<400

SEQUENCE: 21

atg goc att cag cqg citg citc gog agc tog citc gtg gcc goc acg cc.g

48

Met Ala Ile Glin Arg Lieu Lleu Ala Ser Ser Lieu Val Ala Ala Thr Pro
1

5

10

15

cgg togg citt coc gtc gcc gcc gac to g titt citc cqg cqc cqc cac cqc

96

Arg Trp Lieu Pro Wall Ala Ala Asp Ser Phe Leu Arg Arg Arg His Arg
2O

25

30

cct cqc toc toc cog citc ccc gog citg cita titt aac agg agg to c togg

144

Pro Arg Cys Ser Pro Leu Pro Ala Lieu Lleu Phe Asn Arg Arg Ser Trp
35

40

45

tot aaa cca agg aaa gtc. tca cqa agc att toc att gtg tot agg aag

192

Ser Lys Pro Arg Lys Val Ser Arg Ser Ile Ser Ile Val Ser Arg Lys
50

55

60

atgaac aaa caa goa gat citc tot aat gala ggc atg citg cca cat att

240

Met Asn Lys Glin Gly Asp Lieu. Cys Asn. Glu Gly Met Leu Pro His Ile
65

70

75

8O

citg togg tog aaa gag aaa atg gag agg togc agg aaa cca to a toa atg

288

Leu Trp Trp Lys Glu Lys Met Glu Arg Cys Arg Lys Pro Ser Ser Met
85

90

95

caa ttg act cag aga citt gtg tat to a aat att tta gga ttg gat coa

336

Gln Leu Thr Glin Arg Leu Val Tyr Ser Asn. Ile Leu Gly Leu Asp Pro
100

105

110

act tta aga aat gga agc titg aag gat gga agc citg aac acg gala atg

384

Thr Lieu Arg Asn Gly Ser Lieu Lys Asp Gly Ser Lieu. Asn Thr Glu Met
115

120

125

ttg caa ttcaaa tog aag titt colt c.gt gala gtt cita citt toc aga gtg

432

Leu Glin Phe Lys Ser Lys Phe Pro Arg Glu Val Lieu Lieu. Cys Arg Val
130

135

140

gga gat titc tac gag got gtt ggg titt gat gca tot atc citt gtg gag

480

Gly Asp Phe Tyr Glu Ala Val Gly Phe Asp Ala Cys Ile Leu Val Glu
145

15 O

155

160

cat go a ggc tita aat cott titt gga ggc titg cqt tot gat agt att coa

528

His Ala Gly Lieu. Asn Pro Phe Gly Gly Lieu Arg Ser Asp Ser Ile Pro
1.65

170

175

aaa got gga tot coa gtc atgaat ttg cqg cag aca ttg gat gat ttg

576

Lys Ala Gly Cys Pro Wal Met Asn Lieu Arg Glin Thr Lieu. Asp Asp Lieu
18O

185

19 O

act cqa tot ggit tac tot gtg toc at a gtt gala gaa att caa goc coa

624

Thr Arg Cys Gly Tyr Ser Val Cys Ile Val Glu Glu Ile Glin Gly Pro
195

200

2O5

acc caa got cqt gct agg aaa ggc cqa titt att tot goc cat gca cat

672

Thr Glin Ala Arg Ala Arg Lys Gly Arg Phe Ile Ser Gly His Ala His
210

215

220

cct ggt agt cot tat gta titt ggit citt got gala gta gac cat gat gtt

720

Pro Gly Ser Pro Tyr Val Phe Gly Leu Ala Glu Val Asp His Asp Val
225

230

235

240

gag titc cct gat coa atg cct gta gtt ggg att to a cqa tot gca aaa

768

Glu Phe Pro Asp Pro Met Pro Val Val Gly Ile Ser Arg Ser Ala Lys
245

250

255

ggc tat tdc citg att tot gtg cita gag aca atg aaa aca tat to a got

816

Gly Tyr Cys Leu Ile Ser Val Leu Glu Thr Met Lys Thr Tyr Ser Ala
260

265

27 O

gag gag ggc tita aca gag gaa goa gtt gtt act aag citt cqc at a to c

864
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Glu Glu Gly Lieu. Thr Glu Glu Ala Val Val Thr Lys Lieu Arg Ile Cys
275

280

285

cgt tat cat cat cita tac citt cat agt tot ttg agg aac aat tot to a

912

Arg Tyr His His Leu Tyr Lieu. His Ser Ser Lieu Arg Asn. Asn. Ser Ser
29 O

295

3OO

ggC aca. tca cqc togg gga gala titt ggc gala ggt ggg Cta ttg togg gga

96.O

Gly. Thir Ser Arg Trp Gly Glu Phe Gly Glu Gly Gly Lieu Lleu Trp Gly
305

310

315

320

gag toc agt gga aaa tot titt gag togg titt gat ggit aat cot att gala

OO 8

Glu Cys Ser Gly Lys Ser Phe Glu Trp Phe Asp Gly Asn Pro Ile Glu
325

330

335

gaa citg tta toc aag gta agg gala at a tat ggg citt gaa gag aag act

O56

Glu Lieu Lieu. Cys Lys Val Arg Glu Ile Tyr Gly Lieu Glu Glu Lys Thr
340

345

35 O

gtt titc cqt aat gtc. agt gito tca ttg gala ggg agg cct caa coc ttg

104

Val Phe Arg Asn Val Ser Val Ser Leu Glu Gly Arg Pro Gln Pro Leu
355

360

365

tat citt gga aca gct act caa att ggg gtgata cca act gag gga ata

152

Tyr Leu Gly Thr Ala Thr Glin Ile Gly Val Ile Pro Thr Glu Gly Ile
370

375

38O

ccc agit ttg cta aaa att gtt citc cct coa aac titt ggt g g c citt coa

200

Pro Ser Leu Leu Lys Ile Val Leu Pro Pro Asn Phe Gly Gly Leu Pro
385

390

395

400

toa ttg tat att aga gat citt citt citt aac cot coa tot titt gat gtt

248

Ser Leu Tyr Ile Arg Asp Leu Leu Leu Asn Pro Pro Ser Phe Asp Val
405

410

415

gca to a to a gtt caa gag got toc agg citt at g g gt agc ata act togc

296

Ala Ser Ser Val Glin Glu Ala Cys Arg Leu Met Gly Ser Ile Thr Cys
420

425

43 O

tog att cott gala titt aca toc at a cog goa goa aag citt gtg aaa tta

344

Ser Ile Pro Glu Phe Thr Cys Ile Pro Ala Ala Lys Lieu Val Lys Lieu
435

4 40

4 45

citc gag toa aaa gag gtt aat cac atc gala ttt tot aga ata aag aat

392

Leu Glu Ser Lys Glu Val Asn His Ile Glu Phe Cys Arg Ile Lys Asn
450

455

460

gto: ct c gat gag gtg ttg titc at g g gt agc aat gct gag citt tot got

4 40

Val Lieu. Asp Glu Val Lieu Phe Met Gly Ser Asn Ala Glu Lieu Ser Ala
465

470

475

480

atc. citg aat aaa ttg citt gat cot gcc goc ata gtt act ggg ttcaaa

488

Ile Lieu. Asn Lys Lieu Lleu. Asp Pro Ala Ala Ile Val Thr Gly Phe Lys
485

490

495

gtt gala gC c gat ata cita gtgaat gala tot agc titt att to a caa cqt

536

Val Glu Ala Asp Ile Lieu Val Asn. Glu Cys Ser Phe Ile Ser Glin Arg
5 OO

505

51O.

ata got gala gta atc. tct tta ggt ggit gala agt gac cag goa ata act

584

Ile Ala Glu Val Ile Ser Lieu Gly Gly Glu Ser Asp Glin Ala Ile Thr
515

52O

525

toa tot gala tat att cog aaa gag titc titc aat ggt atg gag to a tot

632

Ser Ser Glu Tyr Ile Pro Lys Glu Phe Phe Asn Gly Met Glu Ser Ser
530

535

540

tgg aag gga cqt gta aaa agg gtg cat gct gaa gag gag titc. tca aat

680

Trp Lys Gly Arg Val Lys Arg Val His Ala Glu Glu Glu Phe Ser Asn
545

550

555

560

gtt gat at a got gct gag goa citg to a aca gog gtc att gala gat titt

728

Val Asp Ile Ala Ala Glu Ala Leu Ser Thr Ala Val Ile Glu Asp Phe
565

570

575

citg cca att att toa aga gta aaa tot gtg atg toc toa aat gga agt

776
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Leu Pro Ile Ile Ser Arg Val Lys Ser Val Met Ser Ser Asn Gly Ser
58O

585

59 O

tog aag gga gala atc agt tat goa aaa gag cat gaa tot gtt togg titt

1824

Ser Lys Gly Glu Ile Ser Tyr Ala Lys Glu His Glu Ser Val Trp Phe
595

600

605

aaa ggg agg cqa titc aca cca aat gtg togg gcc aac act cot ggit gala

1872

Lys Gly Arg Arg Phe Thr Pro Asn Val Trp Ala Asn Thr Pro Gly Glu
610

615

62O

cita cag ata aag caa ttg aag cott gca att gac toa aaa ggit aga aag

1920

Leu Glin Ile Lys Glin Leu Lys Pro Ala Ile Asp Ser Lys Gly Arg Lys
625

630

635

640

gto gga gaa gala togg titc acc act atc aaa gtt gag aat got tta acc

1968

Val Gly Glu Glu Trp Phe Thir Thr Ile Llys Val Glu Asn Ala Leu Thr
645

650

655

agg tac cat gala gct tot gat aat gca aaa cqt aaa gtt citt gag ttg

2016

Arg Tyr His Glu Ala Cys Asp Asn Ala Lys Arg Lys Wall Leu Glu Lieu
660

665

67 O

ttg aga gga citt toa agt gala ttg cag gac aag attaat gtc. citt gtc

2O64

Leu Arg Gly Lieu Ser Ser Glu Lieu Glin Asp Lys Ile Asn. Wall Leu Val
675

680

685

titt toc to a acg atg citc atc ata aca aaa goa citt titt ggit cat gtt

2112

Phe Cys Ser Thr Met Leu Ile Ile Thr Lys Ala Leu Phe Gly His Val
69 O.

695

7 OO

agt gala gga cqa aga agg ggit togg gtg citt cott act ata tot coc ttg

216 O

Ser Glu Gly Arg Arg Arg Gly Trp Val Leu Pro Thr Ile Ser Pro Leu
705

710

715

720

tgt aag gat aat gtt aca gag gala atc. tca agt gaa atg gala ttg to a

2208

Cys Lys Asp Asin Val Thr Glu Glu Ile Ser Ser Glu Met Glu Lieu Ser
725

730

735

gga act titt cot tac togg citt gat act aac caa gogg aat goa at a citg

2256

Gly Thr Phe Pro Tyr Trp Leu Asp Thr Asn Gln Gly Asn Ala Ile Leu
740

745

750

aat gat gtc cat atg cac tot ttg titt att citt act ggit coa aac ggit

23O4.

Asn Asp Val His Met His Ser Leu Phe Ile Leu Thr Gly Pro Asn Gly
755

760

765

ggit ggit aaa toc agt atg citg aga to a gtc. tot gct gct gca tta citt

2352

Gly Gly Lys Ser Ser Met Leu Arg Ser Val Cys Ala Ala Ala Lieu Lieu
770

775

78O

gga at a tot ggc citg atg gtg cca gct gct tca gct gtc atc cca cat

24 OO

Gly Ile Cys Gly Leu Met Val Pro Ala Ala Ser Ala Val Ile Pro His
785

790

795

8OO

titc gat toc atc atg citg cat at g aaa goa tat gat agc cca gct gat

2448

Phe Asp Ser Ile Met Lieu. His Met Lys Ala Tyr Asp Ser Pro Ala Asp
805

810

815

ggit aaa agt to g titt cag att gala at g to a gag ata cqa tot tta gtc

2496

Gly Lys Ser Ser Phe Glin Ile Glu Met Ser Glu Ile Arg Ser Leu Val
820

825

83O

tgc cqa gct aca gct agg agt citt gtt cita att gat gaa at a tot agg

2544

Cys Arg Ala Thr Ala Arg Ser Lieu Val Lieu. Ile Asp Glu Ile Cys Arg
835

840

845

ggc aca gala aca gca aaa gqa aca tot at a got got agc atc att gala

2592

Gly Thr Glu Thr Ala Lys Gly Thr Cys Ile Ala Gly Ser Ile Ile Glu
85 O

855

860

aga citc gat aat gtt goc toc at a ggc atc ata tota act cat ttg cat

264 O

Arg Lieu. Asp Asn Val Gly Cys Ile Gly Ile Ile Ser Thr His Lieu. His
865

870

875

88O

ggc att titt gac citt coa citg to a citc. cac aat act gat ttcaaa got

2688
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Gly Ile Phe Asp Leu Pro Leu Ser Lieu. His Asn. Thr Asp Phe Lys Ala
885

890

895

atg gga acc gala atc atc gat agg toc att cag cca aca tog aaa tta

2736

Met Gly Thr Glu Ile Ile Asp Arg Cys Ile Gln Pro Thr Trp Llys Leu
9 OO

905

910

atg gat ggc atc tdt aga gag agt citt got titt caa aca goc agg aaa

2784

Met Asp Gly Ile Cys Arg Glu Ser Lieu Ala Phe Glin Thr Ala Arg Lys
915

920

925

gala ggt at g cct gac ttgata att aga aga got gag gaa cita tat ttg

2832

Glu Gly Met Pro Asp Lieu. Ile Ile Arg Arg Ala Glu Glu Lieu. Tyr Lieu
930

935

940

gct at g agc aca aac agc aag cat aca to a to a gct gtc. cac cat gala

2880

Ala Met Ser Thr Asn Ser Lys His Thr Ser Ser Ala Val His His Glu
945

950

955

96.O

ata toc at a goc aac tot act gta aat agc titg gtt gag aag cott aat

292.8

Ile Ser Ile Ala Asn Ser Thr Val Asn Ser Leu Val Glu Lys Pro Asn
965

970

975

tac citg aga aat gga cita gag citt caa tot ggit toc titc gga tta cita

2976

Tyr Lieu Arg Asn Gly Lieu Glu Lieu Glin Ser Gly Ser Phe Gly Lieu Lieu
98O

985

aga aaa gaa att gag agt gtt gtt

99 O

acc aca at a toc aag

aag aaa citg

3024

Arg Lys Glu Ile Glu Ser Val Val Thir Thr Ile Cys Lys Lys Lys Lieu
995

ttg gat

10 OO

citc tac aac aaa agg

1005

agc atc. tca gaa citg

att gag gtg

3 O 69

Leu Asp Leu Tyr Asn Lys Arg Ser Ile Ser Glu Lieu. Ile Glu Val
O 10

gto tdt

O15

gtt gct gtg ggit gct

O20

agg gag caa ccc cca

cott toa act

3114

Val Cys Val Ala Val Gly Ala Arg Glu Gln Pro Pro Pro Ser Thr
O25

gtt ggc

O3O

agg toc agc att tat

O35

gta att atc aga C gt

gac agc aag

31.59

Val Gly Arg Ser Ser Ile Tyr Val Ile Ile Arg Arg Asp Ser Lys
O40

citc tat

O45

att goa cag acg gat

O5 O

gat citt gtg g g t c ga

citt agit gct

3204

Leu Tyr Ile Gly Glin Thr Asp Asp Leu Val Gly Arg Lieu Ser Ala
O55

cac aga.

O60

tcg aag gala ggt at g

O65

cag gait gcc acg ata

tta tat att

3249

His Arg Ser Lys Glu Gly Met Glin Asp Ala Thir Ile Leu Tyr Ile
OFO

ttg gta

O75

cott gogg aag agc att

O8O

goa toc caa citg gaa

act citt citc

3294.

Leu Val Pro Gly Lys Ser Ile Ala Cys Glin Lieu Glu Thir Lieu Lieu
O85

ata aat

O9 O

cag cita cct ttg aaa

O95

ggt ttcaag citc atc

aac aag goa

3339

Ile Asin Glin Leu Pro Leu Lys Gly Phe Lys Lieu. Ile Asn Lys Ala
1 OO

gat ggc

105

aag cat cqa aat titc

110

ggt at a tot citt gto

coa gga gag

3384

Asp Gly Lys His Arg Asn. Phe Gly Ile Ser Lieu Val Pro Gly Glu
115

gca att

120

125

gcc gca

Ala Ile Ala Ala
130

<210> SEQ ID NO 22
<211& LENGTH: 1132
&212> TYPE PRT

<213> ORGANISM: Oryza sativa
<400

SEQUENCE: 22

Met Ala Ile Glin Arg Lieu Lleu Ala Ser Ser Lieu Val Ala Ala Thr Pro

3396
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1

5

10

15

Arg Trp Lieu Pro Wall Ala Ala Asp Ser Phe Leu Arg Arg Arg His Arg
2O

25

30

Pro Arg Cys Ser Pro Leu Pro Ala Lieu Lleu Phe Asn Arg Arg Ser Trp
35

40

45

Ser Lys Pro Arg Lys Val Ser Arg Ser Ile Ser Ile Val Ser Arg Lys
50

55

60

Met Asn Lys Glin Gly Asp Lieu. Cys Asn. Glu Gly Met Leu Pro His Ile
65

70

75

8O

Leu Trp Trp Lys Glu Lys Met Glu Arg Cys Arg Lys Pro Ser Ser Met
85

90

95

Glin Lieu. Thr Glin Arg Lieu Val Tyr Ser Asn. Ile Leu Gly Lieu. Asp Pro
100

105

110

Thr Lieu Arg Asn Gly Ser Lieu Lys Asp Gly Ser Lieu. Asn Thr Glu Met
115

120

125

Leu Glin Phe Lys Ser Lys Phe Pro Arg Glu Val Lieu Lieu. Cys Arg Val
130

135

140

Gly Asp Phe Tyr Glu Ala Val Gly Phe Asp Ala Cys Ile Leu Val Glu
145

15 O

155

160

His Ala Gly Lieu. Asn Pro Phe Gly Gly Lieu Arg Ser Asp Ser Ile Pro
1.65

170

175

Lys Ala Gly Cys Pro Val Met Asn Leu Arg Gln Thr Lieu. Asp Asp Leu
18O

185

19 O

Thr Arg Cys Gly Tyr Ser Val Cys Ile Val Glu Glu Ile Glin Gly Pro
195

200

2O5

Thr Glin Ala Arg Ala Arg Lys Gly Arg Phe Ile Ser Gly His Ala His
210

215

220

Pro Gly Ser Pro Tyr Val Phe Gly Leu Ala Glu Val Asp His Asp Val
225

230

235

240

Glu Phe Pro Asp Pro Met Pro Val Val Gly Ile Ser Arg Ser Ala Lys
245

250

255

Gly Tyr Cys Leu Ile Ser Val Leu Glu Thr Met Lys Thr Tyr Ser Ala
260

265

27 O

Glu Glu Gly Lieu. Thr Glu Glu Ala Val Val Thr Lys Lieu Arg Ile Cys
275

280

285

Arg Tyr His His Leu Tyr Lieu. His Ser Ser Lieu Arg Asn. Asn. Ser Ser
29 O

295

3OO

Gly. Thir Ser Arg Trp Gly Glu Phe Gly Glu Gly Gly Lieu Lleu Trp Gly
305

310

315

320

Glu Cys Ser Gly Lys Ser Phe Glu Trp Phe Asp Gly Asn Pro Ile Glu
325

330

335

Glu Lieu Lieu. Cys Lys Val Arg Glu Ile Tyr Gly Lieu Glu Glu Lys Thr
340

345

35 O

Val Phe Arg Asn Val Ser Val Ser Leu Glu Gly Arg Pro Gln Pro Leu
355

360

365

Tyr Leu Gly Thr Ala Thr Glin Ile Gly Val Ile Pro Thr Glu Gly Ile
370

375

38O

Pro Ser Leu Leu Lys Ile Val Leu Pro Pro Asn Phe Gly Gly Leu Pro
385

390

395

400

Ser Leu Tyr Ile Arg Asp Lieu Lleu Lieu. Asn Pro Pro Ser Phe Asp Wall
405

410

415
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Ala Ser Ser Val Glin Glu Ala Cys Arg Leu Met Gly Ser Ile Thr Cys
420

425

43 O

Ser Ile Pro Glu Phe Thr Cys Ile Pro Ala Ala Lys Lieu Val Lys Lieu
435

4 40

4 45

Leu Glu Ser Lys Glu Val Asn His Ile Glu Phe Cys Arg Ile Lys Asn
450

455

460

Val Lieu. Asp Glu Val Lieu Phe Met Gly Ser Asn Ala Glu Lieu Ser Ala
465

470

475

480

Ile Lieu. Asn Lys Lieu Lleu. Asp Pro Ala Ala Ile Val Thr Gly Phe Lys
485

490

495

Val Glu Ala Asp Ile Lieu Val Asn. Glu Cys Ser Phe Ile Ser Glin Arg
5 OO

Ile Ala

505

51O.

Val Ile Ser Leu Gly Gly Glu Ser Asp Glin Ala Ile Thr
52O

525

Ser Ser Glu Tyr Ile Pro Lys Glu Phe Phe Asn Gly Met Glu Ser Ser
530

535

540

Trp Lys Gly Arg Val Lys Arg Val His Ala Glu Glu Glu Phe Ser Asn
545

550

555

560

Val Asp Ile Ala Ala Glu Ala Leu Ser Thr Ala Val Ile Glu Asp Phe
565

570

575

Leu Pro Ile Ile Ser Arg Val Lys Ser Val Met Ser Ser Asn Gly Ser
58O

585

59 O

Ser Lys Gly Glu Ile Ser Tyr Ala Lys Glu His Glu Ser Val Trp Phe
595

600

605

Lys Gly Arg Arg Phe Thr Pro Asn Val Trp Ala Asn Thr Pro Gly Glu
610

615

62O

Leu Glin Ile Lys Glin Leu Lys Pro Ala Ile Asp Ser Lys Gly Arg Lys
625

630

635

640

Val Gly Glu Glu Trp Phe Thir Thr Ile Llys Val Glu Asn Ala Leu Thr
645

650

655

Arg Tyr His Glu Ala Cys Asp Asn Ala Lys Arg Lys Wall Leu Glu Lieu
660

665

67 O

Leu Arg Gly Lieu Ser Ser Glu Lieu Glin Asp Lys Ile Asn. Wall Leu Val
675

680

685

Phe Cys Ser Thr Met Leu Ile Ile Thr Lys Ala Leu Phe Gly His Val
69 O.

695

7 OO

Ser Glu Gly Arg Arg Arg Gly Trp Val Leu Pro Thr Ile Ser Pro Leu
705

710

715

720

Cys Lys Asp Asin Val Thr Glu Glu Ile Ser Ser Glu Met Glu Lieu Ser
725

730

735

Gly Thr Phe Pro Tyr Trp Leu Asp Thr Asn Gln Gly Asn Ala Ile Leu
740

745

750

Asn Asp Val His Met His Ser Leu Phe Ile Leu Thr Gly Pro Asn Gly
755

760

765

Gly Gly Lys Ser Ser Met Leu Arg Ser Val Cys Ala Ala Ala Lieu Lieu
770

775

78O

Gly Ile Cys Gly Leu Met Val Pro Ala Ala Ser Ala Val Ile Pro His
785

790

795

8OO

Phe Asp Ser Ile Met Lieu. His Met Lys Ala Tyr Asp Ser Pro Ala Asp
805

810

815
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Gly Lys Ser Ser Phe Glin Ile Glu Met Ser Glu Ile Arg Ser Leu Val
820

825

83O

Cys Arg Ala Thr Ala Arg Ser Lieu Val Lieu. Ile Asp Glu Ile Cys Arg
835

840

845

Gly Thr Glu Thr Ala Lys Gly Thr Cys Ile Ala Gly Ser Ile Ile Glu
85 O

855

860

Arg Lieu. Asp Asn Val Gly Cys Ile Gly Ile Ile Ser Thr His Lieu. His
865

870

875

88O

Gly Ile Phe Asp Leu Pro Leu Ser Lieu. His Asn. Thr Asp Phe Lys Ala
885

890

895

Met Gly Thr Glu Ile Ile Asp Arg Cys Ile Gln Pro Thr Trp Llys Leu
9 OO

905

910

Met Asp Gly Ile Cys Arg Glu Ser Lieu Ala Phe Glin Thr Ala Arg Lys
915

920

925

Glu Gly Met Pro Asp Lieu. Ile Ile Arg Arg Ala Glu Glu Lieu. Tyr Lieu
930

935

940

Ala Met Ser Thr Asn Ser Lys His Thr Ser Ser Ala Val His His Glu
945

950

955

96.O

Ile Ser Ile Ala Asn Ser Thr Val Asn Ser Leu Val Glu Lys Pro Asn
965

970

975

Tyr Lieu Arg Asn Gly Lieu Glu Lieu Glin Ser Gly Ser Phe Gly Lieu Lieu
98O

985

99 O

Arg Lys Glu Ile Glu Ser Val Val Thir Thr Ile Cys Lys Lys Lys Lieu
995

10 OO

1005

Leu Asp Leu Tyr Asn Lys Arg Ser Ile Ser Glu Lieu. Ile Glu Val
O 10

O15

O20

Val Cys Val Ala Val Gly Ala Arg Glu Gln Pro Pro Pro Ser Thr
Val Gly Arg Ser Ser Ile Tyr Val Ile Ile Arg Arg Asp Ser Lys
Leu Tyr Ile Gly Glin Thr Asp Asp Leu Val Gly Arg Lieu Ser Ala

His Arg Ser Lys Glu Gly Met Glin Asp Ala Thir Ile Leu Tyr Ile
Leu Val Pro Gly Lys Ser Ile Ala Cys Glin Lieu Glu Thir Lieu Lieu
Ile Asin Glin Leu Pro Leu Lys Gly Phe Lys Lieu. Ile Asn Lys Ala

Asp Gly Lys His Arg Asn. Phe Gly Ile Ser Lieu Val Pro Gly Glu
115

Ala Ile

120

125

Ala Ala

<210> SEQ ID NO 23
&2 11s LENGTH 433
&212> TYPE DNA

<213> ORGANISM: Sorghum bicolor
<400

SEQUENCE: 23

aaggaaggca togcaggatgc tacgatatta tacatcttgg titcctggcaa gag.cgttgcc

60

tgc.ca.gctgg aaaccottct cataaatcag citt cottcga ggggcttcaa got catcaac

120

aagg cagacg gaaag catag gaactitcggt atatoto gaa totctggaga ggcaatcgc.c

18O
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acco agctaa actaatcago taaagatcta atttagttag tottgacgct agtgagt citc

240

attittgcatc citt catctot tittgcttittg gctactcaat aggaggcagg alacta actoga

3OO

caccatatgc cqc cocaatt ttgtgagatgaattatcagt ggtgctaccc ttgttgcatag

360

taggggccita ggggg.cgatc titcc cittgtc. taagcatgta gtacggtgca aatgattagc

420

aatgcaatga cac

433

<210> SEQ ID NO 24
&2 11s LENGTH 64
&212> TYPE PRT

<213> ORGANISM: Sorghum bicolor
<400

SEQUENCE: 24

Lys Glu Gly Met Glin Asp Ala Thir Ile Leu Tyr Ile Lieu Val Pro Gly
1

5

10

15

Lys Ser Val Ala Cys Glin Leu Glu Thir Lieu Lieu. Ile Asn Glin Leu Pro
2O

25

30

Ser Arg Gly Phe Lys Lieu. Ile Asn Lys Ala Asp Gly Lys His Arg Asn
35

40

45

Phe Gly Ile Ser Arg Ile Ser Gly Glu Ala Ile Ala Thr Glin Lieu. Asn
50

55

60

<210> SEQ ID NO 25
&2 11s LENGTH 667
&212> TYPE DNA

<213> ORGANISM: Sorghum bicolor
<400

SEQUENCE: 25

tggtaaatct actatottgc gatcagtctg tdcagottcg citgcttggaa tatgtggcct

60

gatggtacct tcaactitcag citgtaatc.cc gcattttgat to cattatgc tigcatatgaa

120

agccitacgat agcc.ca.gc.cg atgggaaaag titcatttcag attgaaatgt c ggagatacg

18O

tgctittagtc agcc.gagcta citgctaggag tottgtc.ctg attggtgaaa tatgtagggg

240

cacagaaact gcaaaaggaa cct gtattgc tiggtag catc atcgaaaggc tiggataatgt

3OO

tggctgccta ggcatcatat caacticacct gcatgggatt tittgacttgc citctotcact

360

cago actact gatttcaaag citatgggaac talagtogto gacgggtgca ttcatccaac

420

atggaaactg atggatggca totgtagaga aagccittgct tittcaaacag coaggaggga

480

agg catgcct gagttcataa totagaagggc tigaggagcta tatttgacta toagtacaaa

540

taacaa.gcag accgcatcaa togg to cacaa tagcct cqt aatgacago C ccagtgtaaa

600

tggcttggitt gagaa.gc.ctd aatat citgaa atacaggcta gaaattctgc citggtacctt

660

tgagcc.g

667

<210> SEQ ID NO 26
<211& LENGTH 222
&212> TYPE PRT

<213> ORGANISM: Sorghum bicolor
<400

SEQUENCE: 26

Gly Lys Ser Thr Met Leu Arg Ser Val Cys Ala Ala Ser Lieu Lieu Gly
1

5

10

15

Ile Cys Gly Leu Met Val Pro Ser Thr Ser Ala Val Ile Pro His Phe
2O

25

30
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Asp Ser Ile Met Lieu. His Met Lys Ala Tyr Asp Ser Pro Ala Asp Gly
35

40

45

Lys Ser Ser Phe Glin Ile Glu Met Ser Glu Ile Arg Ala Leu Val Ser
50

55

60

Arg Ala Thr Ala Arg Ser Lieu Val Lieu. Ile Gly Glu Ile Cys Arg Gly
65

70

75

8O

Thr Glu Thr Ala Lys Gly. Thir Cys Ile Ala Gly Ser Ile Ile Glu Arg
85

90

95

Leu Asp Asn Val Gly Cys Lieu Gly Ile Ile Ser Thr His Lieu. His Gly
100

105

110

Ile Phe Asp Leu Pro Leu Ser Leu Ser Thr Thr Asp Phe Lys Ala Met
115

120

125

Gly Thr Glu Val Val Asp Gly Cys Ile His Pro Thr Trp Llys Leu Met
130

135

140

Asp Gly Ile Cys Arg Glu Ser Lieu Ala Phe Glin Thr Ala Arg Arg Glu
145

15 O

155

160

Gly Met Pro Glu Phe Ile Ile Arg Arg Ala Glu Glu Leu Tyr Leu Thr
1.65

170

175

Met Ser Thr Asn Asn Lys Gln Thr Ala Ser Met Val His Asn Glu Pro
18O

185

19 O

Arg Asn Asp Ser Pro Ser Val Asn Gly Lieu Val Glu Lys Pro Glu Tyr
195

200

2O5

Leu Lys Tyr Arg Leu Glu Ile Leu Pro Gly Thr Phe Glu Pro
210

<210

215

220

SEQ ID NO 27

&2 11s LENGTH 351
&212> TYPE DNA

<213> ORGANISM: Glycine max
&220s FEATURE

<221 NAME/KEY: misc feature
<222> LOCATION: (89).. (91)

<223> OTHER INFORMATION: n is a c, g, or t
<400

SEQUENCE: 27

ggaaatattt tottacaatc ttgttacago aag galacaca aaaatttaat agtgttgatct

60

ttgacatgtc titccatataa agtcagtcnn inctitttgcac caagttaggc ccaaatttitt

120

toatcaaaga aatagaaaag aatgagaaag tacaaac cac aagaatticcg cct caaggat

18O

gtatgcaaaa ataagtaatg atattggcaa gtacgaagct tcgtaacaac togcttcttct

240

gtoaa.gcaat cittcagaaga atatgtc.ttc atggtotcta gtaccatatt aatgcaataa

3OO

cc cctogcag aatgagatat toc tactaca ggcattggitt citgccitcgtg c

351

<210> SEQ ID NO 28
&2 11s LENGTH 4O6
&212> TYPE DNA

<213> ORGANISM: Glycine max
<400

SEQUENCE: 28

ggaatticggc acgaggctga gct caatgaa atattgaaac atttaatcga gcc cacatgg

60

gtggcaactg g gttagaaat tdactittgaa accittggttg caggatgtga gatc.gcatct

120

agtaagattg gtgaaatagt atctotggat gatgagaatg atcagaaaat caactic gttc

18O

tottttatto citcacgaatt ttittgaggat atggagticta aatggaaagg to gaataaaa

240
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gctggtagcc citygagagga acaaattaaa cagcttaggc atgctittaga ttctaaaggt

1920

agaaaggtag g g gaggaatg gtttaccaca ccalaaggtog aggctgcatt aacaaggtac

1980

catgaa.gcaa atgcca aggc aaaagaaaga gttittggaaa ttitta agggg acticgctgct

20 40

gagttgcaat acagtataaa cattcttgtc titttctitcca tattgcttgt tattgccaaa

2100

gctittatttg citcatgcaag tdaagggaga agaaggagat gggtotttcc cacgcttgta

216 O

gaatcc catg g gtttgagga tigtgaagttca ttggacaaaa cccatgggat galagataagt

2220

ggitttattgc catattggitt coacatagoa galaggtottg togcgtaatga tigttgatatg

228O

caatcatt at ttctgttgac agg accgaat ggtggtogga aatcaagttt tottagg to a

234. O

atttgtgctg. citgcactact toggatatgt ggact catgg titcctgcaga atcagcc cta

24 OO

attccittatt ttgacticcat cacgcttcat atgaagttcat atgatagtcc agctgataaa

2460

aagagttcct titcaggttga aatgtcagaa citt.cgatcca to attgg.cgg aacaaccaac

252O

aggagccttg tacttgttga tigaaatatgc cqaggaacag aaactgcaaa agg gacittgc

258O

attgctggta gcatcattga aaccottgat ggaattgggt gtctgggitat totaticcact

264 O

cacttgcatg gaatatttac tittgc.cccita aacaaaaaaa acactgtgca caaag caatg

27 OO

ggcacaa.cat coattgatgg acaaataatg cctacatgga agttgacaga tiggagtttgt

276 O.

aaagaaagtc. ttgcttittga aacggctaag agggaaggaa titcct gag ca tattgttaga

282O

agagctgaat atctittatca gttggtttat gctaaggaaa togctttittgc agaaaattitc

2880

ccaaatgaag aaaagttt to tacct gcatc aatgttaata atttgaatgg alacacatctt

2.940

cattcaaaaa gottccitatc aggagctaat caaatggaag titttacgcga ggaagttgag

3OOO

agagctgtca citgtgatttg ccaggatcat ataaagg acc taaaatgcaa aaagattgca

3060

ttggagctta citgagataaa atgtc.tcata attggtacaa gogagctacc accitc catcg

312 O

gttgtaggitt cittcaag.cgt citatgtgatg titcagaccag ataagaaact citatgtagga

318O

gag act gatg atcto gaggg acgggtocga agacatc gat taaaggaagg aatgcatgat

324 O

gcatcattcc tittattittct totcc.caggit aaaagcttgg catgccaatt tdaatctotg

33OO

citcatcaa.cc aactittctgg toaaggottc caactgagca atatagotga tiggtaaacat

3360

aggaattittg gcactitccaa cct gtataca taa

3393

<210

SEQ ID NO 30

&2 11s LENGTH 3393
&212> TYPE DNA

<213> ORGANISM: Glycine max
&220s FEATURE

<221 NAME/KEY: CDS
<222> LOCATION: (1) . . (3393)
<400

SEQUENCE: 30

atg tac agg gta gcc aca aga aac gtc goc gtt titc titc cct cqt togc

48

Met Tyr Arg Val Ala Thr Arg Asn Val Ala Val Phe Phe Pro Arg Cys
1

5

10

15

tgttcc citc gog cac tac act cot tot cta titt coc att titc act tca

96

Cys Ser Leu Ala His Tyr Thr Pro Ser Leu Phe Pro Ile Phe Thr Ser
2O

25

30

titc gct coc to t c gt titc citt aga ata aat gga tigt gta aag aat gtg

Phe Ala Pro Ser Arg Phe Leu Arg Ile Asin Gly Cys Wall Lys Asn. Wal
35

40

45

144
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tog agt tat acg gat aag aag gtt to a agg ggg agt agt agg gcc acc

192

Ser Ser Tyr Thr Asp Lys Lys Val Ser Arg Gly Ser Ser Arg Ala Thr
50

55

60

aag aag coc aaa ata cca aat aac gtt tta gat gat aaa gac citt cot

240

Lys Llys Pro Lys Ile Pro Asn. Asn Val Lieu. Asp Asp Lys Asp Leu Pro
65

70

75

8O

cac at a citg tog tog aag gag agg ttg caa atg togc aga aag titt to a

288

His Ile Leu Trp Trp Lys Glu Arg Lieu Gln Met Cys Arg Llys Phe Ser
85

90

95

act gtc. cag tta att gaa aga citt gala ttt tot aat ttg citt ggc citg

336

Thr Val Glin Lieu. Ile Glu Arg Lieu Glu Phe Ser Asn Lieu Lieu Gly Lieu
100

105

110

aat to c aac titg aaa aat gga agt citg aag gaa goa aca citc aac togg

384

Asn Ser Asn Lieu Lys Asn Gly Ser Lieu Lys Glu Gly. Thir Lieu. Asn Trp
115

120

125

gala atg ttg caa titc aag toa aaa titt coa cqt caa gta ttg citt togc

432

Glu Met Leu Glin Phe Lys Ser Lys Phe Pro Arg Glin Val Lieu Lieu. Cys
130

135

140

aga gtt ggg gala titc tat gaa got togg gga ata gat gct tot att citt

480

Arg Val Gly Glu Phe Tyr Glu Ala Trp Gly Ile Asp Ala Cys Ile Leu
145

15 O

155

160

gtt gala tat gt g g gt tta aat coc att ggt ggit citg cqa to a gat agt

528

Val Glu Tyr Val Gly Lieu. Asn. Pro Ile Gly Gly Lieu Arg Ser Asp Ser
1.65

170

175

atc coa aga gct agt tdt CCt gtc gtgaat Ctt Cagg cag act tta gat

576

Ile Pro Arg Ala Ser Cys Pro Val Val Asn Lieu Arg Glin Thr Lieu. Asp
18O

185

19 O

gat citg aca aca aat ggit tat to a gtg togc att gtg gag gag got cag

624

Asp Leu Thir Thr Asn Gly Tyr Ser Val Cys Ile Val Glu Glu Ala Glin
195

200

2O5

ggc cca agt caa got cqa toc agg aaa cqt cqc titt ata tot ggg cat

672

Gly Pro Ser Glin Ala Arg Ser Arg Lys Arg Arg Phe Ile Ser Gly. His
210

215

220

gct cat cott gga aat coc tat gta tat gga citt gct aca gtt gat cat

720

Ala His Pro Gly Asn Pro Tyr Val Tyr Gly Leu Ala Thr Val Asp His
225

230

235

240

gat citt aac titt coa gaa cca at g cct gta gta gga ata tot cat tot

768

Asp Leu Asin Phe Pro Glu Pro Met Pro Val Val Gly Ile Ser His Ser
245

250

255

gc g agg ggit tat tdc attaat at g gta cita gag acc atg aag aca tat

816

Ala Arg Gly Tyr Cys Ile Asn Met Val Leu Glu Thr Met Lys Thr Tyr
260

265

27 O

tot tot gala gat togc titg aca gaa gaa goa gtt gtt acg aag citt cqt

864

Ser Ser Glu Asp Cys Lieu. Thr Glu Glu Ala Val Val Thr Lys Lieu Arg
275

280

285

act tcc caa tat cat tac tta ttt ttg cat aca toc titg agg cqg aat

912

Thr Cys Glin Tyr His Tyr Leu Phe Leu. His Thr Ser Leu Arg Arg Asn
29 O

295

3OO

tot togt gga acc toc aac togg gga gaa titt ggit gag gga ggg cita tta

96.O

Ser Cys Gly. Thir Cys Asn Trp Gly Glu Phe Gly Glu Gly Gly Lieu Lieu
305

310

315

320

tgg gga gaa tot agt tot aga cat titt gait togg titt gat ggc aac cot

1008

Trp Gly Glu Cys Ser Ser Arg His Phe Asp Trp Phe Asp Gly Asn Pro
325

330

335

gto tcc gat citt ttg gcc aag gta aag gaa citt tat agt att gat gat

Val Ser Asp Leu Lleu Ala Lys Wall Lys Glu Lieu. Tyr Ser Ile Asp Asp
340

345

35 O

1056
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gag gtt acc titt cqg aac aca act gtg tot to a gga cat agg gct cqa

104

Glu Val Thr Phe Arg Asn. Thir Thr Val Ser Ser Gly His Arg Ala Arg
355

360

365

cca tta act citt goa aca tot act caa att ggit gcc att coa aca gaa

152

Pro Leu Thir Leu Gly Thr Ser Thr Glin Ile Gly Ala Ile Pro Thr Glu
370

375

38O

gga at a cott tot ttg titg aag gtt tta citt coa toa aat toc aat gga

200

Gly Ile Pro Ser Lieu Lleu Lys Val Lieu Lleu Pro Ser Asn. Cys Asn Gly
385

390

395

400

tta coa gta ttg tac ata agg gaa citt citt ttgaat cot cot to a tat

248

Leu Pro Wall Leu Tyr Ile Arg Glu Lieu Lleu Lieu. Asn Pro Pro Ser Tyr
405

410

415

gag att goa toc aaa att caa goa aca toc aaa citt atg agc agt gta

296

Glu Ile Ala Ser Lys Ile Glin Ala Thr Cys Lys Lieu Met Ser Ser Val
420

425

43 O

acg tdt to a att coa gaa titt aca tot gtt tog to a gca aag citt gta

344

Thr Cys Ser Ile Pro Glu Phe Thr Cys Val Ser Ser Ala Lys Leu Val
435

4 40

4 45

aag cita citt gala togg agg gag gttcaat cat atg gaa ttt tot aga ata

392

Lys Lieu Lieu Glu Trp Arg Glu Val Asn His Met Glu Phe Cys Arg Ile
450

455

460

aag aat gta citg gat gaa att ttg cag atg tat agt acc tot gag citc

4 40

Lys Asn. Wall Leu Asp Glu Ile Leu Gln Met Tyr Ser Thr Ser Glu Lieu
465

470

475

480

aat gaa at a ttg aaa Cat tta atc gag coc aca togg gtg gCa act ggg

488

Asn Glu Ile Leu Lys His Leu Ile Glu Pro Thir Trp Val Ala Thr Gly
485

490

495

tta gaa att gac titt gala acc ttg gtt go a gga tigt gag atc gca tot

536

Leu Glu Ile Asp Phe Glu Thir Lieu Val Ala Gly Cys Glu Ile Ala Ser
5 OO

505

51O.

agt aag att ggit gaa ata gta tot citg gat gat gag aat gat cag aaa

584

Ser Lys Ile Gly Glu Ile Val Ser Lieu. Asp Asp Glu Asn Asp Glin Lys
515

52O

525

atc aac tog titc. tct titt att cot cac gaa ttt titt gag gat atg gag

632

Ile Asin Ser Phe Ser Phe Ile Pro His Glu Phe Phe Glu Asp Met Glu
530

535

540

tot aaa tog aaa got cqa ata aaa aga atc. cac ata gat gat gta titc

680

Ser Lys Trp Lys Gly Arg Ile Lys Arg Ile His Ile Asp Asp Val Phe
545

550

555

560

act gca gtg gala aaa goa gct gag goc tta cat ata gca gtc act gala

728

Thr Ala Val Glu Lys Ala Ala Glu Ala Lieu. His Ile Ala Val Thr Glu
565

570

575

gat titt gtt cot gtt gtt tot aga ata aag got att gta goc cot citc

776

Asp Phe Val Pro Val Val Ser Arg Ile Lys Ala Ile Val Ala Pro Leu
58O

585

59 O

gga ggit cott aag gga gaa ata tot tat got cqg gag caa gaa go a gtt

824

Gly Gly Pro Lys Gly Glu Ile Ser Tyr Ala Arg Glu Glin Glu Ala Wal
595

600

605

tgg ttcaaa ggc aaa cqc titt aca cog aat ttg togg gct ggit agc cct

872

Trp Phe Lys Gly Lys Arg Phe Thr Pro Asn Leu Trp Ala Gly Ser Pro
610

615

62O

gga gag gaa caa att aaa cag citt agg cat gct tta gat tot aaa ggit

920

Gly Glu Glu Glin Ile Lys Glin Leu Arg His Ala Lieu. Asp Ser Lys Gly
625

630

635

640

aga aag gta ggg gag gala tag titt acc aca Cca aag gtC gag gCt gCa

Arg Llys Val Gly Glu Glu Trp Phe Thr Thr Pro Lys Val Glu Ala Ala
645

650

655

968

US 2004/0210962 A1

Oct. 21, 2004
84

-continued
cca aat gala gala aag titt tot acc toc atc aat gtt aat aat ttgaat

Pro Asn. Glu Glu Lys Phe Ser Thr Cys Ile Asn. Wall Asn. Asn
965

970

292.8

Lieu. Asn

975

gga aca cat citt cat toa aaa agg titc cta tota gga gct aat caa atg

2976

Gly Thr His Lieu. His Ser Lys Arg Phe Leu Ser Gly Ala Asn Glin Met
98O

985

gala gtt tta cqc gag gaa gtt gag

99 O

aga gct gtc act gtg

att togc cag

3024

Glu Val Leu Arg Glu Glu Val Glu Arg Ala Val Thr Val Ile Cys Glin
995

gat cat

10 OO

ata aag gac cita aaa

1005

toc aaa aag att gca

ttg gag citt

Asp His Ile Lys Asp Leu Lys Cys Lys Lys Ile Ala Lieu
O 10

act gag

O15

ata aaa tot citc ata

O20

att ggit aca agg gag

cita

cca cost
Pro Pro

3114

titc aga cca

31.59

Thr Glu Ile Lys Cys Lieu. Ile Ile Gly Thr Arg Glu Lieu
O25

cca to g

O3O

gtt gta ggit tot to a

3 O 69

Glu Lieu

O35

agc gtc. tat gtg atg

Pro Ser Val Val Gly Ser Ser Ser Val Tyr Val Met Phe Arg Pro
O40

gat aag

O45

aaa citc tat gta gga

O5 O

gag act gat gat citc

gag gga C gg

3204

Asp Llys Lys Lieu. Tyr Val Gly Glu Thir Asp Asp Leu Glu Gly Arg
O55

gto cqa

O60

aga cat cqa tta aag

O65

gca

toa titc.

Val Arg Arg His Arg Lieu Lys Glu Gly Met His Asp Ala

Ser Phe

OFO

gala gga atg cat gat

O75

Ctt tat titt Ctt gtc. cca ggit aaa agc titg gca togc caa titt gaa
Leu Tyr Phe Leu Val Pro Gly Lys Ser Lieu Ala Cys Glin Phe Glu
O85

tot citg

O9 O

aat at a

citc atc aac caa citt tot ggit caa ggc titc
105

gct gat ggit aaa cat

caa citg agc

tat aca

agg aat titt goc act

tcc aac citg

120

3384

Asn Lieu

125
3393

tala

Tyr Thr
130

<210> SEQ ID NO 31
&2 11s LENGTH 1130
&212> TYPE PRT

<213> ORGANISM: Glycine max
<400

3339

Teu Ser

110

Asn. Ile Ala Asp Gly Lys His Arg Asn. Phe Gly Thr Ser
115

3294.

O95

Ser Lieu Lieu. Ile Asn Gln Leu Ser Gly Glin Gly Phe Glin
1 OO

3249

O8O

SEQUENCE: 31

Met Tyr Arg Val Ala Thr Arg Asn Val Ala Val Phe Phe Pro Arg Cys
1

5

10

15

Cys Ser Leu Ala His Tyr Thr Pro Ser Leu Phe Pro Ile Phe
2O

25

Phe Ala Pro Ser Arg Phe Leu Arg Ile Asin Gly Cys Wall Lys
35

40

55

Ala Thr

60

Lys Llys Pro Lys Ile Pro Asn. Asn Val Lieu. Asp Asp Lys Asp
65

Asn Wall

45

Ser Ser Tyr Thr Asp Lys Lys Val Ser Arg Gly Ser Ser Arg
50

Thir Ser

30

70

75

8O

His Ile Leu Trp Trp Lys Glu Arg Lieu Gln Met Cys Arg Lys
85

Leu Pro

90

Phe Ser
95

Thr Val Glin Lieu. Ile Glu Arg Lieu Glu Phe Ser Asn Lieu Lieu Gly Lieu
100

105

110
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Asn Ser Asn Lieu Lys Asn Gly Ser Lieu Lys Glu Gly. Thir Lieu. Asn Trp
115

120

125

Glu Met Leu Glin Phe Lys Ser Lys Phe Pro Arg Glin Val Lieu Lieu. Cys
130

135

140

Arg Val Gly Glu Phe Tyr Glu Ala Trp Gly Ile Asp Ala Cys Ile Leu
145

15 O

155

160

Val Glu Tyr Val Gly Lieu. Asn. Pro Ile Gly Gly Lieu Arg Ser Asp Ser
1.65

170

175

Ile Pro Arg Ala Ser Cys Pro Val Val Asn Lieu Arg Glin Thr Lieu. Asp
18O

185

19 O

Asp Leu Thir Thr Asn Gly Tyr Ser Val Cys Ile Val Glu Glu Ala Glin
195

200

2O5

Gly Pro Ser Glin Ala Arg Ser Arg Lys Arg Arg Phe Ile Ser Gly. His
210

215

220

Ala His Pro Gly Asn Pro Tyr Val Tyr Gly Leu Ala Thr Val Asp His
225

230

235

240

Asp Leu Asin Phe Pro Glu Pro Met Pro Val Val Gly Ile Ser His Ser
245

250

255

Ala Arg Gly Tyr Cys Ile Asn Met Val Leu Glu Thr Met Lys Thr Tyr
260

265

27 O

Ser Ser Glu Asp Cys Lieu. Thr Glu Glu Ala Val Val Thr Lys Lieu Arg
275

280

285

Thr Cys Glin Tyr His Tyr Leu Phe Leu. His Thr Ser Leu Arg Arg Asn
29 O

295

3OO

Ser Cys Gly. Thir Cys Asn Trp Gly Glu Phe Gly Glu Gly Gly Lieu Lieu
305

310

315

320

Trp Gly Glu Cys Ser Ser Arg His Phe Asp Trp Phe Asp Gly Asn Pro
325

330

335

Val Ser Asp Leu Lleu Ala Lys Wall Lys Glu Lieu. Tyr Ser Ile Asp Asp
340

345

35 O

Glu Val Thr Phe Arg Asn. Thir Thr Val Ser Ser Gly His Arg Ala Arg
355

360

365

Pro Leu Thir Leu Gly Thr Ser Thr Glin Ile Gly Ala Ile Pro Thr Glu
370

375

38O

Gly Ile Pro Ser Lieu Lleu Lys Val Lieu Lleu Pro Ser Asn. Cys Asn Gly
385

390

395

400

Leu Pro Wall Leu Tyr Ile Arg Glu Lieu Lleu Lieu. Asn Pro Pro Ser Tyr
405

410

415

Glu Ile Ala Ser Lys Ile Glin Ala Thr Cys Lys Lieu Met Ser Ser Val
420

425

43 O

Thr Cys Ser Ile Pro Glu Phe Thr Cys Val Ser Ser Ala Lys Leu Val
435

4 40

4 45

Lys Lieu Lieu Glu Trp Arg Glu Val Asn His Met Glu Phe Cys Arg Ile
450

455

460

Lys Asn. Wall Leu Asp Glu Ile Leu Gln Met Tyr Ser Thr Ser Glu Lieu
465

470

475

480

Asn Glu Ile Leu Lys His Leu Ile Glu Pro Thir Trp Val Ala Thr Gly
485

490

495

Leu Glu Ile Asp Phe Glu Thir Lieu Val Ala Gly Cys Glu Ile Ala Ser
5 OO

505

51O.

US 2004/0210962 A1

Oct. 21, 2004
86

-continued
Ser Lys Ile Gly Glu Ile Val Ser Lieu. Asp Asp Glu Asn Asp Glin Lys
515

52O

525

Ile Asin Ser Phe Ser Phe Ile Pro His Glu Phe Phe Glu Asp Met Glu
530

535

540

Ser Lys Trp Lys Gly Arg Ile Lys Arg Ile His Ile Asp Asp Val Phe
545

550

555

560

Thr Ala Val Glu Lys Ala Ala Glu Ala Lieu. His Ile Ala Val Thr Glu
565

570

575

Asp Phe Val Pro Val Val Ser Arg Ile Lys Ala Ile Val Ala Pro Leu
58O

585

59 O

Gly Gly Pro Lys Gly Glu Ile Ser Tyr Ala Arg Glu Glin Glu Ala Wal
595

600

605

Trp Phe Lys Gly Lys Arg Phe Thr Pro Asn Leu Trp Ala Gly Ser Pro
610

615

62O

Gly Glu Glu Glin Ile Lys Glin Leu Arg His Ala Lieu. Asp Ser Lys Gly
625

630

635

640

Arg Llys Val Gly Glu Glu Trp Phe Thr Thr Pro Lys Val Glu Ala Ala
645

650

655

Lieu. Thir Arg Tyr His Glu Ala Asn Ala Lys Ala Lys Glu Arg Val Lieu
660

665

67 O

Glu Ile Leu Arg Gly Lieu Ala Ala Glu Lieu Glin Tyr Ser Ile Asn. Ile
675

680

685

Leu Val Phe Ser Ser Met Leu Lieu Val Ile Ala Lys Ala Lieu Phe Ala
69 O.

695

7 OO

His Ala Ser Glu Gly Arg Arg Arg Arg Trp Val Phe Pro Thr Leu Val
705

710

715

720

Glu Ser His Gly Phe Glu Asp Wall Lys Ser Lieu. Asp Lys Thr His Gly
725

730

735

Met Lys Ile Ser Gly Leu Leu Pro Tyr Trp Phe His Ile Ala Glu Gly
740

745

750

Val Val Arg Asn Asp Wall Asp Met Glin Ser Lieu Phe Leu Lieu. Thr Gly
755

760

765

Pro Asn Gly Gly Gly Lys Ser Ser Phe Leu Arg Ser Ile Cys Ala Ala
770

775

78O

Ala Lieu Lieu Gly Ile Cys Gly Lieu Met Val Pro Ala Glu Ser Ala Lieu
785

790

795

8OO

Ile Pro Tyr Phe Asp Ser Ile Thr Leu. His Met Lys Ser Tyr Asp Ser
805

810

815

Pro Ala Asp Llys Lys Ser Ser Phe Glin Val Glu Met Ser Glu Lieu Arg
820

825

83O

Ser Ile Ile Gly Gly Thr Thr Asn Arg Ser Lieu Val Lieu Val Asp Glu
835

840

845

Ile Cys Arg Gly Thr Glu Thr Ala Lys Gly. Thir Cys Ile Ala Gly Ser
85 O

855

860

Ile Ile Glu Thir Lieu. Asp Gly Ile Gly Cys Lieu Gly Ile Val Ser Thr
865

870

875

88O

His Lieu. His Gly Ile Phe Thr Lieu Pro Leu Asn Lys Lys Asn Thr Val
885

890

895

His Lys Ala Met Gly Thr Thr Ser Ile Asp Gly Glin Ile Met Pro Thr
9 OO

905

910

Trp Llys Lieu. Thir Asp Gly Val Cys Lys Glu Ser Leu Ala Phe Glu Thr
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915

920

925

Ala Lys Arg Glu Gly Ile Pro Glu His Ile Val Arg Arg Ala Glu Tyr
930

935

940

Leu Tyr Glin Leu Val Tyr Ala Lys Glu Met Leu Phe Ala Glu Asn. Phe
945

950

955

96.O

Pro Asn. Glu Glu Lys Phe Ser Thr Cys Ile Asn. Wall Asn. Asn Lieu. Asn
965

970

975

Gly Thr His Lieu. His Ser Lys Arg Phe Leu Ser Gly Ala Asn Gln Met
98O

985

99 O

Glu Val Leu Arg Glu Glu Val Glu Arg Ala Val Thr Val Ile Cys Glin
995

10 OO

1005

Asp His Ile Lys Asp Leu Lys Cys Lys Lys Ile Ala Leu Glu Lieu
O 10

O15

O20

Thr Glu Ile Lys Cys Leu Ile Ile Gly Thr Arg Glu Leu Pro Pro
O25

O3O

O35

Pro Ser Val Val Gly Ser Ser Ser Val Tyr Val Met Phe Arg Pro
O40

O45

O5 O

Asp Llys Lys Lieu. Tyr Val Gly Glu Thir Asp Asp Leu Glu Gly Arg

Val Arg Arg His Arg Lieu Lys Glu Gly Met His Asp Ala Ser Phe
Leu Tyr Phe Leu Val Pro Gly Lys Ser Leu Ala Cys Glin Phe Glu
Ser Lieu Lieu. Ile Asn Gln Leu Ser Gly Glin Gly Phe Glin Leu Ser
1 OO

105

110

Asn. Ile Ala Asp Gly Lys His Arg Asn. Phe Gly Thr Ser Asn Lieu
115

120

125

Tyr Thr
130

<210> SEQ ID NO 32
&2 11s LENGTH 757
&212> TYPE DNA

<213> ORGANISM: Saccharum officinarum
&220s FEATURE

<221 NAME/KEY: misc feature
<222> LOCATION: (512) . . (512)

<223> OTHER INFORMATION: n is a c, g, or t
<400

SEQUENCE: 32

cc.gc.ctcitct cq.cccc.ccac titcccacgcc ccacgcc.gcc toccattcca gttccagogit

60

ggacgcgacg ccggcgcgga gacgcggcgt citcgaag cac tag coccct g ttgttctitcc

120

gc gcc.ggcgc gcc.ggcgc.ca tocaccgggit gctcgtgagc ticgctcqtgg cc.gc.cacgc.c

18O

gc ggtggcto coccitc.gc.cg acticcatcct coggc gcc.gc cqc cogc gct gct coccitct

240

toccatgctg. citatto gacc ggagg acttg gttccaagcca aggaaggtot cac gagg cat

3OO

ttcagtggca totaggaaag citaacaaaca gggagaatat tdtgatgaaa goatgctato

360

toatat catg togtggaaag agaaaatgga gaagtgcaga aaaccatcat citgtacagtt

420

gacticagagg cittgttgtatt cqaatatatt agg gttggat cogaatttaa gaaatggaag

480

cittgaaagat ggalacc ct ga acatggagat timtgctattt aaatcaaaat titccitcqtga

540

ggttct actt togcagaaa.ca toc aggotta aattctottt gagggttgc gttctgacag

600
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aatticcitaaa gotgggtgtc. cago.cggaat ttacggagac attggatgag ttgactic gat

660

gtgg gaattic totgtgcaaa gtgaagaaat tacaggc.cga cccaag.ccct gcc.ccggaaa

720

gtogattaat totggg catg cccatcctgg agcc.cta

757

<210

SEQ ID NO 33

&2 11s LENGTH 139
&212> TYPE PRT

<213> ORGANISM: Saccharum officinarum
&220s FEATURE

<221 NAME/KEY: misc feature
<222> LOCATION: (125) . . (125)

<223> OTHER INFORMATION: Xaa can be any naturally occurring amino acid
<400

SEQUENCE: 33

Met His Arg Val Leu Val Ser Ser Leu Val Ala Ala Thr Pro Arg Trp
1

5

10

15

Leu Pro Leu Ala Asp Ser Ile Leu Arg Arg Arg Arg Pro Arg Cys Ser
2O

25

30

Pro Leu Pro Met Leu Lleu Phe Asp Arg Arg Thr Trp Ser Lys Pro Arg
35

40

45

Lys Val Ser Arg Gly Ile Ser Val Ala Ser Arg Lys Ala Asn Lys Glin
50

55

60

Gly Glu Tyr Cys Asp Glu Ser Met Leu Ser His Ile Met Trp Trp Lys
65

70

75

8O

Glu Lys Met Glu Lys Cys Arg Llys Pro Ser Ser Val Glin Lieu. Thr Glin
85

90

95

Arg Lieu Val Tyr Ser Asn. Ile Leu Gly Lieu. Asp Pro Asn Lieu Arg Asn
100

105

110

Gly Ser Lieu Lys Asp Gly. Thir Lieu. Asn Met Glu Ile Xaa Lieu Phe Lys
115

120

125

Ser Lys Phe Pro Arg Glu Val Lieu Lieu. Cys Arg
130

135

<210> SEQ ID NO 34
&2 11s LENGTH 504
&212> TYPE DNA

<213> ORGANISM: Saccharum officinarum

<400

SEQUENCE: 34

cacgtacctg. tcc toga attc ccc gaccgac ccatgcgtga gaacaagctt taattaaaac

60

atacctaagt atcttctggg gtc.gc.cittca cqc coacaga ggggaggaag goatgcaaga

120

tgctaccacc ctatacatct toggttcctgg caagagc gtt gcc toccago tagaaaccot

18O

totcataaat cagottccitt citgagggctt Caagctdatc aacaaggtag acggaaag.ca

240

taggaact to ggtatattitc gaatctotgg agaggcaatt gctactcaac taalactaatc

3OO

acgtgaagat citaatttago tag acgacac tagtgagtct cattttggct act caatagg

360

aggcaggagc taactgacac catgcc.gc.cc caatattgtt gaactgatag cqgagctago

420

cittgaccata atacggg cat citttittcticg totaatgatg tagtacaatig caaatgatta

480

gcaatgcaat gacactic gtt gtgc

504

<210

SEQ ID NO 35

&2 11s LENGTH 72
&212> TYPE PRT

<213> ORGANISM: Saccharum officinarum
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-continued
SEQUENCE: 35

Gly Arg Lieu. His Ala His Arg Gly Glu Glu Gly Met Glin Asp
1

5

10

Thr Leu Tyr Ile Leu Val Pro Gly Lys Ser Val Ala Cys Glin
2O

25

Leu Glu

30

Thr Lieu Lieu. Ile Asn Gln Leu Pro Ser Glu Gly Phe Lys Lieu
35

Ala Thr
15

40

Ile Asn

45

Lys Val Asp Gly Lys His Arg Asn. Phe Gly Ile Phe Arg Ile Ser Gly
50

55

60

Glu Ala Ile Ala Thr Glin Lieu. Asn
65
70

SEQ ID NO 36
LENGTH
TYPE

671
DNA

ORGANISM: Nicotiana tabacum.
<400 SEQUENCE: 36

aacaattctt agccttctat gcttcagttt gtaaatgcta citgttgagat ttitttgttgt

60

citatttacag citggtoaagt togcttgagtt gagggaggca aatcatgtag agttctgcaa

120

aataaagaat gtgg to gatgaaatactgca gatgtacaga aattcagagc titcgtgctat

18O

tittagagtca gCtgatggat CCtacttggg toggcaa.ccgg gttaaaagtc gattittgata

240

citctagtgaa togaatgtggg gagatttctg gtagaatcag tgaaataata totgtacatg
gtgaaagtga toaaaagata agticcictato citatcatccc aaatgattitt tittgaagata

360

tggagtc.gcc atggaaaggit cqtgtcaaga ggatc cattt ggaggaagca tatgcagaag

420

taga caaggc tigcagatgct ttatctttgg citgtgagtct

cittitt tattit atcttcaa.ca

480

atcc taatga tttacaagtt gtgcatctgt gtgcgctitta

a tact cittitc

attagctaag

540

atatacattt gct gtaaagg cagtcagott ttcaacgtoc agtaaaagct ttittgataaa

600

to cagtaata ttatctagga atttactgat cqatgaacaa ttittggggta atcgatagac

660

aaataaacaa g

671

SEQ ID NO 37
LENGTH
TYPE

488
DNA

ORGANISM: Lycopersicon esculentum
<400 SEQUENCE: 37

gtttggtgaa gotggactitt totggggaga atgtaatgct aga Cagc agg aatggttgga

60

tggcaatcct atc gatgagc titttgttcaa gqtaaaagag citttatggto totaatgatga

120

cattcc attc agaaatgtca citgttgtttc agaaaatagg ccc.cgtoctit tacaccittgg

18O

aact gccaca caaattggtg citattocaac cqaagggatt ccatgtttgt taaaggtgtt

240

gctitccitcct cattgcagtg gtctaccagt cotgtatatt agg gatcttic

ttittaaatcc.

accacccitat gagatttctt Cagacattca agagg catgc agacittatoga tgagtgtcac

360

atgttcaatt cotgattitta cotgtattitc atctgcaaag citggtoaa.gc tgcttgagtt

420

gagggaggca aatcacgttg agttctgcaa aataaagagc atggtogaag agatact gca

480

gttgtata

488
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gag cqg aag titt titt gcc aca acg goa aaa aaa citc aaa caa coa aaa

192

Glu Arg Llys Phe Phe Ala Thir Thr Ala Lys Lys Lieu Lys Glin Pro Lys
50

55

60

agt att coa gag gala aaa gac tat gtt aat att atg togg tog aaa gag

240

Ser Ile Pro Glu Glu Lys Asp Tyr Val Asn. Ile Met Trp Trp Lys Glu
65

70

75

8O

aga at g gala titc titg aga aag cott tot to C got citt citg got aag agg

288

Arg Met Glu Phe Leu Arg Lys Pro Ser Ser Ala Lieu Lleu Ala Lys Arg
85

90

95

citt aca tat tdt aac ttg citg ggt gtg gat cog agt titg aga aat gga

336

Lieu. Thir Tyr Cys Asn Lieu Lleu Gly Val Asp Pro Ser Lieu Arg Asn Gly
100

105

110

agt citt aaa gag gga aca citt aac to g gag atg ttg cag titc aag to a

384

Ser Lieu Lys Glu Gly Thr Lieu. Asn. Ser Glu Met Leu Glin Phe Lys Ser
115

120

125

aaa titt coa cqt gaa gtt ttg ctic tot aga gta ggit gat ttt tat gala

432

Lys Phe Pro Arg Glu Val Lieu Lieu. Cys Arg Val Gly Asp Phe Tyr Glu
130

135

140

gct att gga titc gat gct tot att citt gtg gaa tat gct ggit tta aat

480

Ala Ile Gly Phe Asp Ala Cys Ile Leu Val Glu Tyr Ala Gly Lieu. Asn
145

15 O

55

160

cca titt ggt ggc citg cac to a gat agt at a coa aaa got ggit tot coa

528

Pro Phe Gly Gly Lieu. His Ser Asp Ser Ile Pro Lys Ala Gly Cys Pro
1.65

170

175

gtt gtgaat cita aga cag acg citt gat gat citc aca C gt aat ggt titc

576

Val Val Asn Lieu Arg Glin Thr Lieu. Asp Asp Lieu. Thr Arg Asn Gly Phe
18O

185

19 O

tot gtg to C gttc gtg gag gala gtt cag ggit coa act caa got cqt gct

624

Ser Val Cys Val Val Glu Glu Val Glin Gly Pro Thr Glin Ala Arg Ala
195

200

2O5

cgt aag agt cqa titt ata to a ggg cat go a cat coa ggc agt coc tat

672

Arg Lys Ser Arg Phe Ile Ser Gly His Ala His Pro Gly Ser Pro Tyr
210

215

220

gtt titt ggc citt gtt gna gat gat caa gat citt gat titt coa gaa coa

720

Val Phe Gly Lieu Val Xaa Asp Asp Glin Asp Lieu. Asp Phe Pro Glu Pro
225

230

235

240

atg cct gtt gtt goa ata toc cqt to a gog aag ggg tat toc att atc

768

Met Pro Val Val Gly Ile Ser Arg Ser Ala Lys Gly Tyr Cys Ile Ile
245

250

255

tot gtt tac gag act atg aag act tac tot gtg gaa gat ggc cta act

816

Ser Val Tyr Glu Thr Met Lys Thr Tyr Ser Val Glu Asp Gly Leu Thr
260

265

27 O

gala gaa goc gta gtc. acc aaa citt cqt act tot cqa toc cat cat titt

864

Glu Glu Ala Val Val Thr Lys Leu Arg Thr Cys Arg Cys His His Phe
275

280

285

titt ttg cat aat to a titg aag aac aat toc to a gga aca to g c gt tog

912

Phe Lieu. His Asn. Ser Lieu Lys Asn. Asn. Ser Ser Gly Thr Ser Arg Trp
29 O

295

3OO

gga gag titt ggit gaa got goa citt ttg togg gga gaa tot aat gct aga

96.O

Gly Glu Phe Gly Glu Gly Gly Lieu Lleu Trp Gly Glu Cys Asn Ala Arg
305

310

315

320

cag cag gala tog titg gat ggc aat cot atc gat gag citt ttg ttcaag

1008

Glin Glin Glu Trp Lieu. Asp Gly Asn Pro Ile Asp Glu Lieu Lleu Phe Lys
325

330

335

gta aaa gag citt tat ggit citc aat gat gac att coa titc aga aat gtc

Wall Lys Glu Lieu. Tyr Gly Lieu. Asn Asp Asp Ile Pro Phe Arg Asn Val
340

345

35 O

1056
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act gtt gtt to a gaa aat agg ccc cqt cott tta cac citt gga act gcc

104

Thr Val Val Ser Glu Asn Arg Pro Arg Pro Leu. His Leu Gly Thr Ala
355

360

365

aca caa att ggit gct att coa acc gala ggg att coa tot ttg tta aag

152

Thr Glin Ile Gly Ala Ile Pro Thr Glu Gly Ile Pro Cys Leu Leu Lys
370

375

38O

gtg ttg citt cot cott cat tdc agt ggit cita coa gtc. citg tat att agg

200

Val Leu Leu Pro Pro His Cys Ser Gly Leu Pro Val Leu Tyr Ile Arg
385

390

395

400

gat citt citt tta aat coa coa goc tat gag att tot to a gac ata caa

248

Asp Leu Lleu Lieu. Asn Pro Pro Ala Tyr Glu Ile Ser Ser Asp Ile Glin
405

410

415

gag goa toc aga citt atg atg agt gtc. aca tot toa att cot gat titt

296

Glu Ala Cys Arg Leu Met Met Ser Val Thr Cys Ser Ile Pro Asp Phe
420

425

43 O

acc tot att to a tot gca aag ct g g to aag citg citt gag titg agg gag

344

Thr Cys Ile Ser Ser Ala Lys Lieu Val Lys Lieu Lleu Glu Lieu Arg Glu
435

4 40

4 45

gca aat cac gtt gag titc toc aaa ata aag agc atg gtc. gala gag ata

392

Ala Asn His Val Glu Phe Cys Lys Ile Lys Ser Met Val Glu Glu Ile
450

455

460

citg cag ttg tat aga aat to a gag citt cqt gct atw gta gag tta citg

4 40

Leu Gln Leu Tyr Arg Asn. Ser Glu Lieu Arg Ala Xaa Val Glu Lieu Lieu
465

470

475

480

atg gat cott act togg gtg gca act ggg ttg aaa gtt gat titt gat aca

488

Met Asp Pro Thr Trp Val Ala Thr Gly Leu Lys Val Asp Phe Asp Thr
485

490

495

cita gta aat gala tot goa aag att tot togt aga atc agt gala ata ata

536

Leu Val Asn. Glu Cys Gly Lys Ile Ser Cys Arg Ile Ser Glu Ile Ile
5 OO

505

51O.

to C gta cat ggit gala aat gat caa aag att agt toc tat cot atc atc

584

Ser Val His Gly Glu Asn Asp Gln Lys Ile Ser Ser Tyr Pro Ile Ile
515

52O

525

cca aat gat titc titt gaa gat at g gag ttg ttg tog aaa ggc cqt gtc

632

Pro Asn Asp Phe Phe Glu Asp Met Glu Lieu Lleu Trp Lys Gly Arg Val
530

535

540

aag agg atc cat ttg gag gaa goa tat go a gaa gta gaa aag got gog

680

Lys Arg Ile His Leu Glu Glu Ala Tyr Ala Glu Val Glu Lys Ala Ala
545

550

555

560

gat got tta tot tta gcc ata aca gaa gat titc cta cct att att to a

728

Asp Ala Leu Ser Leu Ala Ile Thr Glu Asp Phe Leu Pro Ile Ile Ser
565

570

575

aga ata agg gcc acg atg gcc cca citt gga gga act aaa ggg gag att

776

Arg Ile Arg Ala Thr Met Ala Pro Leu Gly Gly Thr Lys Gly Glu Ile
58O

585

59 O

ttg tat goc cqt gag cat gga got gta tog titt aag gga aag aga titt

824

Leu Tyr Ala Arg Glu His Gly Ala Val Trp Phe Lys Gly Lys Arg Phe
595

600

605

gta coa act gtt togg gct gga acc gct gga gaa gaa caa att aag caa

872

Val Pro Thr Val Trp Ala Gly. Thr Ala Gly Glu Glu Glin Ile Lys Glin
610

615

62O

citc aga cct gct cita gat toa aag ggg aag aag gtt goa gaa gaa togg

920

Leu Arg Pro Ala Lieu. Asp Ser Lys Gly Lys Lys Val Gly Glu Glu Trp
625

630

635

640

titc act aca at g agg gtg gala gat gca at a got agg tat cac gag goa

Phe Thr Thr Met Arg Val Glu Asp Ala Ile Ala Arg Tyr His Glu Ala
645

650

655

968

